Warning message:
package 'XML' was built under R version 3.3.2 
Warning message:
package 'ggplot2' was built under R version 3.3.2 
Warning message:
package 'data.table' was built under R version 3.3.2 
Warning message:
package 'caret' was built under R version 3.3.2 
Warning message:
package 'coda' was built under R version 3.3.2 
Warning message:
package 'ggbeeswarm' was built under R version 3.3.2 
Examine metabolic pathways/genes
mkdir: output/: File exists
Logging in
Please upgrade to the latest version of the Synapse Client, 1.14-3, by running the following commands:
	source('http://depot.sagebase.org/CRAN.R')
	pkgInstall("synapseClient")

Here are this version's release notes:
https://sagebionetworks.jira.com/issues/?jql=project%20%3D%20SYNR%20AND%20fixVersion%20in%20(R-1.14-0%2C%20R-1.14-1%2C%20R-1.14-2%2C%20R-1.14-3)%20ORDER%20BY%20key%20DESC



Welcome brian.white!
Logged in
Reading clinical data
Reading CMS results
Read 83 records
Read 5691 items
12345678910111213141516171819202122232425262728293031323334353637383940414243444546474849505152535455565758596061626364656667686970717273747576777879808182831
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
Reading bindea
Reading CIRC signature
Reading TCIA Neoantigens
Reading TCGA data
Reading KFS data
doaffy reading file: /Users/Brian/work/sage/middleton/input/KFSYSCC_frma_expression.tsv
Read 73.2% of 54675 rowsRead 54675 rows and 323 (of 323) columns from 0.277 GB file in 00:00:03
[1] 0.04382975
Doing TCGA analysis
Number of rows analyzed: 20294
Number of columns analyzed: 344
tcga-all: 49 of 49 genes from data set analyzed in set Glutathione: G6PD GCLC GCLM GGCT GGT1 GGT5 GGT6 GGT7 GPX1 GPX2 GPX3 GPX4 GPX5 GPX6 GPX7 GSR GSS GSTA1 GSTA2 GSTA3 GSTA4 GSTA5 GSTK1 GSTM1 GSTM2 GSTM3 GSTM4 GSTM5 GSTO1 GSTO2 GSTP1 GSTT1 GSTT2 GSTZ1 IDH1 IDH2 LAP3 MGST1 MGST2 MGST3 ODC1 OPLAH PGD RRM1 RRM2 RRM2B SMS SRM TXNDC12
tcga-all: 26 of 27 genes from data set analyzed in set Glutamine: CRYL1 DCXR DHDH GUSB LOC729020 RPE UGDH UGP2 UGT1A1 UGT1A10 UGT1A3 UGT1A4 UGT1A5 UGT1A6 UGT1A7 UGT1A8 UGT1A9 UGT2A1 UGT2A3 UGT2B10 UGT2B11 UGT2B15 UGT2B28 UGT2B4 UGT2B7 XYLB
tcga-all: 1 of 27 genes missing from data set analyzed in set Glutamine: UGT2B17
Estimating GSVA scores for 26 gene sets.
Computing observed enrichment scores
Estimating ECDFs in microarray data with Gaussian kernels
Using parallel with 1 cores
  |                                                                              |                                                                      |   0%  |                                                                              |===                                                                   |   4%  |                                                                              |=====                                                                 |   8%  |                                                                              |========                                                              |  12%  |                                                                              |===========                                                           |  15%  |                                                                              |=============                                                         |  19%  |                                                                              |================                                                      |  23%  |                                                                              |===================                                                   |  27%  |                                                                              |======================                                                |  31%  |                                                                              |========================                                              |  35%  |                                                                              |===========================                                           |  38%  |                                                                              |==============================                                        |  42%  |                                                                              |================================                                      |  46%  |                                                                              |===================================                                   |  50%  |                                                                              |======================================                                |  54%  |                                                                              |========================================                              |  58%  |                                                                              |===========================================                           |  62%  |                                                                              |==============================================                        |  65%  |                                                                              |================================================                      |  69%  |                                                                              |===================================================                   |  73%  |                                                                              |======================================================                |  77%  |                                                                              |=========================================================             |  81%  |                                                                              |===========================================================           |  85%  |                                                                              |==============================================================        |  88%  |                                                                              |=================================================================     |  92%  |                                                                              |===================================================================   |  96%  |                                                                              |======================================================================| 100%
Done with gsva.
tcga-all wnt vs CIRC: t = -7.66668942196379 df = 342 nrow = 344 cor = -0.3829621607261 pval = 1.84617074915233e-13
tcga-all tak1 vs CIRC: t = -1.90764957903146 df = 342 nrow = 344 cor = -0.102609400758207 pval = 0.0572738736909823
tcga-all wnt vs myc.sig: t = 29.5867669875905 df = 342 nrow = 344 cor = 0.847978818740452 pval = 2.60927229013165e-96

tcga-all: Analyzing Glutathione vs KRAS using Wilcoxon rank sum test with continuity correction: W = 13679, n_WT = 219, n_MT = 125, p = 0.992805043475444
tcga-all: Analyzing Glutamine vs KRAS using Wilcoxon rank sum test with continuity correction: W = 12631, n_WT = 219, n_MT = 125, p = 0.233916121227267
tcga-all: Analyzing HK2 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 12720, n_WT = 219, n_MT = 125, p = 0.27570873534618
tcga-all: Analyzing LDHA vs KRAS using Wilcoxon rank sum test with continuity correction: W = 13838, n_WT = 219, n_MT = 125, p = 0.865732787805684
tcga-all: Analyzing MGLL vs KRAS using Wilcoxon rank sum test with continuity correction: W = 10922, n_WT = 219, n_MT = 125, p = 0.00182869122406527
tcga-all: Analyzing ANGPTL4 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 15177, n_WT = 219, n_MT = 125, p = 0.0932665960030798
tcga-all: Analyzing VEGFA vs KRAS using Wilcoxon rank sum test with continuity correction: W = 13459, n_WT = 219, n_MT = 125, p = 0.797176153078799
tcga-all: Analyzing ACSL5 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 13640, n_WT = 219, n_MT = 125, p = 0.957748823198076
tcga-all: Analyzing PCK2 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 14211, n_WT = 219, n_MT = 125, p = 0.555505984706517
tcga-all: Analyzing LPCAT4 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 12728, n_WT = 219, n_MT = 125, p = 0.279700518562223
tcga-all: Analyzing SLCO1B3 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 11948.5, n_WT = 219, n_MT = 125, p = 0.0500269821325581

tcga-all: Analyzing Glutathione CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 3160, n_CMS2 = 136, n_CMS1 = 51, p = 0.3509080023731
tcga-all: Analyzing Glutamine CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1952, n_CMS2 = 136, n_CMS1 = 51, p = 4.27778338644534e-06
tcga-all: Analyzing HK2 CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 4740, n_CMS2 = 136, n_CMS1 = 51, p = 0.000114687638558307
tcga-all: Analyzing LDHA CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 4680, n_CMS2 = 136, n_CMS1 = 51, p = 0.000237666339046479
tcga-all: Analyzing MGLL CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 2793, n_CMS2 = 136, n_CMS1 = 51, p = 0.0407408539446423
tcga-all: Analyzing ANGPTL4 CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 5717, n_CMS2 = 136, n_CMS1 = 51, p = 9.03891874010153e-12
tcga-all: Analyzing VEGFA CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 2921, n_CMS2 = 136, n_CMS1 = 51, p = 0.0973461365117863
tcga-all: Analyzing ACSL5 CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 680, n_CMS2 = 136, n_CMS1 = 51, p = 2.76379871029315e-17
tcga-all: Analyzing PCK2 CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 2493, n_CMS2 = 136, n_CMS1 = 51, p = 0.0031141940378644
tcga-all: Analyzing LPCAT4 CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 5339, n_CMS2 = 136, n_CMS1 = 51, p = 1.39229535781998e-08
tcga-all: Analyzing SLCO1B3 CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 4529.5, n_CMS2 = 136, n_CMS1 = 51, p = 0.00128653111213644
tcga-all: Analyzing Glutathione CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2828, n_CMS2 = 136, n_CMS3 = 42, p = 0.924941359361169
tcga-all: Analyzing Glutamine CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2148, n_CMS2 = 136, n_CMS3 = 42, p = 0.0153591391244068
tcga-all: Analyzing HK2 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1995, n_CMS2 = 136, n_CMS3 = 42, p = 0.00319883393575102
tcga-all: Analyzing LDHA CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2513, n_CMS2 = 136, n_CMS3 = 42, p = 0.240652223363293
tcga-all: Analyzing MGLL CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1427, n_CMS2 = 136, n_CMS3 = 42, p = 9.88844876066129e-07
tcga-all: Analyzing ANGPTL4 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2402, n_CMS2 = 136, n_CMS3 = 42, p = 0.12027295448586
tcga-all: Analyzing VEGFA CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 3635, n_CMS2 = 136, n_CMS3 = 42, p = 0.00765238279873538
tcga-all: Analyzing ACSL5 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 3857, n_CMS2 = 136, n_CMS3 = 42, p = 0.000608995671761657
tcga-all: Analyzing PCK2 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2606, n_CMS2 = 136, n_CMS3 = 42, p = 0.392687985056824
tcga-all: Analyzing LPCAT4 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1055, n_CMS2 = 136, n_CMS3 = 42, p = 6.90426805279502e-10
tcga-all: Analyzing SLCO1B3 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2108, n_CMS2 = 136, n_CMS3 = 42, p = 0.010439870393915
tcga-all: Analyzing Glutathione CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 8658, n_CMS2 = 136, n_CMS4 = 87, p = 5.42915535078127e-09
tcga-all: Analyzing Glutamine CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 8626, n_CMS2 = 136, n_CMS4 = 87, p = 8.14820636098855e-09
tcga-all: Analyzing HK2 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 7040, n_CMS2 = 136, n_CMS4 = 87, p = 0.0168199360088738
tcga-all: Analyzing LDHA CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 6493, n_CMS2 = 136, n_CMS4 = 87, p = 0.219936982290017
tcga-all: Analyzing MGLL CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 5434, n_CMS2 = 136, n_CMS4 = 87, p = 0.305574824082429
tcga-all: Analyzing ANGPTL4 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 2324, n_CMS2 = 136, n_CMS4 = 87, p = 2.13686996065978e-14
tcga-all: Analyzing VEGFA CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 7113, n_CMS2 = 136, n_CMS4 = 87, p = 0.0108980127058298
tcga-all: Analyzing ACSL5 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 9044, n_CMS2 = 136, n_CMS4 = 87, p = 2.83690165611255e-11
tcga-all: Analyzing PCK2 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 6684, n_CMS2 = 136, n_CMS4 = 87, p = 0.102445484730002
tcga-all: Analyzing LPCAT4 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 6659, n_CMS2 = 136, n_CMS4 = 87, p = 0.114126109487349
tcga-all: Analyzing SLCO1B3 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 5602.5, n_CMS2 = 136, n_CMS4 = 87, p = 0.505384146097691


tcga-all: Analyzing Glutathione CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 217, n_CMS2 = 41, n_CMS1 = 12, p = 0.54950421731813
tcga-all: Analyzing Glutamine CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 90, n_CMS2 = 41, n_CMS1 = 12, p = 0.000559899244015074
tcga-all: Analyzing HK2 CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 253, n_CMS2 = 41, n_CMS1 = 12, p = 0.891588086469456
tcga-all: Analyzing LDHA CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 366, n_CMS2 = 41, n_CMS1 = 12, p = 0.00977254663815796
tcga-all: Analyzing MGLL CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 127, n_CMS2 = 41, n_CMS1 = 12, p = 0.0104462176088574
tcga-all: Analyzing ANGPTL4 CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 425, n_CMS2 = 41, n_CMS1 = 12, p = 4.97008627052545e-05
tcga-all: Analyzing VEGFA CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 209, n_CMS2 = 41, n_CMS1 = 12, p = 0.442908010094174
tcga-all: Analyzing ACSL5 CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 31, n_CMS2 = 41, n_CMS1 = 12, p = 2.19848978999018e-07
tcga-all: Analyzing PCK2 CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 190, n_CMS2 = 41, n_CMS1 = 12, p = 0.241679226051556
tcga-all: Analyzing LPCAT4 CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 373, n_CMS2 = 41, n_CMS1 = 12, p = 0.00602196214436271
tcga-all: Analyzing SLCO1B3 CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test with continuity correction: W = 280, n_CMS2 = 41, n_CMS1 = 12, p = 0.476453582233946
tcga-all: Analyzing Glutathione CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 552, n_CMS2 = 41, n_CMS3 = 28, p = 0.794123373135232
tcga-all: Analyzing Glutamine CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 416, n_CMS2 = 41, n_CMS3 = 28, p = 0.0538725707268066
tcga-all: Analyzing HK2 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 423, n_CMS2 = 41, n_CMS3 = 28, p = 0.0656555433556854
tcga-all: Analyzing LDHA CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 499, n_CMS2 = 41, n_CMS3 = 28, p = 0.365032964893459
tcga-all: Analyzing MGLL CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 292, n_CMS2 = 41, n_CMS3 = 28, p = 0.000435103001953079
tcga-all: Analyzing ANGPTL4 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 458, n_CMS2 = 41, n_CMS3 = 28, p = 0.159106383601962
tcga-all: Analyzing VEGFA CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 810, n_CMS2 = 41, n_CMS3 = 28, p = 0.00355214636925408
tcga-all: Analyzing ACSL5 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 786, n_CMS2 = 41, n_CMS3 = 28, p = 0.00911523839794177
tcga-all: Analyzing PCK2 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 445, n_CMS2 = 41, n_CMS3 = 28, p = 0.116811537908463
tcga-all: Analyzing LPCAT4 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 144, n_CMS2 = 41, n_CMS3 = 28, p = 1.60921596454694e-08
tcga-all: Analyzing SLCO1B3 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test with continuity correction: W = 436, n_CMS2 = 41, n_CMS3 = 28, p = 0.0929061114864502
tcga-all: Analyzing Glutathione CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 896, n_CMS2 = 41, n_CMS4 = 27, p = 7.68869844821638e-06
tcga-all: Analyzing Glutamine CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 799, n_CMS2 = 41, n_CMS4 = 27, p = 0.00179884666614718
tcga-all: Analyzing HK2 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 593, n_CMS2 = 41, n_CMS4 = 27, p = 0.627217706504773
tcga-all: Analyzing LDHA CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 534, n_CMS2 = 41, n_CMS4 = 27, p = 0.813046728023713
tcga-all: Analyzing MGLL CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 567, n_CMS2 = 41, n_CMS4 = 27, p = 0.871461197174713
tcga-all: Analyzing ANGPTL4 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 159, n_CMS2 = 41, n_CMS4 = 27, p = 1.41812864866733e-07
tcga-all: Analyzing VEGFA CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 743, n_CMS2 = 41, n_CMS4 = 27, p = 0.0171139395572444
tcga-all: Analyzing ACSL5 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 876, n_CMS2 = 41, n_CMS4 = 27, p = 2.85894132048103e-05
tcga-all: Analyzing PCK2 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 605, n_CMS2 = 41, n_CMS4 = 27, p = 0.525215617263732
tcga-all: Analyzing LPCAT4 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 538, n_CMS2 = 41, n_CMS4 = 27, p = 0.851896437510396
tcga-all: Analyzing SLCO1B3 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test with continuity correction: W = 583, n_CMS2 = 41, n_CMS4 = 27, p = 0.716214347161936

tcga-all: Analyzing Glutathione CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1997, n_CMS2-MT = 41, n_CMS2-WT = 95, p = 0.81625371007963
tcga-all: Analyzing Glutamine CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 2002, n_CMS2-MT = 41, n_CMS2-WT = 95, p = 0.797891474688482
tcga-all: Analyzing HK2 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 2039, n_CMS2-MT = 41, n_CMS2-WT = 95, p = 0.666077982360512
tcga-all: Analyzing LDHA CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1774, n_CMS2-MT = 41, n_CMS2-WT = 95, p = 0.411991280635863
tcga-all: Analyzing MGLL CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 2367, n_CMS2-MT = 41, n_CMS2-WT = 95, p = 0.0469260655354071
tcga-all: Analyzing ANGPTL4 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1585, n_CMS2-MT = 41, n_CMS2-WT = 95, p = 0.0860406686737495
tcga-all: Analyzing VEGFA CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 2219, n_CMS2-MT = 41, n_CMS2-WT = 95, p = 0.19874806166327
tcga-all: Analyzing ACSL5 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1985, n_CMS2-MT = 41, n_CMS2-WT = 95, p = 0.860718132674325
tcga-all: Analyzing PCK2 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1769, n_CMS2-MT = 41, n_CMS2-WT = 95, p = 0.398610584128341
tcga-all: Analyzing LPCAT4 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1661, n_CMS2-MT = 41, n_CMS2-WT = 95, p = 0.17501676728276
tcga-all: Analyzing SLCO1B3 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 2354, n_CMS2-MT = 41, n_CMS2-WT = 95, p = 0.0541734149796852
tcga-all: Analyzing Glutathione CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 275, n_CMS2-MT = 41, n_CMS1-MT = 12, p = 0.54950421731813
tcga-all: Analyzing Glutamine CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 402, n_CMS2-MT = 41, n_CMS1-MT = 12, p = 0.000559899244015074
tcga-all: Analyzing HK2 CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 239, n_CMS2-MT = 41, n_CMS1-MT = 12, p = 0.891588086469456
tcga-all: Analyzing LDHA CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 126, n_CMS2-MT = 41, n_CMS1-MT = 12, p = 0.00977254663815796
tcga-all: Analyzing MGLL CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 365, n_CMS2-MT = 41, n_CMS1-MT = 12, p = 0.0104462176088574
tcga-all: Analyzing ANGPTL4 CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 67, n_CMS2-MT = 41, n_CMS1-MT = 12, p = 4.97008627052545e-05
tcga-all: Analyzing VEGFA CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 283, n_CMS2-MT = 41, n_CMS1-MT = 12, p = 0.442908010094174
tcga-all: Analyzing ACSL5 CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 461, n_CMS2-MT = 41, n_CMS1-MT = 12, p = 2.19848978999018e-07
tcga-all: Analyzing PCK2 CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 302, n_CMS2-MT = 41, n_CMS1-MT = 12, p = 0.241679226051556
tcga-all: Analyzing LPCAT4 CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 119, n_CMS2-MT = 41, n_CMS1-MT = 12, p = 0.00602196214436271
tcga-all: Analyzing SLCO1B3 CMS2-MT vs CMS1-MT using Wilcoxon rank sum test with continuity correction: W = 212, n_CMS2-MT = 41, n_CMS1-MT = 12, p = 0.476453582233946
tcga-all: Analyzing Glutathione CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 890, n_CMS2-MT = 41, n_CMS1-WT = 39, p = 0.388359283652958
tcga-all: Analyzing Glutamine CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 1119, n_CMS2-MT = 41, n_CMS1-WT = 39, p = 0.00186776592051606
tcga-all: Analyzing HK2 CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 437, n_CMS2-MT = 41, n_CMS1-WT = 39, p = 0.00038474705501588
tcga-all: Analyzing LDHA CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 518, n_CMS2-MT = 41, n_CMS1-WT = 39, p = 0.00637172573793041
tcga-all: Analyzing MGLL CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 1020, n_CMS2-MT = 41, n_CMS1-WT = 39, p = 0.033692019983421
tcga-all: Analyzing ANGPTL4 CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 227, n_CMS2-MT = 41, n_CMS1-WT = 39, p = 4.18919704334689e-09
tcga-all: Analyzing VEGFA CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 1010, n_CMS2-MT = 41, n_CMS1-WT = 39, p = 0.0428034919559772
tcga-all: Analyzing ACSL5 CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 1438, n_CMS2-MT = 41, n_CMS1-WT = 39, p = 1.83605925937333e-11
tcga-all: Analyzing PCK2 CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 965, n_CMS2-MT = 41, n_CMS1-WT = 39, p = 0.112569224025249
tcga-all: Analyzing LPCAT4 CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 313, n_CMS2-MT = 41, n_CMS1-WT = 39, p = 1.07560755183011e-06
tcga-all: Analyzing SLCO1B3 CMS2-MT vs CMS1-WT using Wilcoxon rank sum test with continuity correction: W = 633, n_CMS2-MT = 41, n_CMS1-WT = 39, p = 0.110037979819357
tcga-all: Analyzing Glutathione CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 552, n_CMS2-MT = 41, n_CMS3-MT = 28, p = 0.794123373135232
tcga-all: Analyzing Glutamine CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 416, n_CMS2-MT = 41, n_CMS3-MT = 28, p = 0.0538725707268066
tcga-all: Analyzing HK2 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 423, n_CMS2-MT = 41, n_CMS3-MT = 28, p = 0.0656555433556854
tcga-all: Analyzing LDHA CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 499, n_CMS2-MT = 41, n_CMS3-MT = 28, p = 0.365032964893459
tcga-all: Analyzing MGLL CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 292, n_CMS2-MT = 41, n_CMS3-MT = 28, p = 0.000435103001953079
tcga-all: Analyzing ANGPTL4 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 458, n_CMS2-MT = 41, n_CMS3-MT = 28, p = 0.159106383601962
tcga-all: Analyzing VEGFA CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 810, n_CMS2-MT = 41, n_CMS3-MT = 28, p = 0.00355214636925408
tcga-all: Analyzing ACSL5 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 786, n_CMS2-MT = 41, n_CMS3-MT = 28, p = 0.00911523839794177
tcga-all: Analyzing PCK2 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 445, n_CMS2-MT = 41, n_CMS3-MT = 28, p = 0.116811537908463
tcga-all: Analyzing LPCAT4 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 144, n_CMS2-MT = 41, n_CMS3-MT = 28, p = 1.60921596454694e-08
tcga-all: Analyzing SLCO1B3 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test with continuity correction: W = 436, n_CMS2-MT = 41, n_CMS3-MT = 28, p = 0.0929061114864502
tcga-all: Analyzing Glutathione CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 310, n_CMS2-MT = 41, n_CMS3-WT = 14, p = 0.667242494225661
tcga-all: Analyzing Glutamine CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 255, n_CMS2-MT = 41, n_CMS3-WT = 14, p = 0.546956864083505
tcga-all: Analyzing HK2 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 206, n_CMS2-MT = 41, n_CMS3-WT = 14, p = 0.120733644880514
tcga-all: Analyzing LDHA CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 202, n_CMS2-MT = 41, n_CMS3-WT = 14, p = 0.103011129945879
tcga-all: Analyzing MGLL CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 268, n_CMS2-MT = 41, n_CMS3-WT = 14, p = 0.723773355833699
tcga-all: Analyzing ANGPTL4 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 153, n_CMS2-MT = 41, n_CMS3-WT = 14, p = 0.00878420923722032
tcga-all: Analyzing VEGFA CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 348, n_CMS2-MT = 41, n_CMS3-WT = 14, p = 0.245512840714018
tcga-all: Analyzing ACSL5 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 391, n_CMS2-MT = 41, n_CMS3-WT = 14, p = 0.0446368355095785
tcga-all: Analyzing PCK2 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 264, n_CMS2-MT = 41, n_CMS3-WT = 14, p = 0.667242494225661
tcga-all: Analyzing LPCAT4 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 134, n_CMS2-MT = 41, n_CMS3-WT = 14, p = 0.00251164628448909
tcga-all: Analyzing SLCO1B3 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test with continuity correction: W = 302, n_CMS2-MT = 41, n_CMS3-WT = 14, p = 0.779349621174529
tcga-all: Analyzing Glutathione CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 896, n_CMS2-MT = 41, n_CMS4-MT = 27, p = 7.68869844821638e-06
tcga-all: Analyzing Glutamine CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 799, n_CMS2-MT = 41, n_CMS4-MT = 27, p = 0.00179884666614718
tcga-all: Analyzing HK2 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 593, n_CMS2-MT = 41, n_CMS4-MT = 27, p = 0.627217706504773
tcga-all: Analyzing LDHA CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 534, n_CMS2-MT = 41, n_CMS4-MT = 27, p = 0.813046728023713
tcga-all: Analyzing MGLL CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 567, n_CMS2-MT = 41, n_CMS4-MT = 27, p = 0.871461197174713
tcga-all: Analyzing ANGPTL4 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 159, n_CMS2-MT = 41, n_CMS4-MT = 27, p = 1.41812864866733e-07
tcga-all: Analyzing VEGFA CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 743, n_CMS2-MT = 41, n_CMS4-MT = 27, p = 0.0171139395572444
tcga-all: Analyzing ACSL5 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 876, n_CMS2-MT = 41, n_CMS4-MT = 27, p = 2.85894132048103e-05
tcga-all: Analyzing PCK2 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 605, n_CMS2-MT = 41, n_CMS4-MT = 27, p = 0.525215617263732
tcga-all: Analyzing LPCAT4 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 538, n_CMS2-MT = 41, n_CMS4-MT = 27, p = 0.851896437510396
tcga-all: Analyzing SLCO1B3 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test with continuity correction: W = 583, n_CMS2-MT = 41, n_CMS4-MT = 27, p = 0.716214347161936
tcga-all: Analyzing Glutathione CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1801, n_CMS2-MT = 41, n_CMS4-WT = 60, p = 7.97043622207438e-05
tcga-all: Analyzing Glutamine CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1795, n_CMS2-MT = 41, n_CMS4-WT = 60, p = 9.46962589087391e-05
tcga-all: Analyzing HK2 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1606, n_CMS2-MT = 41, n_CMS4-WT = 60, p = 0.00941058312549941
tcga-all: Analyzing LDHA CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1294, n_CMS2-MT = 41, n_CMS4-WT = 60, p = 0.660564704321773
tcga-all: Analyzing MGLL CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1359, n_CMS2-MT = 41, n_CMS4-WT = 60, p = 0.374196307997976
tcga-all: Analyzing ANGPTL4 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 381, n_CMS2-MT = 41, n_CMS4-WT = 60, p = 4.41632487047202e-09
tcga-all: Analyzing VEGFA CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1526, n_CMS2-MT = 41, n_CMS4-WT = 60, p = 0.0410002561529018
tcga-all: Analyzing ACSL5 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1896, n_CMS2-MT = 41, n_CMS4-WT = 60, p = 4.17933291251527e-06
tcga-all: Analyzing PCK2 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1273, n_CMS2-MT = 41, n_CMS4-WT = 60, p = 0.768827943081601
tcga-all: Analyzing LPCAT4 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1264, n_CMS2-MT = 41, n_CMS4-WT = 60, p = 0.816795166068841
tcga-all: Analyzing SLCO1B3 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1356, n_CMS2-MT = 41, n_CMS4-WT = 60, p = 0.385446803381852

Computing linear model with interaction for Glutathione
Computing linear model with interaction for Glutamine
Computing linear model with interaction for HK2
Computing linear model with interaction for LDHA
Computing linear model with interaction for MGLL
Computing linear model with interaction for ANGPTL4
Computing linear model with interaction for VEGFA
Computing linear model with interaction for ACSL5
Computing linear model with interaction for PCK2
Computing linear model with interaction for LPCAT4
Computing linear model with interaction for SLCO1B3
Computing linear model for Glutathione
Computing linear model for Glutamine
Computing linear model for HK2
Computing linear model for LDHA
Computing linear model for MGLL
Computing linear model for ANGPTL4
Computing linear model for VEGFA
Computing linear model for ACSL5
Computing linear model for PCK2
Computing linear model for LPCAT4
Computing linear model for SLCO1B3
tcga-all: Analyzing Glutathione CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 973, n_MT = 27, n_WT = 60, p = 0.13599078900762
tcga-all: Analyzing Glutamine CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 844, n_MT = 27, n_WT = 60, p = 0.758575166915793
tcga-all: Analyzing HK2 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 570, n_MT = 27, n_WT = 60, p = 0.0279961599913847
tcga-all: Analyzing LDHA CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 745, n_MT = 27, n_WT = 60, p = 0.554005938338347
tcga-all: Analyzing MGLL CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 737, n_MT = 27, n_WT = 60, p = 0.505944575074492
tcga-all: Analyzing ANGPTL4 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 812, n_MT = 27, n_WT = 60, p = 0.989019821720159
tcga-all: Analyzing VEGFA CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 866, n_MT = 27, n_WT = 60, p = 0.610615027837956
tcga-all: Analyzing ACSL5 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 828, n_MT = 27, n_WT = 60, p = 0.872442154498887
tcga-all: Analyzing PCK2 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 840, n_MT = 27, n_WT = 60, p = 0.786657472927406
tcga-all: Analyzing LPCAT4 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 777, n_MT = 27, n_WT = 60, p = 0.765567551293402
tcga-all: Analyzing SLCO1B3 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 780.5, n_MT = 27, n_WT = 60, p = 0.790183523863262
tcga-all: Analyzing Glutathione CMS1 MT vs WT using Wilcoxon rank sum test: W = 251, n_MT = 12, n_WT = 39, p = 0.717614088730712
tcga-all: Analyzing Glutamine CMS1 MT vs WT using Wilcoxon rank sum test: W = 276, n_MT = 12, n_WT = 39, p = 0.361521773929692
tcga-all: Analyzing HK2 CMS1 MT vs WT using Wilcoxon rank sum test: W = 334, n_MT = 12, n_WT = 39, p = 0.0257552843726709
tcga-all: Analyzing LDHA CMS1 MT vs WT using Wilcoxon rank sum test: W = 198, n_MT = 12, n_WT = 39, p = 0.435533110162582
tcga-all: Analyzing MGLL CMS1 MT vs WT using Wilcoxon rank sum test: W = 274, n_MT = 12, n_WT = 39, p = 0.385292107856904
tcga-all: Analyzing ANGPTL4 CMS1 MT vs WT using Wilcoxon rank sum test: W = 151, n_MT = 12, n_WT = 39, p = 0.066495903341967
tcga-all: Analyzing VEGFA CMS1 MT vs WT using Wilcoxon rank sum test: W = 196, n_MT = 12, n_WT = 39, p = 0.409967599375338
tcga-all: Analyzing ACSL5 CMS1 MT vs WT using Wilcoxon rank sum test: W = 218, n_MT = 12, n_WT = 39, p = 0.734076557403956
tcga-all: Analyzing PCK2 CMS1 MT vs WT using Wilcoxon rank sum test: W = 244, n_MT = 12, n_WT = 39, p = 0.835118823689446
tcga-all: Analyzing LPCAT4 CMS1 MT vs WT using Wilcoxon rank sum test: W = 266, n_MT = 12, n_WT = 39, p = 0.48925431909785
tcga-all: Analyzing SLCO1B3 CMS1 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 237.5, n_MT = 12, n_WT = 39, p = 0.946874339113159
tcga-all: Analyzing Glutathione CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1898, n_MT = 41, n_WT = 95, p = 0.81625371007963
tcga-all: Analyzing Glutamine CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1893, n_MT = 41, n_WT = 95, p = 0.797891474688482
tcga-all: Analyzing HK2 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1856, n_MT = 41, n_WT = 95, p = 0.666077982360512
tcga-all: Analyzing LDHA CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 2121, n_MT = 41, n_WT = 95, p = 0.411991280635863
tcga-all: Analyzing MGLL CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1528, n_MT = 41, n_WT = 95, p = 0.0469260655354071
tcga-all: Analyzing ANGPTL4 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 2310, n_MT = 41, n_WT = 95, p = 0.0860406686737495
tcga-all: Analyzing VEGFA CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1676, n_MT = 41, n_WT = 95, p = 0.19874806166327
tcga-all: Analyzing ACSL5 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1910, n_MT = 41, n_WT = 95, p = 0.860718132674325
tcga-all: Analyzing PCK2 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 2126, n_MT = 41, n_WT = 95, p = 0.398610584128341
tcga-all: Analyzing LPCAT4 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 2234, n_MT = 41, n_WT = 95, p = 0.17501676728276
tcga-all: Analyzing SLCO1B3 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1541, n_MT = 41, n_WT = 95, p = 0.0541734149796852
tcga-all: Analyzing Glutathione CMS3 MT vs WT using Wilcoxon rank sum test: W = 178, n_MT = 28, n_WT = 14, p = 0.644481834091968
tcga-all: Analyzing Glutamine CMS3 MT vs WT using Wilcoxon rank sum test: W = 166, n_MT = 28, n_WT = 14, p = 0.435894904638578
tcga-all: Analyzing HK2 CMS3 MT vs WT using Wilcoxon rank sum test: W = 204, n_MT = 28, n_WT = 14, p = 0.843344658089401
tcga-all: Analyzing LDHA CMS3 MT vs WT using Wilcoxon rank sum test: W = 244, n_MT = 28, n_WT = 14, p = 0.207759058126276
tcga-all: Analyzing MGLL CMS3 MT vs WT using Wilcoxon rank sum test: W = 114, n_MT = 28, n_WT = 14, p = 0.0284028965846472
tcga-all: Analyzing ANGPTL4 CMS3 MT vs WT using Wilcoxon rank sum test: W = 261, n_MT = 28, n_WT = 14, p = 0.0853091740328114
tcga-all: Analyzing VEGFA CMS3 MT vs WT using Wilcoxon rank sum test: W = 251, n_MT = 28, n_WT = 14, p = 0.147464639137353
tcga-all: Analyzing ACSL5 CMS3 MT vs WT using Wilcoxon rank sum test: W = 185, n_MT = 28, n_WT = 14, p = 0.782004862019035
tcga-all: Analyzing PCK2 CMS3 MT vs WT using Wilcoxon rank sum test: W = 159, n_MT = 28, n_WT = 14, p = 0.334372944037949
tcga-all: Analyzing LPCAT4 CMS3 MT vs WT using Wilcoxon rank sum test: W = 122, n_MT = 28, n_WT = 14, p = 0.0490056002988476
tcga-all: Analyzing SLCO1B3 CMS3 MT vs WT using Wilcoxon rank sum test: W = 153, n_MT = 28, n_WT = 14, p = 0.260326296451987

Computing linear model for Glutathione
Computing linear model for Glutamine
Computing linear model for HK2
Computing linear model for LDHA
Computing linear model for MGLL
Computing linear model for ANGPTL4
Computing linear model for VEGFA
Computing linear model for ACSL5
Computing linear model for PCK2
Computing linear model for LPCAT4
Computing linear model for SLCO1B3
Computing rectum vs left
tcga-all: Analyzing Glutathione site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 4213, n_rectum = 60, n_left = 133, p = 0.535608612284401
tcga-all: Analyzing Glutamine site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 4350, n_rectum = 60, n_left = 133, p = 0.316879036766069
tcga-all: Analyzing HK2 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 4524, n_rectum = 60, n_left = 133, p = 0.137456624814498
tcga-all: Analyzing LDHA site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3845, n_rectum = 60, n_left = 133, p = 0.687459078217143
tcga-all: Analyzing MGLL site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 4378, n_rectum = 60, n_left = 133, p = 0.280655760542024
tcga-all: Analyzing ANGPTL4 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3710, n_rectum = 60, n_left = 133, p = 0.436473404265445
tcga-all: Analyzing VEGFA site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3495, n_rectum = 60, n_left = 133, p = 0.168590021783935
tcga-all: Analyzing ACSL5 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 4409, n_rectum = 60, n_left = 133, p = 0.243956179458335
tcga-all: Analyzing PCK2 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 4208, n_rectum = 60, n_left = 133, p = 0.544815867980527
tcga-all: Analyzing LPCAT4 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 4103, n_rectum = 60, n_left = 133, p = 0.75411826409068
tcga-all: Analyzing SLCO1B3 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3525, n_rectum = 60, n_left = 133, p = 0.195926783122283
Computing right vs left
tcga-all: Analyzing Glutathione site: right vs leftWilcoxon rank sum test with continuity correction: W = 9579, n_right = 148, n_left = 133, p = 0.699528662204587
tcga-all: Analyzing Glutamine site: right vs leftWilcoxon rank sum test with continuity correction: W = 9764, n_right = 148, n_left = 133, p = 0.909278102526949
tcga-all: Analyzing HK2 site: right vs leftWilcoxon rank sum test with continuity correction: W = 7800, n_right = 148, n_left = 133, p = 0.00268528489747445
tcga-all: Analyzing LDHA site: right vs leftWilcoxon rank sum test with continuity correction: W = 8771, n_right = 148, n_left = 133, p = 0.115494710396609
tcga-all: Analyzing MGLL site: right vs leftWilcoxon rank sum test with continuity correction: W = 10328, n_right = 148, n_left = 133, p = 0.475328414468292
tcga-all: Analyzing ANGPTL4 site: right vs leftWilcoxon rank sum test with continuity correction: W = 7948, n_right = 148, n_left = 133, p = 0.00536872305770496
tcga-all: Analyzing VEGFA site: right vs leftWilcoxon rank sum test with continuity correction: W = 10282, n_right = 148, n_left = 133, p = 0.518148571191606
tcga-all: Analyzing ACSL5 site: right vs leftWilcoxon rank sum test with continuity correction: W = 12838, n_right = 148, n_left = 133, p = 1.06116956558004e-05
tcga-all: Analyzing PCK2 site: right vs leftWilcoxon rank sum test with continuity correction: W = 10957, n_right = 148, n_left = 133, p = 0.101283608673418
tcga-all: Analyzing LPCAT4 site: right vs leftWilcoxon rank sum test with continuity correction: W = 8407, n_right = 148, n_left = 133, p = 0.0349305985909412
tcga-all: Analyzing SLCO1B3 site: right vs leftWilcoxon rank sum test with continuity correction: W = 8296, n_right = 148, n_left = 133, p = 0.02305391963445

Plotting Glutathione ~ site
Plotting Glutamine ~ site
Plotting HK2 ~ site
Plotting LDHA ~ site
Plotting MGLL ~ site
Plotting ANGPTL4 ~ site
Plotting VEGFA ~ site
Plotting ACSL5 ~ site
Plotting PCK2 ~ site
Plotting LPCAT4 ~ site
Plotting SLCO1B3 ~ site
Computing MSS vs MSI
tcga-all: Analyzing Glutathione status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 8172, n_MSS = 289, n_MSI = 53, p = 0.438157887144853
tcga-all: Analyzing Glutamine status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 5255, n_MSS = 289, n_MSI = 53, p = 0.000281555655728384
tcga-all: Analyzing HK2 status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 10965, n_MSS = 289, n_MSI = 53, p = 5.84022355087092e-07
tcga-all: Analyzing LDHA status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 10229, n_MSS = 289, n_MSI = 53, p = 0.000102711795842707
tcga-all: Analyzing MGLL status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 6838, n_MSS = 289, n_MSI = 53, p = 0.215240641386102
tcga-all: Analyzing ANGPTL4 status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 11061, n_MSS = 289, n_MSI = 53, p = 2.7253345409879e-07
tcga-all: Analyzing VEGFA status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 5683, n_MSS = 289, n_MSI = 53, p = 0.00283709155072034
tcga-all: Analyzing ACSL5 status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 2611, n_MSS = 289, n_MSI = 53, p = 2.39095834380117e-14
tcga-all: Analyzing PCK2 status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 5982, n_MSS = 289, n_MSI = 53, p = 0.0113099361901345
tcga-all: Analyzing LPCAT4 status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 11880, n_MSS = 289, n_MSI = 53, p = 1.77915747560166e-10
tcga-all: Analyzing SLCO1B3 status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 8644, n_MSS = 289, n_MSI = 53, p = 0.136562664655127

Plotting Glutathione ~ status
Plotting Glutamine ~ status
Plotting HK2 ~ status
Plotting LDHA ~ status
Plotting MGLL ~ status
Plotting ANGPTL4 ~ status
Plotting VEGFA ~ status
Plotting ACSL5 ~ status
Plotting PCK2 ~ status
Plotting LPCAT4 ~ status
Plotting SLCO1B3 ~ status
MSI nrow =  559 
  clusters Freq
1        1  390
2        2  169
MSI clusters: 2
MSS clusters: 1
[1] -2.980897e-13
[1] -3.522599e-13
Has MSI
Has BRAF
Has CMS
Has TYMS
Has Genomic
[1] NA  2  4  6  8 10 12 NA
       [,1] [,2] [,3] [,4] [,5] [,6] [,7] [,8]
layout   NA    2    4    6    8   10   12   NA
row       1    3    5    7    9   11   13   15
[1] 1.00 5.00 0.25 0.25 0.25 0.25 1.00 2.00
[1] 1.0 2.5 2.5 2.5 2.5 0.5 1.0 0.5
     [,1] [,2] [,3] [,4] [,5] [,6] [,7] [,8]
[1,]   NA    2    4    6    8   10   12   NA
[2,]    1    3    5    7    9   11   13   15
[3,]    1    3    5    7    9   11   13   16
[4,]    1    3    5    7    9   11   13   17
[5,]    1    3    5    7    9   11   13   18
[6,]   NA   NA   NA   NA   NA   NA   NA   NA
[7,]   NA   14   NA   NA   NA   NA   NA   NA
[8,]   NA   NA   NA   NA   NA   NA   NA   NA
[1] 18
tcga-msi: Analyzing TYMS vs Imputed Status using Wilcoxon rank sum test with continuity correction: W = 54712 p = 2.44358357254431e-35 n_MSS = 390, n_MSI = 169
tcga-msi: Analyzing TYMS vs Annotated Status using Wilcoxon rank sum test with continuity correction: W = 35644 p = 8.82290348137337e-34 n_MSS = 478, n_MSI = 81
Overlap of MSI inferred and annotated in TCGA:
     
      msi mss
  msi  78   3
  mss  91 387
Overlap of MSI and CMS1 in TCGA inferred:
     
      CMS1 CMS2 CMS3 CMS4 NOLBL
  msi   74    1   42   33    19
  mss    2  214   27  105    42
Number of rows analyzed: 20294
Number of columns analyzed: 289
tcga-mss-msi-annotated: 49 of 49 genes from data set analyzed in set Glutathione: G6PD GCLC GCLM GGCT GGT1 GGT5 GGT6 GGT7 GPX1 GPX2 GPX3 GPX4 GPX5 GPX6 GPX7 GSR GSS GSTA1 GSTA2 GSTA3 GSTA4 GSTA5 GSTK1 GSTM1 GSTM2 GSTM3 GSTM4 GSTM5 GSTO1 GSTO2 GSTP1 GSTT1 GSTT2 GSTZ1 IDH1 IDH2 LAP3 MGST1 MGST2 MGST3 ODC1 OPLAH PGD RRM1 RRM2 RRM2B SMS SRM TXNDC12
tcga-mss-msi-annotated: 26 of 27 genes from data set analyzed in set Glutamine: CRYL1 DCXR DHDH GUSB LOC729020 RPE UGDH UGP2 UGT1A1 UGT1A10 UGT1A3 UGT1A4 UGT1A5 UGT1A6 UGT1A7 UGT1A8 UGT1A9 UGT2A1 UGT2A3 UGT2B10 UGT2B11 UGT2B15 UGT2B28 UGT2B4 UGT2B7 XYLB
tcga-mss-msi-annotated: 1 of 27 genes missing from data set analyzed in set Glutamine: UGT2B17
Estimating GSVA scores for 26 gene sets.
Computing observed enrichment scores
Estimating ECDFs in microarray data with Gaussian kernels
Using parallel with 1 cores
  |                                                                              |                                                                      |   0%  |                                                                              |===                                                                   |   4%  |                                                                              |=====                                                                 |   8%  |                                                                              |========                                                              |  12%  |                                                                              |===========                                                           |  15%  |                                                                              |=============                                                         |  19%  |                                                                              |================                                                      |  23%  |                                                                              |===================                                                   |  27%  |                                                                              |======================                                                |  31%  |                                                                              |========================                                              |  35%  |                                                                              |===========================                                           |  38%  |                                                                              |==============================                                        |  42%  |                                                                              |================================                                      |  46%  |                                                                              |===================================                                   |  50%  |                                                                              |======================================                                |  54%  |                                                                              |========================================                              |  58%  |                                                                              |===========================================                           |  62%  |                                                                              |==============================================                        |  65%  |                                                                              |================================================                      |  69%  |                                                                              |===================================================                   |  73%  |                                                                              |======================================================                |  77%  |                                                                              |=========================================================             |  81%  |                                                                              |===========================================================           |  85%  |                                                                              |==============================================================        |  88%  |                                                                              |=================================================================     |  92%  |                                                                              |===================================================================   |  96%  |                                                                              |======================================================================| 100%
Done with gsva.
tcga-mss-msi-annotated wnt vs CIRC: t = -6.48169351043605 df = 287 nrow = 289 cor = -0.357340623456176 pval = 3.94381010590036e-10
tcga-mss-msi-annotated tak1 vs CIRC: t = -1.28667906107693 df = 287 nrow = 289 cor = -0.0757321493474332 pval = 0.199243045098411
tcga-mss-msi-annotated wnt vs myc.sig: t = 32.495758885224 df = 287 nrow = 289 cor = 0.886732906569273 pval = 3.57071642866538e-98

tcga-mss-msi-annotated: Analyzing Glutathione vs KRAS using Wilcoxon rank sum test with continuity correction: W = 9845, n_WT = 178, n_MT = 111, p = 0.961333496154316
tcga-mss-msi-annotated: Analyzing Glutamine vs KRAS using Wilcoxon rank sum test with continuity correction: W = 9435, n_WT = 178, n_MT = 111, p = 0.520989571366633
tcga-mss-msi-annotated: Analyzing HK2 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 8129, n_WT = 178, n_MT = 111, p = 0.011346985925253
tcga-mss-msi-annotated: Analyzing LDHA vs KRAS using Wilcoxon rank sum test with continuity correction: W = 9573, n_WT = 178, n_MT = 111, p = 0.658408864539936
tcga-mss-msi-annotated: Analyzing MGLL vs KRAS using Wilcoxon rank sum test with continuity correction: W = 7705, n_WT = 178, n_MT = 111, p = 0.00165843889453311
tcga-mss-msi-annotated: Analyzing ANGPTL4 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 10993, n_WT = 178, n_MT = 111, p = 0.107086913563183
tcga-mss-msi-annotated: Analyzing VEGFA vs KRAS using Wilcoxon rank sum test with continuity correction: W = 9755, n_WT = 178, n_MT = 111, p = 0.858153061128449
tcga-mss-msi-annotated: Analyzing ACSL5 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 10454, n_WT = 178, n_MT = 111, p = 0.405747540821126
tcga-mss-msi-annotated: Analyzing PCK2 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 10511, n_WT = 178, n_MT = 111, p = 0.3607751317432
tcga-mss-msi-annotated: Analyzing LPCAT4 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 8610, n_WT = 178, n_MT = 111, p = 0.0663964730692853
tcga-mss-msi-annotated: Analyzing SLCO1B3 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 8197.5, n_WT = 178, n_MT = 111, p = 0.0149841110284809

tcga-mss-msi-annotated: Analyzing Glutathione CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 535, n_CMS2 = 134, n_CMS1 = 11, p = 0.132409615415998
tcga-mss-msi-annotated: Analyzing Glutamine CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 547, n_CMS2 = 134, n_CMS1 = 11, p = 0.157051083579145
tcga-mss-msi-annotated: Analyzing HK2 CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 711, n_CMS2 = 134, n_CMS1 = 11, p = 0.848982406439542
tcga-mss-msi-annotated: Analyzing LDHA CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 930, n_CMS2 = 134, n_CMS1 = 11, p = 0.150586937173952
tcga-mss-msi-annotated: Analyzing MGLL CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 304, n_CMS2 = 134, n_CMS1 = 11, p = 0.00123954401149486
tcga-mss-msi-annotated: Analyzing ANGPTL4 CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1032, n_CMS2 = 134, n_CMS1 = 11, p = 0.0278687341413989
tcga-mss-msi-annotated: Analyzing VEGFA CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 912, n_CMS2 = 134, n_CMS1 = 11, p = 0.19255789270034
tcga-mss-msi-annotated: Analyzing ACSL5 CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 285, n_CMS2 = 134, n_CMS1 = 11, p = 0.000747599459955218
tcga-mss-msi-annotated: Analyzing PCK2 CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 512, n_CMS2 = 134, n_CMS1 = 11, p = 0.0936567359067084
tcga-mss-msi-annotated: Analyzing LPCAT4 CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 794, n_CMS2 = 134, n_CMS1 = 11, p = 0.673094907100601
tcga-mss-msi-annotated: Analyzing SLCO1B3 CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1212, n_CMS2 = 134, n_CMS1 = 11, p = 0.000394936791077325
tcga-mss-msi-annotated: Analyzing Glutathione CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2386, n_CMS2 = 134, n_CMS3 = 35, p = 0.875149336512269
tcga-mss-msi-annotated: Analyzing Glutamine CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1753, n_CMS2 = 134, n_CMS3 = 35, p = 0.0217477247973981
tcga-mss-msi-annotated: Analyzing HK2 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1548, n_CMS2 = 134, n_CMS3 = 35, p = 0.0020012273415739
tcga-mss-msi-annotated: Analyzing LDHA CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2097, n_CMS2 = 134, n_CMS3 = 35, p = 0.33696208464113
tcga-mss-msi-annotated: Analyzing MGLL CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 995, n_CMS2 = 134, n_CMS3 = 35, p = 1.64598271062504e-07
tcga-mss-msi-annotated: Analyzing ANGPTL4 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1933, n_CMS2 = 134, n_CMS3 = 35, p = 0.110393068616775
tcga-mss-msi-annotated: Analyzing VEGFA CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2814, n_CMS2 = 134, n_CMS3 = 35, p = 0.0691310387984618
tcga-mss-msi-annotated: Analyzing ACSL5 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2986, n_CMS2 = 134, n_CMS3 = 35, p = 0.0129608745550021
tcga-mss-msi-annotated: Analyzing PCK2 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2032, n_CMS2 = 134, n_CMS3 = 35, p = 0.225376567032345
tcga-mss-msi-annotated: Analyzing LPCAT4 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 915, n_CMS2 = 134, n_CMS3 = 35, p = 2.92619616403307e-08
tcga-mss-msi-annotated: Analyzing SLCO1B3 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1659, n_CMS2 = 134, n_CMS3 = 35, p = 0.00782534262235364
tcga-mss-msi-annotated: Analyzing Glutathione CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 7818, n_CMS2 = 134, n_CMS4 = 81, p = 6.36398832827082e-08
tcga-mss-msi-annotated: Analyzing Glutamine CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 7847, n_CMS2 = 134, n_CMS4 = 81, p = 4.40312560301115e-08
tcga-mss-msi-annotated: Analyzing HK2 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 6557, n_CMS2 = 134, n_CMS4 = 81, p = 0.0106072676573528
tcga-mss-msi-annotated: Analyzing LDHA CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 5972, n_CMS2 = 134, n_CMS4 = 81, p = 0.217995695317609
tcga-mss-msi-annotated: Analyzing MGLL CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 5105, n_CMS2 = 134, n_CMS4 = 81, p = 0.467005039045607
tcga-mss-msi-annotated: Analyzing ANGPTL4 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 2245, n_CMS2 = 134, n_CMS4 = 81, p = 6.11844387649996e-13
tcga-mss-msi-annotated: Analyzing VEGFA CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 6290, n_CMS2 = 134, n_CMS4 = 81, p = 0.0510192869157164
tcga-mss-msi-annotated: Analyzing ACSL5 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 8139, n_CMS2 = 134, n_CMS4 = 81, p = 8.54329331949428e-10
tcga-mss-msi-annotated: Analyzing PCK2 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 5956, n_CMS2 = 134, n_CMS4 = 81, p = 0.23182267831183
tcga-mss-msi-annotated: Analyzing LPCAT4 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 6154, n_CMS2 = 134, n_CMS4 = 81, p = 0.10025234193301
tcga-mss-msi-annotated: Analyzing SLCO1B3 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 5306.5, n_CMS2 = 134, n_CMS4 = 81, p = 0.78600553123861


tcga-mss-msi-annotated: Analyzing Glutathione CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 73, n_CMS2 = 41, n_CMS1 = 5, p = 0.31633247103419
tcga-mss-msi-annotated: Analyzing Glutamine CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 51, n_CMS2 = 41, n_CMS1 = 5, p = 0.07112873644724
tcga-mss-msi-annotated: Analyzing HK2 CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 106, n_CMS2 = 41, n_CMS1 = 5, p = 0.918303357130455
tcga-mss-msi-annotated: Analyzing LDHA CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 149, n_CMS2 = 41, n_CMS1 = 5, p = 0.10604382697406
tcga-mss-msi-annotated: Analyzing MGLL CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 45, n_CMS2 = 41, n_CMS1 = 5, p = 0.0416500699614957
tcga-mss-msi-annotated: Analyzing ANGPTL4 CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 140, n_CMS2 = 41, n_CMS1 = 5, p = 0.198149339706468
tcga-mss-msi-annotated: Analyzing VEGFA CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 106, n_CMS2 = 41, n_CMS1 = 5, p = 0.918303357130455
tcga-mss-msi-annotated: Analyzing ACSL5 CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 7, n_CMS2 = 41, n_CMS1 = 5, p = 6.12801421699298e-05
tcga-mss-msi-annotated: Analyzing PCK2 CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 83, n_CMS2 = 41, n_CMS1 = 5, p = 0.513937584716149
tcga-mss-msi-annotated: Analyzing LPCAT4 CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 130, n_CMS2 = 41, n_CMS1 = 5, p = 0.351504354537722
tcga-mss-msi-annotated: Analyzing SLCO1B3 CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test with continuity correction: W = 137, n_CMS2 = 41, n_CMS1 = 5, p = 0.230165281428849
tcga-mss-msi-annotated: Analyzing Glutathione CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 453, n_CMS2 = 41, n_CMS3 = 23, p = 0.802659012046896
tcga-mss-msi-annotated: Analyzing Glutamine CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 334, n_CMS2 = 41, n_CMS3 = 23, p = 0.0548046052498345
tcga-mss-msi-annotated: Analyzing HK2 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 339, n_CMS2 = 41, n_CMS3 = 23, p = 0.0644577320092351
tcga-mss-msi-annotated: Analyzing LDHA CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 426, n_CMS2 = 41, n_CMS3 = 23, p = 0.531769995364772
tcga-mss-msi-annotated: Analyzing MGLL CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 220, n_CMS2 = 41, n_CMS3 = 23, p = 0.000305465455511434
tcga-mss-msi-annotated: Analyzing ANGPTL4 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 404, n_CMS2 = 41, n_CMS3 = 23, p = 0.351242825730706
tcga-mss-msi-annotated: Analyzing VEGFA CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 647, n_CMS2 = 41, n_CMS3 = 23, p = 0.0135451653522999
tcga-mss-msi-annotated: Analyzing ACSL5 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 589, n_CMS2 = 41, n_CMS3 = 23, p = 0.101915207235432
tcga-mss-msi-annotated: Analyzing PCK2 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 339, n_CMS2 = 41, n_CMS3 = 23, p = 0.0644577320092351
tcga-mss-msi-annotated: Analyzing LPCAT4 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 113, n_CMS2 = 41, n_CMS3 = 23, p = 6.27696698099888e-08
tcga-mss-msi-annotated: Analyzing SLCO1B3 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test with continuity correction: W = 317, n_CMS2 = 41, n_CMS3 = 23, p = 0.0311787220553413
tcga-mss-msi-annotated: Analyzing Glutathione CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 819, n_CMS2 = 41, n_CMS4 = 25, p = 2.61785006567465e-05
tcga-mss-msi-annotated: Analyzing Glutamine CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 735, n_CMS2 = 41, n_CMS4 = 25, p = 0.00289188744092403
tcga-mss-msi-annotated: Analyzing HK2 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 552, n_CMS2 = 41, n_CMS4 = 25, p = 0.60863146126904
tcga-mss-msi-annotated: Analyzing LDHA CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 485, n_CMS2 = 41, n_CMS4 = 25, p = 0.723068108256618
tcga-mss-msi-annotated: Analyzing MGLL CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 512, n_CMS2 = 41, n_CMS4 = 25, p = 1
tcga-mss-msi-annotated: Analyzing ANGPTL4 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 159, n_CMS2 = 41, n_CMS4 = 25, p = 7.64732999616803e-07
tcga-mss-msi-annotated: Analyzing VEGFA CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 672, n_CMS2 = 41, n_CMS4 = 25, p = 0.0349027415141507
tcga-mss-msi-annotated: Analyzing ACSL5 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 796, n_CMS2 = 41, n_CMS4 = 25, p = 0.00011394582006428
tcga-mss-msi-annotated: Analyzing PCK2 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 558, n_CMS2 = 41, n_CMS4 = 25, p = 0.554568324184186
tcga-mss-msi-annotated: Analyzing LPCAT4 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 500, n_CMS2 = 41, n_CMS4 = 25, p = 0.874886453258001
tcga-mss-msi-annotated: Analyzing SLCO1B3 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test with continuity correction: W = 557, n_CMS2 = 41, n_CMS4 = 25, p = 0.560777582863411

tcga-mss-msi-annotated: Analyzing Glutathione CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1961, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.794303928087426
tcga-mss-msi-annotated: Analyzing Glutamine CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1922, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.942264606757935
tcga-mss-msi-annotated: Analyzing HK2 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1998, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.660392486921863
tcga-mss-msi-annotated: Analyzing LDHA CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1759, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.477856879479211
tcga-mss-msi-annotated: Analyzing MGLL CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 2306, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.0540451711439347
tcga-mss-msi-annotated: Analyzing ANGPTL4 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1569, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.103711094050806
tcga-mss-msi-annotated: Analyzing VEGFA CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 2187, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.176403523546092
tcga-mss-msi-annotated: Analyzing ACSL5 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1954, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.820479685013008
tcga-mss-msi-annotated: Analyzing PCK2 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1753, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.460075065694574
tcga-mss-msi-annotated: Analyzing LPCAT4 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1631, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.184253920527406
tcga-mss-msi-annotated: Analyzing SLCO1B3 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 2303, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.0558604059103083
tcga-mss-msi-annotated: Analyzing Glutathione CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 132, n_CMS2-MT = 41, n_CMS1-MT = 5, p = 0.31633247103419
tcga-mss-msi-annotated: Analyzing Glutamine CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 154, n_CMS2-MT = 41, n_CMS1-MT = 5, p = 0.07112873644724
tcga-mss-msi-annotated: Analyzing HK2 CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 99, n_CMS2-MT = 41, n_CMS1-MT = 5, p = 0.918303357130455
tcga-mss-msi-annotated: Analyzing LDHA CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 56, n_CMS2-MT = 41, n_CMS1-MT = 5, p = 0.10604382697406
tcga-mss-msi-annotated: Analyzing MGLL CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 160, n_CMS2-MT = 41, n_CMS1-MT = 5, p = 0.0416500699614957
tcga-mss-msi-annotated: Analyzing ANGPTL4 CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 65, n_CMS2-MT = 41, n_CMS1-MT = 5, p = 0.198149339706468
tcga-mss-msi-annotated: Analyzing VEGFA CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 99, n_CMS2-MT = 41, n_CMS1-MT = 5, p = 0.918303357130455
tcga-mss-msi-annotated: Analyzing ACSL5 CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 198, n_CMS2-MT = 41, n_CMS1-MT = 5, p = 6.12801421699298e-05
tcga-mss-msi-annotated: Analyzing PCK2 CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 122, n_CMS2-MT = 41, n_CMS1-MT = 5, p = 0.513937584716149
tcga-mss-msi-annotated: Analyzing LPCAT4 CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 75, n_CMS2-MT = 41, n_CMS1-MT = 5, p = 0.351504354537722
tcga-mss-msi-annotated: Analyzing SLCO1B3 CMS2-MT vs CMS1-MT using Wilcoxon rank sum test with continuity correction: W = 68, n_CMS2-MT = 41, n_CMS1-MT = 5, p = 0.230165281428849
tcga-mss-msi-annotated: Analyzing Glutathione CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 161, n_CMS2-MT = 41, n_CMS1-WT = 6, p = 0.238598238167973
tcga-mss-msi-annotated: Analyzing Glutamine CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 130, n_CMS2-MT = 41, n_CMS1-WT = 6, p = 0.839950331420331
tcga-mss-msi-annotated: Analyzing HK2 CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 148, n_CMS2-MT = 41, n_CMS1-WT = 6, p = 0.444493369218538
tcga-mss-msi-annotated: Analyzing LDHA CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 109, n_CMS2-MT = 41, n_CMS1-WT = 6, p = 0.674559325463957
tcga-mss-msi-annotated: Analyzing MGLL CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 218, n_CMS2-MT = 41, n_CMS1-WT = 6, p = 0.00117046934162869
tcga-mss-msi-annotated: Analyzing ANGPTL4 CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 57, n_CMS2-MT = 41, n_CMS1-WT = 6, p = 0.0343265652303365
tcga-mss-msi-annotated: Analyzing VEGFA CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 100, n_CMS2-MT = 41, n_CMS1-WT = 6, p = 0.482892176844805
tcga-mss-msi-annotated: Analyzing ACSL5 CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 170, n_CMS2-MT = 41, n_CMS1-WT = 6, p = 0.141236758064415
tcga-mss-msi-annotated: Analyzing PCK2 CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 157, n_CMS2-MT = 41, n_CMS1-WT = 6, p = 0.293630786025855
tcga-mss-msi-annotated: Analyzing LPCAT4 CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 113, n_CMS2-MT = 41, n_CMS1-WT = 6, p = 0.767782067698166
tcga-mss-msi-annotated: Analyzing SLCO1B3 CMS2-MT vs CMS1-WT using Wilcoxon rank sum test with continuity correction: W = 32, n_CMS2-MT = 41, n_CMS1-WT = 6, p = 0.00391266938019603
tcga-mss-msi-annotated: Analyzing Glutathione CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 453, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.802659012046896
tcga-mss-msi-annotated: Analyzing Glutamine CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 334, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.0548046052498345
tcga-mss-msi-annotated: Analyzing HK2 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 339, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.0644577320092351
tcga-mss-msi-annotated: Analyzing LDHA CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 426, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.531769995364772
tcga-mss-msi-annotated: Analyzing MGLL CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 220, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.000305465455511434
tcga-mss-msi-annotated: Analyzing ANGPTL4 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 404, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.351242825730706
tcga-mss-msi-annotated: Analyzing VEGFA CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 647, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.0135451653522999
tcga-mss-msi-annotated: Analyzing ACSL5 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 589, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.101915207235432
tcga-mss-msi-annotated: Analyzing PCK2 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 339, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.0644577320092351
tcga-mss-msi-annotated: Analyzing LPCAT4 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 113, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 6.27696698099888e-08
tcga-mss-msi-annotated: Analyzing SLCO1B3 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test with continuity correction: W = 317, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.0311787220553413
tcga-mss-msi-annotated: Analyzing Glutathione CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 288, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.382621310002744
tcga-mss-msi-annotated: Analyzing Glutamine CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 211, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.468424690823948
tcga-mss-msi-annotated: Analyzing HK2 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 154, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.0509563688192696
tcga-mss-msi-annotated: Analyzing LDHA CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 177, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.147107291206972
tcga-mss-msi-annotated: Analyzing MGLL CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 191, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.250371241998623
tcga-mss-msi-annotated: Analyzing ANGPTL4 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 105, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.00207200480093645
tcga-mss-msi-annotated: Analyzing VEGFA CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 275, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.54950421731813
tcga-mss-msi-annotated: Analyzing ACSL5 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 338, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.0509563688192696
tcga-mss-msi-annotated: Analyzing PCK2 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 223, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.636770815283705
tcga-mss-msi-annotated: Analyzing LPCAT4 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 132, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.0144474077783903
tcga-mss-msi-annotated: Analyzing SLCO1B3 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test with continuity correction: W = 266, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.678556865940687
tcga-mss-msi-annotated: Analyzing Glutathione CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 819, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 2.61785006567465e-05
tcga-mss-msi-annotated: Analyzing Glutamine CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 735, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 0.00289188744092403
tcga-mss-msi-annotated: Analyzing HK2 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 552, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 0.60863146126904
tcga-mss-msi-annotated: Analyzing LDHA CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 485, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 0.723068108256618
tcga-mss-msi-annotated: Analyzing MGLL CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 512, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 1
tcga-mss-msi-annotated: Analyzing ANGPTL4 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 159, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 7.64732999616803e-07
tcga-mss-msi-annotated: Analyzing VEGFA CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 672, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 0.0349027415141507
tcga-mss-msi-annotated: Analyzing ACSL5 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 796, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 0.00011394582006428
tcga-mss-msi-annotated: Analyzing PCK2 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 558, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 0.554568324184186
tcga-mss-msi-annotated: Analyzing LPCAT4 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 500, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 0.874886453258001
tcga-mss-msi-annotated: Analyzing SLCO1B3 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test with continuity correction: W = 557, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 0.560777582863411
tcga-mss-msi-annotated: Analyzing Glutathione CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1635, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 0.000381109950996709
tcga-mss-msi-annotated: Analyzing Glutamine CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1652, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 0.000236012706912607
tcga-mss-msi-annotated: Analyzing HK2 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1528, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 0.00558112070713796
tcga-mss-msi-annotated: Analyzing LDHA CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1237, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 0.518084357406474
tcga-mss-msi-annotated: Analyzing MGLL CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1308, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 0.244098906939641
tcga-mss-msi-annotated: Analyzing ANGPTL4 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 379, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 1.9973490345459e-08
tcga-mss-msi-annotated: Analyzing VEGFA CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1381, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 0.089524798012285
tcga-mss-msi-annotated: Analyzing ACSL5 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1742, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 1.46268448528259e-05
tcga-mss-msi-annotated: Analyzing PCK2 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1146, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 0.991259942731066
tcga-mss-msi-annotated: Analyzing LPCAT4 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1194, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 0.739678511625657
tcga-mss-msi-annotated: Analyzing SLCO1B3 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1293, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 0.291300069512686

Computing linear model with interaction for Glutathione
Computing linear model with interaction for Glutamine
Computing linear model with interaction for HK2
Computing linear model with interaction for LDHA
Computing linear model with interaction for MGLL
Computing linear model with interaction for ANGPTL4
Computing linear model with interaction for VEGFA
Computing linear model with interaction for ACSL5
Computing linear model with interaction for PCK2
Computing linear model with interaction for LPCAT4
Computing linear model with interaction for SLCO1B3
Computing linear model for Glutathione
Computing linear model for Glutamine
Computing linear model for HK2
Computing linear model for LDHA
Computing linear model for MGLL
Computing linear model for ANGPTL4
Computing linear model for VEGFA
Computing linear model for ACSL5
Computing linear model for PCK2
Computing linear model for LPCAT4
Computing linear model for SLCO1B3
tcga-mss-msi-annotated: Analyzing Glutathione CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 855, n_MT = 25, n_WT = 56, p = 0.114197634382995
tcga-mss-msi-annotated: Analyzing Glutamine CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 757, n_MT = 25, n_WT = 56, p = 0.563497434438313
tcga-mss-msi-annotated: Analyzing HK2 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 473, n_MT = 25, n_WT = 56, p = 0.0205730259868062
tcga-mss-msi-annotated: Analyzing LDHA CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 614, n_MT = 25, n_WT = 56, p = 0.382036755509193
tcga-mss-msi-annotated: Analyzing MGLL CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 591, n_MT = 25, n_WT = 56, p = 0.267300339881126
tcga-mss-msi-annotated: Analyzing ANGPTL4 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 712, n_MT = 25, n_WT = 56, p = 0.906403871481628
tcga-mss-msi-annotated: Analyzing VEGFA CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 752, n_MT = 25, n_WT = 56, p = 0.598516824390564
tcga-mss-msi-annotated: Analyzing ACSL5 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 719, n_MT = 25, n_WT = 56, p = 0.849980353390142
tcga-mss-msi-annotated: Analyzing PCK2 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 759, n_MT = 25, n_WT = 56, p = 0.549771608996584
tcga-mss-msi-annotated: Analyzing LPCAT4 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 662, n_MT = 25, n_WT = 56, p = 0.701423963706452
tcga-mss-msi-annotated: Analyzing SLCO1B3 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 684.5, n_MT = 25, n_WT = 56, p = 0.878111296567606
tcga-mss-msi-annotated: Analyzing Glutathione CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1852, n_MT = 41, n_WT = 93, p = 0.794303928087426
tcga-mss-msi-annotated: Analyzing Glutamine CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1891, n_MT = 41, n_WT = 93, p = 0.942264606757935
tcga-mss-msi-annotated: Analyzing HK2 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1815, n_MT = 41, n_WT = 93, p = 0.660392486921863
tcga-mss-msi-annotated: Analyzing LDHA CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 2054, n_MT = 41, n_WT = 93, p = 0.477856879479211
tcga-mss-msi-annotated: Analyzing MGLL CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1507, n_MT = 41, n_WT = 93, p = 0.0540451711439347
tcga-mss-msi-annotated: Analyzing ANGPTL4 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 2244, n_MT = 41, n_WT = 93, p = 0.103711094050806
tcga-mss-msi-annotated: Analyzing VEGFA CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1626, n_MT = 41, n_WT = 93, p = 0.176403523546092
tcga-mss-msi-annotated: Analyzing ACSL5 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1859, n_MT = 41, n_WT = 93, p = 0.820479685013008
tcga-mss-msi-annotated: Analyzing PCK2 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 2060, n_MT = 41, n_WT = 93, p = 0.460075065694574
tcga-mss-msi-annotated: Analyzing LPCAT4 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 2182, n_MT = 41, n_WT = 93, p = 0.184253920527406
tcga-mss-msi-annotated: Analyzing SLCO1B3 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1510, n_MT = 41, n_WT = 93, p = 0.0558604059103083
tcga-mss-msi-annotated: Analyzing Glutathione CMS3 MT vs WT using Wilcoxon rank sum test: W = 112, n_MT = 23, n_WT = 12, p = 0.380873315870371
tcga-mss-msi-annotated: Analyzing Glutamine CMS3 MT vs WT using Wilcoxon rank sum test: W = 120, n_MT = 23, n_WT = 12, p = 0.548398682823861
tcga-mss-msi-annotated: Analyzing HK2 CMS3 MT vs WT using Wilcoxon rank sum test: W = 152, n_MT = 23, n_WT = 12, p = 0.643616846413418
tcga-mss-msi-annotated: Analyzing LDHA CMS3 MT vs WT using Wilcoxon rank sum test: W = 174, n_MT = 23, n_WT = 12, p = 0.22080595188362
tcga-mss-msi-annotated: Analyzing MGLL CMS3 MT vs WT using Wilcoxon rank sum test: W = 83, n_MT = 23, n_WT = 12, p = 0.0574397802245738
tcga-mss-msi-annotated: Analyzing ANGPTL4 CMS3 MT vs WT using Wilcoxon rank sum test: W = 199, n_MT = 23, n_WT = 12, p = 0.0341124172780261
tcga-mss-msi-annotated: Analyzing VEGFA CMS3 MT vs WT using Wilcoxon rank sum test: W = 179, n_MT = 23, n_WT = 12, p = 0.161490149580839
tcga-mss-msi-annotated: Analyzing ACSL5 CMS3 MT vs WT using Wilcoxon rank sum test: W = 116, n_MT = 23, n_WT = 12, p = 0.460505855461035
tcga-mss-msi-annotated: Analyzing PCK2 CMS3 MT vs WT using Wilcoxon rank sum test: W = 103, n_MT = 23, n_WT = 12, p = 0.234284103647449
tcga-mss-msi-annotated: Analyzing LPCAT4 CMS3 MT vs WT using Wilcoxon rank sum test: W = 67, n_MT = 23, n_WT = 12, p = 0.0127244593396527
tcga-mss-msi-annotated: Analyzing SLCO1B3 CMS3 MT vs WT using Wilcoxon rank sum test: W = 92, n_MT = 23, n_WT = 12, p = 0.114767144129835
tcga-mss-msi-annotated: Analyzing Glutathione CMS1 MT vs WT using Wilcoxon rank sum test: W = 14, n_MT = 5, n_WT = 6, p = 0.930735930735931
tcga-mss-msi-annotated: Analyzing Glutamine CMS1 MT vs WT using Wilcoxon rank sum test: W = 18, n_MT = 5, n_WT = 6, p = 0.662337662337662
tcga-mss-msi-annotated: Analyzing HK2 CMS1 MT vs WT using Wilcoxon rank sum test: W = 12, n_MT = 5, n_WT = 6, p = 0.662337662337662
tcga-mss-msi-annotated: Analyzing LDHA CMS1 MT vs WT using Wilcoxon rank sum test: W = 8, n_MT = 5, n_WT = 6, p = 0.246753246753247
tcga-mss-msi-annotated: Analyzing MGLL CMS1 MT vs WT using Wilcoxon rank sum test: W = 12, n_MT = 5, n_WT = 6, p = 0.662337662337662
tcga-mss-msi-annotated: Analyzing ANGPTL4 CMS1 MT vs WT using Wilcoxon rank sum test: W = 18, n_MT = 5, n_WT = 6, p = 0.662337662337662
tcga-mss-msi-annotated: Analyzing VEGFA CMS1 MT vs WT using Wilcoxon rank sum test: W = 18, n_MT = 5, n_WT = 6, p = 0.662337662337662
tcga-mss-msi-annotated: Analyzing ACSL5 CMS1 MT vs WT using Wilcoxon rank sum test: W = 22, n_MT = 5, n_WT = 6, p = 0.246753246753247
tcga-mss-msi-annotated: Analyzing PCK2 CMS1 MT vs WT using Wilcoxon rank sum test: W = 14, n_MT = 5, n_WT = 6, p = 0.930735930735931
tcga-mss-msi-annotated: Analyzing LPCAT4 CMS1 MT vs WT using Wilcoxon rank sum test: W = 12, n_MT = 5, n_WT = 6, p = 0.662337662337662
tcga-mss-msi-annotated: Analyzing SLCO1B3 CMS1 MT vs WT using Wilcoxon rank sum test: W = 20, n_MT = 5, n_WT = 6, p = 0.428571428571429

Computing linear model for Glutathione
Computing linear model for Glutamine
Computing linear model for HK2
Computing linear model for LDHA
Computing linear model for MGLL
Computing linear model for ANGPTL4
Computing linear model for VEGFA
Computing linear model for ACSL5
Computing linear model for PCK2
Computing linear model for LPCAT4
Computing linear model for SLCO1B3
Computing rectum vs left
tcga-mss-msi-annotated: Analyzing Glutathione site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3800, n_rectum = 58, n_left = 126, p = 0.664666514575562
tcga-mss-msi-annotated: Analyzing Glutamine site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3917, n_rectum = 58, n_left = 126, p = 0.434184896610761
tcga-mss-msi-annotated: Analyzing HK2 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 4121, n_rectum = 58, n_left = 126, p = 0.164584923033718
tcga-mss-msi-annotated: Analyzing LDHA site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3398, n_rectum = 58, n_left = 126, p = 0.446540115396755
tcga-mss-msi-annotated: Analyzing MGLL site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 4007, n_rectum = 58, n_left = 126, p = 0.29363439857122
tcga-mss-msi-annotated: Analyzing ANGPTL4 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3349, n_rectum = 58, n_left = 126, p = 0.364312369907604
tcga-mss-msi-annotated: Analyzing VEGFA site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3278, n_rectum = 58, n_left = 126, p = 0.263266174464341
tcga-mss-msi-annotated: Analyzing ACSL5 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 4115, n_rectum = 58, n_left = 126, p = 0.170082111421007
tcga-mss-msi-annotated: Analyzing PCK2 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3884, n_rectum = 58, n_left = 126, p = 0.494142152565901
tcga-mss-msi-annotated: Analyzing LPCAT4 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3802, n_rectum = 58, n_left = 126, p = 0.660344270270557
tcga-mss-msi-annotated: Analyzing SLCO1B3 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3049, n_rectum = 58, n_left = 126, p = 0.0717058851466442
Computing right vs left
tcga-mss-msi-annotated: Analyzing Glutathione site: right vs leftWilcoxon rank sum test with continuity correction: W = 6205, n_right = 103, n_left = 126, p = 0.569744008439374
tcga-mss-msi-annotated: Analyzing Glutamine site: right vs leftWilcoxon rank sum test with continuity correction: W = 5607, n_right = 103, n_left = 126, p = 0.0771542576623718
tcga-mss-msi-annotated: Analyzing HK2 site: right vs leftWilcoxon rank sum test with continuity correction: W = 5990, n_right = 103, n_left = 126, p = 0.317546762134318
tcga-mss-msi-annotated: Analyzing LDHA site: right vs leftWilcoxon rank sum test with continuity correction: W = 6186, n_right = 103, n_left = 126, p = 0.544166656863479
tcga-mss-msi-annotated: Analyzing MGLL site: right vs leftWilcoxon rank sum test with continuity correction: W = 6658, n_right = 103, n_left = 126, p = 0.735476930719821
tcga-mss-msi-annotated: Analyzing ANGPTL4 site: right vs leftWilcoxon rank sum test with continuity correction: W = 5872, n_right = 103, n_left = 126, p = 0.216418967560386
tcga-mss-msi-annotated: Analyzing VEGFA site: right vs leftWilcoxon rank sum test with continuity correction: W = 6351, n_right = 103, n_left = 126, p = 0.782783980303121
tcga-mss-msi-annotated: Analyzing ACSL5 site: right vs leftWilcoxon rank sum test with continuity correction: W = 7557, n_right = 103, n_left = 126, p = 0.0323241412860232
tcga-mss-msi-annotated: Analyzing PCK2 site: right vs leftWilcoxon rank sum test with continuity correction: W = 6783, n_right = 103, n_left = 126, p = 0.556210865240849
tcga-mss-msi-annotated: Analyzing LPCAT4 site: right vs leftWilcoxon rank sum test with continuity correction: W = 6684, n_right = 103, n_left = 126, p = 0.696551275786625
tcga-mss-msi-annotated: Analyzing SLCO1B3 site: right vs leftWilcoxon rank sum test with continuity correction: W = 5490, n_right = 103, n_left = 126, p = 0.0452694655955612

Plotting Glutathione ~ site
Plotting Glutamine ~ site
Plotting HK2 ~ site
Plotting LDHA ~ site
Plotting MGLL ~ site
Plotting ANGPTL4 ~ site
Plotting VEGFA ~ site
Plotting ACSL5 ~ site
Plotting PCK2 ~ site
Plotting LPCAT4 ~ site
Plotting SLCO1B3 ~ site
Overlap of MSI and CMS1 in TCGA annotated:
     
      CMS1 CMS2 CMS3 CMS4 NOLBL
  msi   62    1   11    6     1
  mss   14  214   58  132    60
Number of rows analyzed: 20294
Number of columns analyzed: 278
tcga-mss-msi-annotated-no-cms1: 49 of 49 genes from data set analyzed in set Glutathione: G6PD GCLC GCLM GGCT GGT1 GGT5 GGT6 GGT7 GPX1 GPX2 GPX3 GPX4 GPX5 GPX6 GPX7 GSR GSS GSTA1 GSTA2 GSTA3 GSTA4 GSTA5 GSTK1 GSTM1 GSTM2 GSTM3 GSTM4 GSTM5 GSTO1 GSTO2 GSTP1 GSTT1 GSTT2 GSTZ1 IDH1 IDH2 LAP3 MGST1 MGST2 MGST3 ODC1 OPLAH PGD RRM1 RRM2 RRM2B SMS SRM TXNDC12
tcga-mss-msi-annotated-no-cms1: 26 of 27 genes from data set analyzed in set Glutamine: CRYL1 DCXR DHDH GUSB LOC729020 RPE UGDH UGP2 UGT1A1 UGT1A10 UGT1A3 UGT1A4 UGT1A5 UGT1A6 UGT1A7 UGT1A8 UGT1A9 UGT2A1 UGT2A3 UGT2B10 UGT2B11 UGT2B15 UGT2B28 UGT2B4 UGT2B7 XYLB
tcga-mss-msi-annotated-no-cms1: 1 of 27 genes missing from data set analyzed in set Glutamine: UGT2B17
Estimating GSVA scores for 26 gene sets.
Computing observed enrichment scores
Estimating ECDFs in microarray data with Gaussian kernels
Using parallel with 1 cores
  |                                                                              |                                                                      |   0%  |                                                                              |===                                                                   |   4%  |                                                                              |=====                                                                 |   8%  |                                                                              |========                                                              |  12%  |                                                                              |===========                                                           |  15%  |                                                                              |=============                                                         |  19%  |                                                                              |================                                                      |  23%  |                                                                              |===================                                                   |  27%  |                                                                              |======================                                                |  31%  |                                                                              |========================                                              |  35%  |                                                                              |===========================                                           |  38%  |                                                                              |==============================                                        |  42%  |                                                                              |================================                                      |  46%  |                                                                              |===================================                                   |  50%  |                                                                              |======================================                                |  54%  |                                                                              |========================================                              |  58%  |                                                                              |===========================================                           |  62%  |                                                                              |==============================================                        |  65%  |                                                                              |================================================                      |  69%  |                                                                              |===================================================                   |  73%  |                                                                              |======================================================                |  77%  |                                                                              |=========================================================             |  81%  |                                                                              |===========================================================           |  85%  |                                                                              |==============================================================        |  88%  |                                                                              |=================================================================     |  92%  |                                                                              |===================================================================   |  96%  |                                                                              |======================================================================| 100%
Done with gsva.
tcga-mss-msi-annotated-no-cms1 wnt vs CIRC: t = -7.16772312556457 df = 276 nrow = 278 cor = -0.39614815084246 pval = 6.9847963099518e-12
tcga-mss-msi-annotated-no-cms1 tak1 vs CIRC: t = -1.07297584012558 df = 276 nrow = 278 cor = -0.064451273208696 pval = 0.28421919478325
tcga-mss-msi-annotated-no-cms1 wnt vs myc.sig: t = 32.1863024961148 df = 276 nrow = 278 cor = 0.888609825973405 pval = 2.01588326488796e-95

tcga-mss-msi-annotated-no-cms1: Analyzing Glutathione vs KRAS using Wilcoxon rank sum test with continuity correction: W = 9053, n_WT = 172, n_MT = 106, p = 0.92352405742152
tcga-mss-msi-annotated-no-cms1: Analyzing Glutamine vs KRAS using Wilcoxon rank sum test with continuity correction: W = 8530, n_WT = 172, n_MT = 106, p = 0.368499865827972
tcga-mss-msi-annotated-no-cms1: Analyzing HK2 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 7535, n_WT = 172, n_MT = 106, p = 0.0152017344128762
tcga-mss-msi-annotated-no-cms1: Analyzing LDHA vs KRAS using Wilcoxon rank sum test with continuity correction: W = 8981, n_WT = 172, n_MT = 106, p = 0.836335883545174
tcga-mss-msi-annotated-no-cms1: Analyzing MGLL vs KRAS using Wilcoxon rank sum test with continuity correction: W = 7008, n_WT = 172, n_MT = 106, p = 0.00120805245854814
tcga-mss-msi-annotated-no-cms1: Analyzing ANGPTL4 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 10161, n_WT = 172, n_MT = 106, p = 0.108652640326181
tcga-mss-msi-annotated-no-cms1: Analyzing VEGFA vs KRAS using Wilcoxon rank sum test with continuity correction: W = 8998, n_WT = 172, n_MT = 106, p = 0.856782229736522
tcga-mss-msi-annotated-no-cms1: Analyzing ACSL5 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 9448, n_WT = 172, n_MT = 106, p = 0.610639568510249
tcga-mss-msi-annotated-no-cms1: Analyzing PCK2 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 9733, n_WT = 172, n_MT = 106, p = 0.343689371634264
tcga-mss-msi-annotated-no-cms1: Analyzing LPCAT4 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 7981, n_WT = 172, n_MT = 106, p = 0.0814188318535533
tcga-mss-msi-annotated-no-cms1: Analyzing SLCO1B3 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 7395.5, n_WT = 172, n_MT = 106, p = 0.00824470727349942

tcga-mss-msi-annotated-no-cms1: Analyzing Glutathione CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2389, n_CMS2 = 134, n_CMS3 = 35, p = 0.865985580918248
tcga-mss-msi-annotated-no-cms1: Analyzing Glutamine CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1754, n_CMS2 = 134, n_CMS3 = 35, p = 0.0219711783189681
tcga-mss-msi-annotated-no-cms1: Analyzing HK2 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1548, n_CMS2 = 134, n_CMS3 = 35, p = 0.0020012273415739
tcga-mss-msi-annotated-no-cms1: Analyzing LDHA CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2097, n_CMS2 = 134, n_CMS3 = 35, p = 0.33696208464113
tcga-mss-msi-annotated-no-cms1: Analyzing MGLL CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 995, n_CMS2 = 134, n_CMS3 = 35, p = 1.64598271062504e-07
tcga-mss-msi-annotated-no-cms1: Analyzing ANGPTL4 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1933, n_CMS2 = 134, n_CMS3 = 35, p = 0.110393068616775
tcga-mss-msi-annotated-no-cms1: Analyzing VEGFA CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2814, n_CMS2 = 134, n_CMS3 = 35, p = 0.0691310387984618
tcga-mss-msi-annotated-no-cms1: Analyzing ACSL5 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2986, n_CMS2 = 134, n_CMS3 = 35, p = 0.0129608745550021
tcga-mss-msi-annotated-no-cms1: Analyzing PCK2 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2032, n_CMS2 = 134, n_CMS3 = 35, p = 0.225376567032345
tcga-mss-msi-annotated-no-cms1: Analyzing LPCAT4 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 915, n_CMS2 = 134, n_CMS3 = 35, p = 2.92619616403307e-08
tcga-mss-msi-annotated-no-cms1: Analyzing SLCO1B3 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1659, n_CMS2 = 134, n_CMS3 = 35, p = 0.00782534262235364
tcga-mss-msi-annotated-no-cms1: Analyzing Glutathione CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 7823, n_CMS2 = 134, n_CMS4 = 81, p = 5.97417877378826e-08
tcga-mss-msi-annotated-no-cms1: Analyzing Glutamine CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 7820, n_CMS2 = 134, n_CMS4 = 81, p = 6.20519434925965e-08
tcga-mss-msi-annotated-no-cms1: Analyzing HK2 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 6557, n_CMS2 = 134, n_CMS4 = 81, p = 0.0106072676573528
tcga-mss-msi-annotated-no-cms1: Analyzing LDHA CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 5972, n_CMS2 = 134, n_CMS4 = 81, p = 0.217995695317609
tcga-mss-msi-annotated-no-cms1: Analyzing MGLL CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 5105, n_CMS2 = 134, n_CMS4 = 81, p = 0.467005039045607
tcga-mss-msi-annotated-no-cms1: Analyzing ANGPTL4 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 2245, n_CMS2 = 134, n_CMS4 = 81, p = 6.11844387649996e-13
tcga-mss-msi-annotated-no-cms1: Analyzing VEGFA CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 6290, n_CMS2 = 134, n_CMS4 = 81, p = 0.0510192869157164
tcga-mss-msi-annotated-no-cms1: Analyzing ACSL5 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 8139, n_CMS2 = 134, n_CMS4 = 81, p = 8.54329331949428e-10
tcga-mss-msi-annotated-no-cms1: Analyzing PCK2 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 5956, n_CMS2 = 134, n_CMS4 = 81, p = 0.23182267831183
tcga-mss-msi-annotated-no-cms1: Analyzing LPCAT4 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 6154, n_CMS2 = 134, n_CMS4 = 81, p = 0.10025234193301
tcga-mss-msi-annotated-no-cms1: Analyzing SLCO1B3 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 5306.5, n_CMS2 = 134, n_CMS4 = 81, p = 0.78600553123861


tcga-mss-msi-annotated-no-cms1: Analyzing Glutathione CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 453, n_CMS2 = 41, n_CMS3 = 23, p = 0.802659012046896
tcga-mss-msi-annotated-no-cms1: Analyzing Glutamine CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 337, n_CMS2 = 41, n_CMS3 = 23, p = 0.0604427326084323
tcga-mss-msi-annotated-no-cms1: Analyzing HK2 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 339, n_CMS2 = 41, n_CMS3 = 23, p = 0.0644577320092351
tcga-mss-msi-annotated-no-cms1: Analyzing LDHA CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 426, n_CMS2 = 41, n_CMS3 = 23, p = 0.531769995364772
tcga-mss-msi-annotated-no-cms1: Analyzing MGLL CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 220, n_CMS2 = 41, n_CMS3 = 23, p = 0.000305465455511434
tcga-mss-msi-annotated-no-cms1: Analyzing ANGPTL4 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 404, n_CMS2 = 41, n_CMS3 = 23, p = 0.351242825730706
tcga-mss-msi-annotated-no-cms1: Analyzing VEGFA CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 647, n_CMS2 = 41, n_CMS3 = 23, p = 0.0135451653522999
tcga-mss-msi-annotated-no-cms1: Analyzing ACSL5 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 589, n_CMS2 = 41, n_CMS3 = 23, p = 0.101915207235432
tcga-mss-msi-annotated-no-cms1: Analyzing PCK2 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 339, n_CMS2 = 41, n_CMS3 = 23, p = 0.0644577320092351
tcga-mss-msi-annotated-no-cms1: Analyzing LPCAT4 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 113, n_CMS2 = 41, n_CMS3 = 23, p = 6.27696698099888e-08
tcga-mss-msi-annotated-no-cms1: Analyzing SLCO1B3 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test with continuity correction: W = 317, n_CMS2 = 41, n_CMS3 = 23, p = 0.0311787220553413
tcga-mss-msi-annotated-no-cms1: Analyzing Glutathione CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 820, n_CMS2 = 41, n_CMS4 = 25, p = 2.44702460352516e-05
tcga-mss-msi-annotated-no-cms1: Analyzing Glutamine CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 730, n_CMS2 = 41, n_CMS4 = 25, p = 0.00362848008318771
tcga-mss-msi-annotated-no-cms1: Analyzing HK2 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 552, n_CMS2 = 41, n_CMS4 = 25, p = 0.60863146126904
tcga-mss-msi-annotated-no-cms1: Analyzing LDHA CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 485, n_CMS2 = 41, n_CMS4 = 25, p = 0.723068108256618
tcga-mss-msi-annotated-no-cms1: Analyzing MGLL CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 512, n_CMS2 = 41, n_CMS4 = 25, p = 1
tcga-mss-msi-annotated-no-cms1: Analyzing ANGPTL4 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 159, n_CMS2 = 41, n_CMS4 = 25, p = 7.64732999616803e-07
tcga-mss-msi-annotated-no-cms1: Analyzing VEGFA CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 672, n_CMS2 = 41, n_CMS4 = 25, p = 0.0349027415141507
tcga-mss-msi-annotated-no-cms1: Analyzing ACSL5 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 796, n_CMS2 = 41, n_CMS4 = 25, p = 0.00011394582006428
tcga-mss-msi-annotated-no-cms1: Analyzing PCK2 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 558, n_CMS2 = 41, n_CMS4 = 25, p = 0.554568324184186
tcga-mss-msi-annotated-no-cms1: Analyzing LPCAT4 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 500, n_CMS2 = 41, n_CMS4 = 25, p = 0.874886453258001
tcga-mss-msi-annotated-no-cms1: Analyzing SLCO1B3 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test with continuity correction: W = 557, n_CMS2 = 41, n_CMS4 = 25, p = 0.560777582863411

tcga-mss-msi-annotated-no-cms1: Analyzing Glutathione CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1972, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.753645088610222
tcga-mss-msi-annotated-no-cms1: Analyzing Glutamine CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1923, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.938422992127688
tcga-mss-msi-annotated-no-cms1: Analyzing HK2 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1998, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.660392486921863
tcga-mss-msi-annotated-no-cms1: Analyzing LDHA CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1759, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.477856879479211
tcga-mss-msi-annotated-no-cms1: Analyzing MGLL CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 2306, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.0540451711439347
tcga-mss-msi-annotated-no-cms1: Analyzing ANGPTL4 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1569, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.103711094050806
tcga-mss-msi-annotated-no-cms1: Analyzing VEGFA CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 2187, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.176403523546092
tcga-mss-msi-annotated-no-cms1: Analyzing ACSL5 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1954, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.820479685013008
tcga-mss-msi-annotated-no-cms1: Analyzing PCK2 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1753, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.460075065694574
tcga-mss-msi-annotated-no-cms1: Analyzing LPCAT4 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1631, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.184253920527406
tcga-mss-msi-annotated-no-cms1: Analyzing SLCO1B3 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 2303, n_CMS2-MT = 41, n_CMS2-WT = 93, p = 0.0558604059103083
tcga-mss-msi-annotated-no-cms1: Analyzing Glutathione CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 453, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.802659012046896
tcga-mss-msi-annotated-no-cms1: Analyzing Glutamine CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 337, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.0604427326084323
tcga-mss-msi-annotated-no-cms1: Analyzing HK2 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 339, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.0644577320092351
tcga-mss-msi-annotated-no-cms1: Analyzing LDHA CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 426, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.531769995364772
tcga-mss-msi-annotated-no-cms1: Analyzing MGLL CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 220, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.000305465455511434
tcga-mss-msi-annotated-no-cms1: Analyzing ANGPTL4 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 404, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.351242825730706
tcga-mss-msi-annotated-no-cms1: Analyzing VEGFA CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 647, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.0135451653522999
tcga-mss-msi-annotated-no-cms1: Analyzing ACSL5 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 589, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.101915207235432
tcga-mss-msi-annotated-no-cms1: Analyzing PCK2 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 339, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.0644577320092351
tcga-mss-msi-annotated-no-cms1: Analyzing LPCAT4 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 113, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 6.27696698099888e-08
tcga-mss-msi-annotated-no-cms1: Analyzing SLCO1B3 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test with continuity correction: W = 317, n_CMS2-MT = 41, n_CMS3-MT = 23, p = 0.0311787220553413
tcga-mss-msi-annotated-no-cms1: Analyzing Glutathione CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 286, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.406124593414241
tcga-mss-msi-annotated-no-cms1: Analyzing Glutamine CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 207, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.418183832314173
tcga-mss-msi-annotated-no-cms1: Analyzing HK2 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 154, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.0509563688192696
tcga-mss-msi-annotated-no-cms1: Analyzing LDHA CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 177, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.147107291206972
tcga-mss-msi-annotated-no-cms1: Analyzing MGLL CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 191, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.250371241998623
tcga-mss-msi-annotated-no-cms1: Analyzing ANGPTL4 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 105, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.00207200480093645
tcga-mss-msi-annotated-no-cms1: Analyzing VEGFA CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 275, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.54950421731813
tcga-mss-msi-annotated-no-cms1: Analyzing ACSL5 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 338, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.0509563688192696
tcga-mss-msi-annotated-no-cms1: Analyzing PCK2 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 223, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.636770815283705
tcga-mss-msi-annotated-no-cms1: Analyzing LPCAT4 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 132, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.0144474077783903
tcga-mss-msi-annotated-no-cms1: Analyzing SLCO1B3 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test with continuity correction: W = 266, n_CMS2-MT = 41, n_CMS3-WT = 12, p = 0.678556865940687
tcga-mss-msi-annotated-no-cms1: Analyzing Glutathione CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 820, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 2.44702460352516e-05
tcga-mss-msi-annotated-no-cms1: Analyzing Glutamine CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 730, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 0.00362848008318771
tcga-mss-msi-annotated-no-cms1: Analyzing HK2 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 552, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 0.60863146126904
tcga-mss-msi-annotated-no-cms1: Analyzing LDHA CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 485, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 0.723068108256618
tcga-mss-msi-annotated-no-cms1: Analyzing MGLL CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 512, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 1
tcga-mss-msi-annotated-no-cms1: Analyzing ANGPTL4 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 159, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 7.64732999616803e-07
tcga-mss-msi-annotated-no-cms1: Analyzing VEGFA CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 672, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 0.0349027415141507
tcga-mss-msi-annotated-no-cms1: Analyzing ACSL5 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 796, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 0.00011394582006428
tcga-mss-msi-annotated-no-cms1: Analyzing PCK2 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 558, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 0.554568324184186
tcga-mss-msi-annotated-no-cms1: Analyzing LPCAT4 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 500, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 0.874886453258001
tcga-mss-msi-annotated-no-cms1: Analyzing SLCO1B3 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test with continuity correction: W = 557, n_CMS2-MT = 41, n_CMS4-MT = 25, p = 0.560777582863411
tcga-mss-msi-annotated-no-cms1: Analyzing Glutathione CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1638, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 0.000350577432128502
tcga-mss-msi-annotated-no-cms1: Analyzing Glutamine CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1647, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 0.000272146580795852
tcga-mss-msi-annotated-no-cms1: Analyzing HK2 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1528, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 0.00558112070713796
tcga-mss-msi-annotated-no-cms1: Analyzing LDHA CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1237, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 0.518084357406474
tcga-mss-msi-annotated-no-cms1: Analyzing MGLL CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1308, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 0.244098906939641
tcga-mss-msi-annotated-no-cms1: Analyzing ANGPTL4 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 379, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 1.9973490345459e-08
tcga-mss-msi-annotated-no-cms1: Analyzing VEGFA CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1381, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 0.089524798012285
tcga-mss-msi-annotated-no-cms1: Analyzing ACSL5 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1742, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 1.46268448528259e-05
tcga-mss-msi-annotated-no-cms1: Analyzing PCK2 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1146, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 0.991259942731066
tcga-mss-msi-annotated-no-cms1: Analyzing LPCAT4 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1194, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 0.739678511625657
tcga-mss-msi-annotated-no-cms1: Analyzing SLCO1B3 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1293, n_CMS2-MT = 41, n_CMS4-WT = 56, p = 0.291300069512686

Computing linear model with interaction for Glutathione
Computing linear model with interaction for Glutamine
Computing linear model with interaction for HK2
Computing linear model with interaction for LDHA
Computing linear model with interaction for MGLL
Computing linear model with interaction for ANGPTL4
Computing linear model with interaction for VEGFA
Computing linear model with interaction for ACSL5
Computing linear model with interaction for PCK2
Computing linear model with interaction for LPCAT4
Computing linear model with interaction for SLCO1B3
Computing linear model for Glutathione
Computing linear model for Glutamine
Computing linear model for HK2
Computing linear model for LDHA
Computing linear model for MGLL
Computing linear model for ANGPTL4
Computing linear model for VEGFA
Computing linear model for ACSL5
Computing linear model for PCK2
Computing linear model for LPCAT4
Computing linear model for SLCO1B3
tcga-mss-msi-annotated-no-cms1: Analyzing Glutathione CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 858, n_MT = 25, n_WT = 56, p = 0.107337683418012
tcga-mss-msi-annotated-no-cms1: Analyzing Glutamine CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 759, n_MT = 25, n_WT = 56, p = 0.549771608996584
tcga-mss-msi-annotated-no-cms1: Analyzing HK2 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 473, n_MT = 25, n_WT = 56, p = 0.0205730259868062
tcga-mss-msi-annotated-no-cms1: Analyzing LDHA CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 614, n_MT = 25, n_WT = 56, p = 0.382036755509193
tcga-mss-msi-annotated-no-cms1: Analyzing MGLL CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 591, n_MT = 25, n_WT = 56, p = 0.267300339881126
tcga-mss-msi-annotated-no-cms1: Analyzing ANGPTL4 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 712, n_MT = 25, n_WT = 56, p = 0.906403871481628
tcga-mss-msi-annotated-no-cms1: Analyzing VEGFA CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 752, n_MT = 25, n_WT = 56, p = 0.598516824390564
tcga-mss-msi-annotated-no-cms1: Analyzing ACSL5 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 719, n_MT = 25, n_WT = 56, p = 0.849980353390142
tcga-mss-msi-annotated-no-cms1: Analyzing PCK2 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 759, n_MT = 25, n_WT = 56, p = 0.549771608996584
tcga-mss-msi-annotated-no-cms1: Analyzing LPCAT4 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 662, n_MT = 25, n_WT = 56, p = 0.701423963706452
tcga-mss-msi-annotated-no-cms1: Analyzing SLCO1B3 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 684.5, n_MT = 25, n_WT = 56, p = 0.878111296567606
tcga-mss-msi-annotated-no-cms1: Analyzing Glutathione CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1841, n_MT = 41, n_WT = 93, p = 0.753645088610222
tcga-mss-msi-annotated-no-cms1: Analyzing Glutamine CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1890, n_MT = 41, n_WT = 93, p = 0.938422992127688
tcga-mss-msi-annotated-no-cms1: Analyzing HK2 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1815, n_MT = 41, n_WT = 93, p = 0.660392486921863
tcga-mss-msi-annotated-no-cms1: Analyzing LDHA CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 2054, n_MT = 41, n_WT = 93, p = 0.477856879479211
tcga-mss-msi-annotated-no-cms1: Analyzing MGLL CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1507, n_MT = 41, n_WT = 93, p = 0.0540451711439347
tcga-mss-msi-annotated-no-cms1: Analyzing ANGPTL4 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 2244, n_MT = 41, n_WT = 93, p = 0.103711094050806
tcga-mss-msi-annotated-no-cms1: Analyzing VEGFA CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1626, n_MT = 41, n_WT = 93, p = 0.176403523546092
tcga-mss-msi-annotated-no-cms1: Analyzing ACSL5 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1859, n_MT = 41, n_WT = 93, p = 0.820479685013008
tcga-mss-msi-annotated-no-cms1: Analyzing PCK2 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 2060, n_MT = 41, n_WT = 93, p = 0.460075065694574
tcga-mss-msi-annotated-no-cms1: Analyzing LPCAT4 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 2182, n_MT = 41, n_WT = 93, p = 0.184253920527406
tcga-mss-msi-annotated-no-cms1: Analyzing SLCO1B3 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1510, n_MT = 41, n_WT = 93, p = 0.0558604059103083
tcga-mss-msi-annotated-no-cms1: Analyzing Glutathione CMS3 MT vs WT using Wilcoxon rank sum test: W = 111, n_MT = 23, n_WT = 12, p = 0.36233063671263
tcga-mss-msi-annotated-no-cms1: Analyzing Glutamine CMS3 MT vs WT using Wilcoxon rank sum test: W = 119, n_MT = 23, n_WT = 12, p = 0.525695837674507
tcga-mss-msi-annotated-no-cms1: Analyzing HK2 CMS3 MT vs WT using Wilcoxon rank sum test: W = 152, n_MT = 23, n_WT = 12, p = 0.643616846413418
tcga-mss-msi-annotated-no-cms1: Analyzing LDHA CMS3 MT vs WT using Wilcoxon rank sum test: W = 174, n_MT = 23, n_WT = 12, p = 0.22080595188362
tcga-mss-msi-annotated-no-cms1: Analyzing MGLL CMS3 MT vs WT using Wilcoxon rank sum test: W = 83, n_MT = 23, n_WT = 12, p = 0.0574397802245738
tcga-mss-msi-annotated-no-cms1: Analyzing ANGPTL4 CMS3 MT vs WT using Wilcoxon rank sum test: W = 199, n_MT = 23, n_WT = 12, p = 0.0341124172780261
tcga-mss-msi-annotated-no-cms1: Analyzing VEGFA CMS3 MT vs WT using Wilcoxon rank sum test: W = 179, n_MT = 23, n_WT = 12, p = 0.161490149580839
tcga-mss-msi-annotated-no-cms1: Analyzing ACSL5 CMS3 MT vs WT using Wilcoxon rank sum test: W = 116, n_MT = 23, n_WT = 12, p = 0.460505855461035
tcga-mss-msi-annotated-no-cms1: Analyzing PCK2 CMS3 MT vs WT using Wilcoxon rank sum test: W = 103, n_MT = 23, n_WT = 12, p = 0.234284103647449
tcga-mss-msi-annotated-no-cms1: Analyzing LPCAT4 CMS3 MT vs WT using Wilcoxon rank sum test: W = 67, n_MT = 23, n_WT = 12, p = 0.0127244593396527
tcga-mss-msi-annotated-no-cms1: Analyzing SLCO1B3 CMS3 MT vs WT using Wilcoxon rank sum test: W = 92, n_MT = 23, n_WT = 12, p = 0.114767144129835

Computing linear model for Glutathione
Computing linear model for Glutamine
Computing linear model for HK2
Computing linear model for LDHA
Computing linear model for MGLL
Computing linear model for ANGPTL4
Computing linear model for VEGFA
Computing linear model for ACSL5
Computing linear model for PCK2
Computing linear model for LPCAT4
Computing linear model for SLCO1B3
Computing rectum vs left
tcga-mss-msi-annotated-no-cms1: Analyzing Glutathione site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3519, n_rectum = 54, n_left = 125, p = 0.652006131925939
tcga-mss-msi-annotated-no-cms1: Analyzing Glutamine site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3657, n_rectum = 54, n_left = 125, p = 0.376335098692358
tcga-mss-msi-annotated-no-cms1: Analyzing HK2 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3822, n_rectum = 54, n_left = 125, p = 0.160552997208899
tcga-mss-msi-annotated-no-cms1: Analyzing LDHA site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3101, n_rectum = 54, n_left = 125, p = 0.390049512618836
tcga-mss-msi-annotated-no-cms1: Analyzing MGLL site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3522, n_rectum = 54, n_left = 125, p = 0.645225487622678
tcga-mss-msi-annotated-no-cms1: Analyzing ANGPTL4 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3091, n_rectum = 54, n_left = 125, p = 0.372953556661804
tcga-mss-msi-annotated-no-cms1: Analyzing VEGFA site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3109, n_rectum = 54, n_left = 125, p = 0.404063502802092
tcga-mss-msi-annotated-no-cms1: Analyzing ACSL5 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3658, n_rectum = 54, n_left = 125, p = 0.374641968950618
tcga-mss-msi-annotated-no-cms1: Analyzing PCK2 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3535, n_rectum = 54, n_left = 125, p = 0.616188053647406
tcga-mss-msi-annotated-no-cms1: Analyzing LPCAT4 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3426, n_rectum = 54, n_left = 125, p = 0.873900362130792
tcga-mss-msi-annotated-no-cms1: Analyzing SLCO1B3 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2993, n_rectum = 54, n_left = 125, p = 0.230543195370785
Computing right vs left
tcga-mss-msi-annotated-no-cms1: Analyzing Glutathione site: right vs leftWilcoxon rank sum test with continuity correction: W = 5751, n_right = 97, n_left = 125, p = 0.512354710089832
tcga-mss-msi-annotated-no-cms1: Analyzing Glutamine site: right vs leftWilcoxon rank sum test with continuity correction: W = 5195, n_right = 97, n_left = 125, p = 0.0677770453675443
tcga-mss-msi-annotated-no-cms1: Analyzing HK2 site: right vs leftWilcoxon rank sum test with continuity correction: W = 5566, n_right = 97, n_left = 125, p = 0.29606444648045
tcga-mss-msi-annotated-no-cms1: Analyzing LDHA site: right vs leftWilcoxon rank sum test with continuity correction: W = 5944, n_right = 97, n_left = 125, p = 0.803679861575079
tcga-mss-msi-annotated-no-cms1: Analyzing MGLL site: right vs leftWilcoxon rank sum test with continuity correction: W = 6104, n_right = 97, n_left = 125, p = 0.931169408369938
tcga-mss-msi-annotated-no-cms1: Analyzing ANGPTL4 site: right vs leftWilcoxon rank sum test with continuity correction: W = 5536, n_right = 97, n_left = 125, p = 0.267814105735212
tcga-mss-msi-annotated-no-cms1: Analyzing VEGFA site: right vs leftWilcoxon rank sum test with continuity correction: W = 6087, n_right = 97, n_left = 125, p = 0.959675998783847
tcga-mss-msi-annotated-no-cms1: Analyzing ACSL5 site: right vs leftWilcoxon rank sum test with continuity correction: W = 6866, n_right = 97, n_left = 125, p = 0.0907109806954596
tcga-mss-msi-annotated-no-cms1: Analyzing PCK2 site: right vs leftWilcoxon rank sum test with continuity correction: W = 6322, n_right = 97, n_left = 125, p = 0.585321299262039
tcga-mss-msi-annotated-no-cms1: Analyzing LPCAT4 site: right vs leftWilcoxon rank sum test with continuity correction: W = 6267, n_right = 97, n_left = 125, p = 0.667369156968675
tcga-mss-msi-annotated-no-cms1: Analyzing SLCO1B3 site: right vs leftWilcoxon rank sum test with continuity correction: W = 5260, n_right = 97, n_left = 125, p = 0.0910940011948934

Plotting Glutathione ~ site
Plotting Glutamine ~ site
Plotting HK2 ~ site
Plotting LDHA ~ site
Plotting MGLL ~ site
Plotting ANGPTL4 ~ site
Plotting VEGFA ~ site
Plotting ACSL5 ~ site
Plotting PCK2 ~ site
Plotting LPCAT4 ~ site
Plotting SLCO1B3 ~ site
There were 50 or more warnings (use warnings() to see the first 50)
Doing KFS analysis
Number of rows analyzed: 20534
Number of columns analyzed: 290
kfs-all: 46 of 49 genes from data set analyzed in set Glutathione: G6PD GCLC GCLM GGCT GGT1 GGT5 GGT6 GGT7 GPX1 GPX2 GPX3 GPX4 GPX5 GPX7 GSR GSS GSTA1 GSTA3 GSTA4 GSTK1 GSTM1 GSTM2 GSTM3 GSTM4 GSTM5 GSTO1 GSTO2 GSTP1 GSTT1 GSTT2 GSTZ1 IDH1 IDH2 LAP3 MGST1 MGST2 MGST3 ODC1 OPLAH PGD RRM1 RRM2 RRM2B SMS SRM TXNDC12
kfs-all: 3 of 49 genes missing from data set analyzed in set Glutathione: GPX6 GSTA2 GSTA5
kfs-all: 14 of 27 genes from data set analyzed in set Glutamine: CRYL1 DCXR DHDH GUSB RPE UGDH UGP2 UGT1A1 UGT2A3 UGT2B15 UGT2B17 UGT2B28 UGT2B4 XYLB
kfs-all: 13 of 27 genes missing from data set analyzed in set Glutamine: LOC729020 UGT1A10 UGT1A3 UGT1A4 UGT1A5 UGT1A6 UGT1A7 UGT1A8 UGT1A9 UGT2A1 UGT2B10 UGT2B11 UGT2B7
Estimating GSVA scores for 26 gene sets.
Computing observed enrichment scores
Estimating ECDFs in microarray data with Gaussian kernels
Using parallel with 1 cores
  |                                                                              |                                                                      |   0%  |                                                                              |===                                                                   |   4%  |                                                                              |=====                                                                 |   8%  |                                                                              |========                                                              |  12%  |                                                                              |===========                                                           |  15%  |                                                                              |=============                                                         |  19%  |                                                                              |================                                                      |  23%  |                                                                              |===================                                                   |  27%  |                                                                              |======================                                                |  31%  |                                                                              |========================                                              |  35%  |                                                                              |===========================                                           |  38%  |                                                                              |==============================                                        |  42%  |                                                                              |================================                                      |  46%  |                                                                              |===================================                                   |  50%  |                                                                              |======================================                                |  54%  |                                                                              |========================================                              |  58%  |                                                                              |===========================================                           |  62%  |                                                                              |==============================================                        |  65%  |                                                                              |================================================                      |  69%  |                                                                              |===================================================                   |  73%  |                                                                              |======================================================                |  77%  |                                                                              |=========================================================             |  81%  |                                                                              |===========================================================           |  85%  |                                                                              |==============================================================        |  88%  |                                                                              |=================================================================     |  92%  |                                                                              |===================================================================   |  96%  |                                                                              |======================================================================| 100%
Done with gsva.
kfs-all wnt vs CIRC: t = -4.05456248411765 df = 288 nrow = 290 cor = -0.232377199819908 pval = 6.47018657543056e-05
kfs-all tak1 vs CIRC: t = 0.0739344032913428 df = 288 nrow = 290 cor = 0.00435658514997042 pval = 0.941113905371728
kfs-all wnt vs myc.sig: t = 36.5923055069957 df = 288 nrow = 290 cor = 0.907186170025461 pval = 2.67104772325775e-110

kfs-all: Analyzing Glutathione vs KRAS using Wilcoxon rank sum test with continuity correction: W = 10036, n_WT = 175, n_MT = 115, p = 0.970311425752835
kfs-all: Analyzing Glutamine vs KRAS using Wilcoxon rank sum test with continuity correction: W = 9112, n_WT = 175, n_MT = 115, p = 0.173868691078931
kfs-all: Analyzing HK2 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 9354, n_WT = 175, n_MT = 115, p = 0.31083734059092
kfs-all: Analyzing LDHA vs KRAS using Wilcoxon rank sum test with continuity correction: W = 10240, n_WT = 175, n_MT = 115, p = 0.799984895958754
kfs-all: Analyzing MGLL vs KRAS using Wilcoxon rank sum test with continuity correction: W = 7469, n_WT = 175, n_MT = 115, p = 0.000205831347447837
kfs-all: Analyzing ANGPTL4 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 10310, n_WT = 175, n_MT = 115, p = 0.723662546359545
kfs-all: Analyzing VEGFA vs KRAS using Wilcoxon rank sum test with continuity correction: W = 9998, n_WT = 175, n_MT = 115, p = 0.927005681102242
kfs-all: Analyzing ACSL5 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 9831, n_WT = 175, n_MT = 115, p = 0.740897579508817
kfs-all: Analyzing PCK2 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 9502, n_WT = 175, n_MT = 115, p = 0.422777432762042
kfs-all: Analyzing LPCAT4 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 8427, n_WT = 175, n_MT = 115, p = 0.0192620256205299
kfs-all: Analyzing SLCO1B3 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 7823, n_WT = 175, n_MT = 115, p = 0.00135054710908031

kfs-all: Analyzing Glutathione CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1901, n_CMS2 = 106, n_CMS1 = 26, p = 0.00279353027479506
kfs-all: Analyzing Glutamine CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1034, n_CMS2 = 106, n_CMS1 = 26, p = 0.0493674436629938
kfs-all: Analyzing HK2 CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1505, n_CMS2 = 106, n_CMS1 = 26, p = 0.46919145333153
kfs-all: Analyzing LDHA CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1977, n_CMS2 = 106, n_CMS1 = 26, p = 0.000616071631425172
kfs-all: Analyzing MGLL CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1269, n_CMS2 = 106, n_CMS1 = 26, p = 0.534728188899034
kfs-all: Analyzing ANGPTL4 CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 2045, n_CMS2 = 106, n_CMS1 = 26, p = 0.000137004738438349
kfs-all: Analyzing VEGFA CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1304, n_CMS2 = 106, n_CMS1 = 26, p = 0.6740873197283
kfs-all: Analyzing ACSL5 CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 419, n_CMS2 = 106, n_CMS1 = 26, p = 4.15225172153869e-08
kfs-all: Analyzing PCK2 CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1133, n_CMS2 = 106, n_CMS1 = 26, p = 0.161826173964204
kfs-all: Analyzing LPCAT4 CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1954, n_CMS2 = 106, n_CMS1 = 26, p = 0.000991811788595342
kfs-all: Analyzing SLCO1B3 CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1611, n_CMS2 = 106, n_CMS1 = 26, p = 0.183420897829387
kfs-all: Analyzing Glutathione CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2463, n_CMS2 = 106, n_CMS3 = 48, p = 0.753511453566905
kfs-all: Analyzing Glutamine CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1431, n_CMS2 = 106, n_CMS3 = 48, p = 1.42732294393739e-05
kfs-all: Analyzing HK2 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1497, n_CMS2 = 106, n_CMS3 = 48, p = 4.46182798063354e-05
kfs-all: Analyzing LDHA CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2514, n_CMS2 = 106, n_CMS3 = 48, p = 0.908387301940459
kfs-all: Analyzing MGLL CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1038, n_CMS2 = 106, n_CMS3 = 48, p = 4.28958092604558e-09
kfs-all: Analyzing ANGPTL4 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2262, n_CMS2 = 106, n_CMS3 = 48, p = 0.272174370795338
kfs-all: Analyzing VEGFA CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 3284, n_CMS2 = 106, n_CMS3 = 48, p = 0.00391879837115252
kfs-all: Analyzing ACSL5 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 3106, n_CMS2 = 106, n_CMS3 = 48, p = 0.0285034445056079
kfs-all: Analyzing PCK2 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2812, n_CMS2 = 106, n_CMS3 = 48, p = 0.296736183227268
kfs-all: Analyzing LPCAT4 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1160, n_CMS2 = 106, n_CMS3 = 48, p = 6.78678288052231e-08
kfs-all: Analyzing SLCO1B3 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2081, n_CMS2 = 106, n_CMS3 = 48, p = 0.0712140995825452
kfs-all: Analyzing Glutathione CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 5876, n_CMS2 = 106, n_CMS4 = 78, p = 1.07251103102367e-06
kfs-all: Analyzing Glutamine CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 5631, n_CMS2 = 106, n_CMS4 = 78, p = 2.76977378707655e-05
kfs-all: Analyzing HK2 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 6547, n_CMS2 = 106, n_CMS4 = 78, p = 1.40607335275883e-11
kfs-all: Analyzing LDHA CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 5507, n_CMS2 = 106, n_CMS4 = 78, p = 0.000120898753969983
kfs-all: Analyzing MGLL CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 4628, n_CMS2 = 106, n_CMS4 = 78, p = 0.166889986656229
kfs-all: Analyzing ANGPTL4 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 2675, n_CMS2 = 106, n_CMS4 = 78, p = 4.40430864867418e-05
kfs-all: Analyzing VEGFA CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 4808, n_CMS2 = 106, n_CMS4 = 78, p = 0.059236196426199
kfs-all: Analyzing ACSL5 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 6867, n_CMS2 = 106, n_CMS4 = 78, p = 1.95458085949092e-14
kfs-all: Analyzing PCK2 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 6494, n_CMS2 = 106, n_CMS4 = 78, p = 3.87372182371631e-11
kfs-all: Analyzing LPCAT4 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 5604, n_CMS2 = 106, n_CMS4 = 78, p = 3.85524121134823e-05
kfs-all: Analyzing SLCO1B3 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 4904, n_CMS2 = 106, n_CMS4 = 78, p = 0.0311362623062059


kfs-all: Analyzing Glutathione CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 179, n_CMS2 = 36, n_CMS1 = 6, p = 0.0085501009762884
kfs-all: Analyzing Glutamine CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 39, n_CMS2 = 36, n_CMS1 = 6, p = 0.010964991709536
kfs-all: Analyzing HK2 CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 59, n_CMS2 = 36, n_CMS1 = 6, p = 0.0812187153650568
kfs-all: Analyzing LDHA CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 177, n_CMS2 = 36, n_CMS1 = 6, p = 0.010964991709536
kfs-all: Analyzing MGLL CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 135, n_CMS2 = 36, n_CMS1 = 6, p = 0.349919344784557
kfs-all: Analyzing ANGPTL4 CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 147, n_CMS2 = 36, n_CMS1 = 6, p = 0.170706925520789
kfs-all: Analyzing VEGFA CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 132, n_CMS2 = 36, n_CMS1 = 6, p = 0.407916754514957
kfs-all: Analyzing ACSL5 CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 35, n_CMS2 = 36, n_CMS1 = 6, p = 0.0065931015866831
kfs-all: Analyzing PCK2 CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 109, n_CMS2 = 36, n_CMS1 = 6, p = 0.986028023255238
kfs-all: Analyzing LPCAT4 CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 154, n_CMS2 = 36, n_CMS1 = 6, p = 0.103063296901551
kfs-all: Analyzing SLCO1B3 CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 106, n_CMS2 = 36, n_CMS1 = 6, p = 0.958111139112423
kfs-all: Analyzing Glutathione CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 456, n_CMS2 = 36, n_CMS3 = 30, p = 0.284322476398598
kfs-all: Analyzing Glutamine CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 324, n_CMS2 = 36, n_CMS3 = 30, p = 0.00499205485776451
kfs-all: Analyzing HK2 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 363, n_CMS2 = 36, n_CMS3 = 30, p = 0.0223210379972394
kfs-all: Analyzing LDHA CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 427, n_CMS2 = 36, n_CMS3 = 30, p = 0.148268917618362
kfs-all: Analyzing MGLL CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 211, n_CMS2 = 36, n_CMS3 = 30, p = 1.05928639943232e-05
kfs-all: Analyzing ANGPTL4 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 450, n_CMS2 = 36, n_CMS3 = 30, p = 0.25094774533553
kfs-all: Analyzing VEGFA CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 583, n_CMS2 = 36, n_CMS3 = 30, p = 0.586527005201648
kfs-all: Analyzing ACSL5 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 618, n_CMS2 = 36, n_CMS3 = 30, p = 0.32053516320865
kfs-all: Analyzing PCK2 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 617, n_CMS2 = 36, n_CMS3 = 30, p = 0.32684751359689
kfs-all: Analyzing LPCAT4 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 362, n_CMS2 = 36, n_CMS3 = 30, p = 0.02155397809898
kfs-all: Analyzing SLCO1B3 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 439, n_CMS2 = 36, n_CMS3 = 30, p = 0.196984777158792
kfs-all: Analyzing Glutathione CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 628, n_CMS2 = 36, n_CMS4 = 28, p = 0.0948189816842378
kfs-all: Analyzing Glutamine CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 685, n_CMS2 = 36, n_CMS4 = 28, p = 0.0138459694665933
kfs-all: Analyzing HK2 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 792, n_CMS2 = 36, n_CMS4 = 28, p = 5.73068012408172e-05
kfs-all: Analyzing LDHA CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 606, n_CMS2 = 36, n_CMS4 = 28, p = 0.170724752958389
kfs-all: Analyzing MGLL CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 618, n_CMS2 = 36, n_CMS4 = 28, p = 0.125126965970328
kfs-all: Analyzing ANGPTL4 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 293, n_CMS2 = 36, n_CMS4 = 28, p = 0.00389291529045654
kfs-all: Analyzing VEGFA CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 555, n_CMS2 = 36, n_CMS4 = 28, p = 0.49698610197016
kfs-all: Analyzing ACSL5 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 879, n_CMS2 = 36, n_CMS4 = 28, p = 5.30067405649127e-08
kfs-all: Analyzing PCK2 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 826, n_CMS2 = 36, n_CMS4 = 28, p = 5.2342762889855e-06
kfs-all: Analyzing LPCAT4 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 728, n_CMS2 = 36, n_CMS4 = 28, p = 0.002114606202923
kfs-all: Analyzing SLCO1B3 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 555, n_CMS2 = 36, n_CMS4 = 28, p = 0.49698610197016

kfs-all: Analyzing Glutathione CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1010, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.0960238666288593
kfs-all: Analyzing Glutamine CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1292, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.833558297529915
kfs-all: Analyzing HK2 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1397, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.362502336489908
kfs-all: Analyzing LDHA CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1093, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.266679960392063
kfs-all: Analyzing MGLL CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1616, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.0177121360087399
kfs-all: Analyzing ANGPTL4 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1241, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.901777974509518
kfs-all: Analyzing VEGFA CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1159, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.502572809321947
kfs-all: Analyzing ACSL5 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1166, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.532792237419438
kfs-all: Analyzing PCK2 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1362, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.498330943660433
kfs-all: Analyzing LPCAT4 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1596, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.0252106706427302
kfs-all: Analyzing SLCO1B3 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1549, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.05427731116211
kfs-all: Analyzing Glutathione CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 37, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.0085501009762884
kfs-all: Analyzing Glutamine CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 177, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.010964991709536
kfs-all: Analyzing HK2 CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 157, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.0812187153650568
kfs-all: Analyzing LDHA CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 39, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.010964991709536
kfs-all: Analyzing MGLL CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 81, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.349919344784557
kfs-all: Analyzing ANGPTL4 CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 69, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.170706925520789
kfs-all: Analyzing VEGFA CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 84, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.407916754514957
kfs-all: Analyzing ACSL5 CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 181, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.0065931015866831
kfs-all: Analyzing PCK2 CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 107, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.986028023255238
kfs-all: Analyzing LPCAT4 CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 62, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.103063296901551
kfs-all: Analyzing SLCO1B3 CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 110, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.958111139112423
kfs-all: Analyzing Glutathione CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 215, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 0.0125670342488362
kfs-all: Analyzing Glutamine CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 427, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 0.257981420720431
kfs-all: Analyzing HK2 CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 300, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 0.311864392548244
kfs-all: Analyzing LDHA CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 174, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 0.00115965948460609
kfs-all: Analyzing MGLL CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 491, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 0.0247268584092454
kfs-all: Analyzing ANGPTL4 CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 167, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 0.000722519255139741
kfs-all: Analyzing VEGFA CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 381, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 0.728222223455761
kfs-all: Analyzing ACSL5 CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 605, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 1.01872045308901e-05
kfs-all: Analyzing PCK2 CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 475, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 0.0496394577049873
kfs-all: Analyzing LPCAT4 CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 278, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 0.164812611474277
kfs-all: Analyzing SLCO1B3 CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 335, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 0.677879024962858
kfs-all: Analyzing Glutathione CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 456, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 0.284322476398598
kfs-all: Analyzing Glutamine CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 324, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 0.00499205485776451
kfs-all: Analyzing HK2 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 363, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 0.0223210379972394
kfs-all: Analyzing LDHA CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 427, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 0.148268917618362
kfs-all: Analyzing MGLL CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 211, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 1.05928639943232e-05
kfs-all: Analyzing ANGPTL4 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 450, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 0.25094774533553
kfs-all: Analyzing VEGFA CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 583, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 0.586527005201648
kfs-all: Analyzing ACSL5 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 618, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 0.32053516320865
kfs-all: Analyzing PCK2 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 617, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 0.32684751359689
kfs-all: Analyzing LPCAT4 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 362, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 0.02155397809898
kfs-all: Analyzing SLCO1B3 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 439, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 0.196984777158792
kfs-all: Analyzing Glutathione CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 280, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 0.428369088095339
kfs-all: Analyzing Glutamine CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 140, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 0.000512093926696793
kfs-all: Analyzing HK2 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 206, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 0.030130679170727
kfs-all: Analyzing LDHA CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 347, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 0.68251403611567
kfs-all: Analyzing MGLL CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 224, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 0.0675744351382051
kfs-all: Analyzing ANGPTL4 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 326, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 0.978256945587691
kfs-all: Analyzing VEGFA CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 492, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 0.0016494298384133
kfs-all: Analyzing ACSL5 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 405, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 0.140733185104561
kfs-all: Analyzing PCK2 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 400, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 0.167473797406819
kfs-all: Analyzing LPCAT4 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 168, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 0.00365256085078755
kfs-all: Analyzing SLCO1B3 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 398, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 0.179157204932334
kfs-all: Analyzing Glutathione CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 628, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 0.0948189816842378
kfs-all: Analyzing Glutamine CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 685, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 0.0138459694665933
kfs-all: Analyzing HK2 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 792, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 5.73068012408172e-05
kfs-all: Analyzing LDHA CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 606, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 0.170724752958389
kfs-all: Analyzing MGLL CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 618, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 0.125126965970328
kfs-all: Analyzing ANGPTL4 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 293, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 0.00389291529045654
kfs-all: Analyzing VEGFA CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 555, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 0.49698610197016
kfs-all: Analyzing ACSL5 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 879, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 5.30067405649127e-08
kfs-all: Analyzing PCK2 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 826, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 5.2342762889855e-06
kfs-all: Analyzing LPCAT4 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 728, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 0.002114606202923
kfs-all: Analyzing SLCO1B3 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 555, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 0.49698610197016
kfs-all: Analyzing Glutathione CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1212, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 0.00639523850862012
kfs-all: Analyzing Glutamine CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1250, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 0.00221751285897791
kfs-all: Analyzing HK2 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1504, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 1.27157943886965e-07
kfs-all: Analyzing LDHA CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1181, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 0.0140716039985989
kfs-all: Analyzing MGLL CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1228, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 0.00414570134842999
kfs-all: Analyzing ANGPTL4 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 600, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 0.00874791197737871
kfs-all: Analyzing VEGFA CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1017, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 0.307817016519284
kfs-all: Analyzing ACSL5 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1419, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 5.65683707271838e-06
kfs-all: Analyzing PCK2 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1437, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 2.64795306439162e-06
kfs-all: Analyzing LPCAT4 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1352, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 7.7395970345572e-05
kfs-all: Analyzing SLCO1B3 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1321, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 0.000232360191637224

Computing linear model with interaction for Glutathione
Computing linear model with interaction for Glutamine
Computing linear model with interaction for HK2
Computing linear model with interaction for LDHA
Computing linear model with interaction for MGLL
Computing linear model with interaction for ANGPTL4
Computing linear model with interaction for VEGFA
Computing linear model with interaction for ACSL5
Computing linear model with interaction for PCK2
Computing linear model with interaction for LPCAT4
Computing linear model with interaction for SLCO1B3
Computing linear model for Glutathione
Computing linear model for Glutamine
Computing linear model for HK2
Computing linear model for LDHA
Computing linear model for MGLL
Computing linear model for ANGPTL4
Computing linear model for VEGFA
Computing linear model for ACSL5
Computing linear model for PCK2
Computing linear model for LPCAT4
Computing linear model for SLCO1B3
kfs-all: Analyzing Glutathione CMS1 MT vs WT using Wilcoxon rank sum test: W = 48, n_MT = 6, n_WT = 20, p = 0.494192763757981
kfs-all: Analyzing Glutamine CMS1 MT vs WT using Wilcoxon rank sum test: W = 86, n_MT = 6, n_WT = 20, p = 0.122903183772749
kfs-all: Analyzing HK2 CMS1 MT vs WT using Wilcoxon rank sum test: W = 98, n_MT = 6, n_WT = 20, p = 0.0193893063458281
kfs-all: Analyzing LDHA CMS1 MT vs WT using Wilcoxon rank sum test: W = 56, n_MT = 6, n_WT = 20, p = 0.835772922729444
kfs-all: Analyzing MGLL CMS1 MT vs WT using Wilcoxon rank sum test: W = 35, n_MT = 6, n_WT = 20, p = 0.138956695478435
kfs-all: Analyzing ANGPTL4 CMS1 MT vs WT using Wilcoxon rank sum test: W = 64, n_MT = 6, n_WT = 20, p = 0.835772922729444
kfs-all: Analyzing VEGFA CMS1 MT vs WT using Wilcoxon rank sum test: W = 45, n_MT = 6, n_WT = 20, p = 0.387456022238631
kfs-all: Analyzing ACSL5 CMS1 MT vs WT using Wilcoxon rank sum test: W = 66, n_MT = 6, n_WT = 20, p = 0.744472918385962
kfs-all: Analyzing PCK2 CMS1 MT vs WT using Wilcoxon rank sum test: W = 41, n_MT = 6, n_WT = 20, p = 0.268079746340616
kfs-all: Analyzing LPCAT4 CMS1 MT vs WT using Wilcoxon rank sum test: W = 42, n_MT = 6, n_WT = 20, p = 0.295426312817617
kfs-all: Analyzing SLCO1B3 CMS1 MT vs WT using Wilcoxon rank sum test: W = 68, n_MT = 6, n_WT = 20, p = 0.656456586891369
kfs-all: Analyzing Glutathione CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1510, n_MT = 36, n_WT = 70, p = 0.0960238666288593
kfs-all: Analyzing Glutamine CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1228, n_MT = 36, n_WT = 70, p = 0.833558297529915
kfs-all: Analyzing HK2 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1123, n_MT = 36, n_WT = 70, p = 0.362502336489908
kfs-all: Analyzing LDHA CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1427, n_MT = 36, n_WT = 70, p = 0.266679960392063
kfs-all: Analyzing MGLL CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 904, n_MT = 36, n_WT = 70, p = 0.0177121360087399
kfs-all: Analyzing ANGPTL4 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1279, n_MT = 36, n_WT = 70, p = 0.901777974509518
kfs-all: Analyzing VEGFA CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1361, n_MT = 36, n_WT = 70, p = 0.502572809321947
kfs-all: Analyzing ACSL5 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1354, n_MT = 36, n_WT = 70, p = 0.532792237419438
kfs-all: Analyzing PCK2 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1158, n_MT = 36, n_WT = 70, p = 0.498330943660433
kfs-all: Analyzing LPCAT4 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 924, n_MT = 36, n_WT = 70, p = 0.0252106706427302
kfs-all: Analyzing SLCO1B3 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 971, n_MT = 36, n_WT = 70, p = 0.05427731116211
kfs-all: Analyzing Glutathione CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 610, n_MT = 28, n_WT = 50, p = 0.351203234230733
kfs-all: Analyzing Glutamine CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 674, n_MT = 28, n_WT = 50, p = 0.790535429329446
kfs-all: Analyzing HK2 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 599, n_MT = 28, n_WT = 50, p = 0.295174698786276
kfs-all: Analyzing LDHA CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 608, n_MT = 28, n_WT = 50, p = 0.340544204724429
kfs-all: Analyzing MGLL CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 646, n_MT = 28, n_WT = 50, p = 0.577341937237642
kfs-all: Analyzing ANGPTL4 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 629, n_MT = 28, n_WT = 50, p = 0.462736402416545
kfs-all: Analyzing VEGFA CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 686, n_MT = 28, n_WT = 50, p = 0.888170215453213
kfs-all: Analyzing ACSL5 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 698, n_MT = 28, n_WT = 50, p = 0.987534011837472
kfs-all: Analyzing PCK2 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 686, n_MT = 28, n_WT = 50, p = 0.888170215453213
kfs-all: Analyzing LPCAT4 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 616, n_MT = 28, n_WT = 50, p = 0.384431461044297
kfs-all: Analyzing SLCO1B3 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 446, n_MT = 28, n_WT = 50, p = 0.00827765867191855
kfs-all: Analyzing Glutathione CMS3 MT vs WT using Wilcoxon rank sum test: W = 266, n_MT = 30, n_WT = 18, p = 0.941194342744294
kfs-all: Analyzing Glutamine CMS3 MT vs WT using Wilcoxon rank sum test: W = 322, n_MT = 30, n_WT = 18, p = 0.275773808792665
kfs-all: Analyzing HK2 CMS3 MT vs WT using Wilcoxon rank sum test: W = 292, n_MT = 30, n_WT = 18, p = 0.650216839339942
kfs-all: Analyzing LDHA CMS3 MT vs WT using Wilcoxon rank sum test: W = 213, n_MT = 30, n_WT = 18, p = 0.231430760545345
kfs-all: Analyzing MGLL CMS3 MT vs WT using Wilcoxon rank sum test: W = 210, n_MT = 30, n_WT = 18, p = 0.207341586763028
kfs-all: Analyzing ANGPTL4 CMS3 MT vs WT using Wilcoxon rank sum test: W = 229, n_MT = 30, n_WT = 18, p = 0.392144231793003
kfs-all: Analyzing VEGFA CMS3 MT vs WT using Wilcoxon rank sum test: W = 160, n_MT = 30, n_WT = 18, p = 0.0186269854240848
kfs-all: Analyzing ACSL5 CMS3 MT vs WT using Wilcoxon rank sum test: W = 247, n_MT = 30, n_WT = 18, p = 0.635083539880693
kfs-all: Analyzing PCK2 CMS3 MT vs WT using Wilcoxon rank sum test: W = 246, n_MT = 30, n_WT = 18, p = 0.620098116458604
kfs-all: Analyzing LPCAT4 CMS3 MT vs WT using Wilcoxon rank sum test: W = 328, n_MT = 30, n_WT = 18, p = 0.2231940194302
kfs-all: Analyzing SLCO1B3 CMS3 MT vs WT using Wilcoxon rank sum test: W = 149, n_MT = 30, n_WT = 18, p = 0.00930237718812748

Computing linear model for Glutathione
Computing linear model for Glutamine
Computing linear model for HK2
Computing linear model for LDHA
Computing linear model for MGLL
Computing linear model for ANGPTL4
Computing linear model for VEGFA
Computing linear model for ACSL5
Computing linear model for PCK2
Computing linear model for LPCAT4
Computing linear model for SLCO1B3
Computing rectum vs left
kfs-all: Analyzing Glutathione site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2518, n_rectum = 188, n_left = 28, p = 0.712967451393763
kfs-all: Analyzing Glutamine site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2079, n_rectum = 188, n_left = 28, p = 0.0733333305743387
kfs-all: Analyzing HK2 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2363, n_rectum = 188, n_left = 28, p = 0.384160431476564
kfs-all: Analyzing LDHA site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2674, n_rectum = 188, n_left = 28, p = 0.893000200453283
kfs-all: Analyzing MGLL site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2410, n_rectum = 188, n_left = 28, p = 0.472806111599641
kfs-all: Analyzing ANGPTL4 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3124, n_rectum = 188, n_left = 28, p = 0.111151499984716
kfs-all: Analyzing VEGFA site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3206, n_rectum = 188, n_left = 28, p = 0.0630533233120351
kfs-all: Analyzing ACSL5 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2461, n_rectum = 188, n_left = 28, p = 0.580523120535704
kfs-all: Analyzing PCK2 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2427, n_rectum = 188, n_left = 28, p = 0.50744533091571
kfs-all: Analyzing LPCAT4 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2483, n_rectum = 188, n_left = 28, p = 0.630292737859599
kfs-all: Analyzing SLCO1B3 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2522, n_rectum = 188, n_left = 28, p = 0.722657813337244
Computing right vs left
kfs-all: Analyzing Glutathione site: right vs leftWilcoxon rank sum test with continuity correction: W = 733, n_right = 74, n_left = 28, p = 0.0233102849045013
kfs-all: Analyzing Glutamine site: right vs leftWilcoxon rank sum test with continuity correction: W = 834, n_right = 74, n_left = 28, p = 0.130799335360846
kfs-all: Analyzing HK2 site: right vs leftWilcoxon rank sum test with continuity correction: W = 803, n_right = 74, n_left = 28, p = 0.0812616306243277
kfs-all: Analyzing LDHA site: right vs leftWilcoxon rank sum test with continuity correction: W = 979, n_right = 74, n_left = 28, p = 0.671808012370056
kfs-all: Analyzing MGLL site: right vs leftWilcoxon rank sum test with continuity correction: W = 937, n_right = 74, n_left = 28, p = 0.460145727808952
kfs-all: Analyzing ANGPTL4 site: right vs leftWilcoxon rank sum test with continuity correction: W = 1074, n_right = 74, n_left = 28, p = 0.778560437823344
kfs-all: Analyzing VEGFA site: right vs leftWilcoxon rank sum test with continuity correction: W = 1307, n_right = 74, n_left = 28, p = 0.0425238208932949
kfs-all: Analyzing ACSL5 site: right vs leftWilcoxon rank sum test with continuity correction: W = 1224, n_right = 74, n_left = 28, p = 0.159730771026825
kfs-all: Analyzing PCK2 site: right vs leftWilcoxon rank sum test with continuity correction: W = 974, n_right = 74, n_left = 28, p = 0.644683344712815
kfs-all: Analyzing LPCAT4 site: right vs leftWilcoxon rank sum test with continuity correction: W = 853, n_right = 74, n_left = 28, p = 0.171160351060295
kfs-all: Analyzing SLCO1B3 site: right vs leftWilcoxon rank sum test with continuity correction: W = 836, n_right = 74, n_left = 28, p = 0.134664030749986

Plotting Glutathione ~ site
Plotting Glutamine ~ site
Plotting HK2 ~ site
Plotting LDHA ~ site
Plotting MGLL ~ site
Plotting ANGPTL4 ~ site
Plotting VEGFA ~ site
Plotting ACSL5 ~ site
Plotting PCK2 ~ site
Plotting LPCAT4 ~ site
Plotting SLCO1B3 ~ site
MSI nrow =  307 
  clusters Freq
1        1   88
2        2  219
MSI clusters: 1
MSS clusters: 2
[1] -7.580742e-16
[1] -2.182282e-15
Has CMS
Has TYMS
[1] 1.00 5.00 0.25 0.25 2.00
[1] 1.0 5.0 5.0 0.5 1.0 0.5
     [,1] [,2] [,3] [,4] [,5]
[1,]   NA    2    4    6   NA
[2,]    1    3    5    7    9
[3,]    1    3    5    7   10
[4,]   NA   NA   NA   NA   NA
[5,]   NA    8   NA   NA   NA
[6,]   NA   NA   NA   NA   NA
[1] 10
Beeswarm: TYMS vs Inferred.Status W = 11946 p = 0.00102436427595825 n_MSI = 88, n_MSS = 219
Number of rows analyzed: 20534
Number of columns analyzed: 290
kfs-all-msi-inferred: 46 of 49 genes from data set analyzed in set Glutathione: G6PD GCLC GCLM GGCT GGT1 GGT5 GGT6 GGT7 GPX1 GPX2 GPX3 GPX4 GPX5 GPX7 GSR GSS GSTA1 GSTA3 GSTA4 GSTK1 GSTM1 GSTM2 GSTM3 GSTM4 GSTM5 GSTO1 GSTO2 GSTP1 GSTT1 GSTT2 GSTZ1 IDH1 IDH2 LAP3 MGST1 MGST2 MGST3 ODC1 OPLAH PGD RRM1 RRM2 RRM2B SMS SRM TXNDC12
kfs-all-msi-inferred: 3 of 49 genes missing from data set analyzed in set Glutathione: GPX6 GSTA2 GSTA5
kfs-all-msi-inferred: 14 of 27 genes from data set analyzed in set Glutamine: CRYL1 DCXR DHDH GUSB RPE UGDH UGP2 UGT1A1 UGT2A3 UGT2B15 UGT2B17 UGT2B28 UGT2B4 XYLB
kfs-all-msi-inferred: 13 of 27 genes missing from data set analyzed in set Glutamine: LOC729020 UGT1A10 UGT1A3 UGT1A4 UGT1A5 UGT1A6 UGT1A7 UGT1A8 UGT1A9 UGT2A1 UGT2B10 UGT2B11 UGT2B7
Estimating GSVA scores for 26 gene sets.
Computing observed enrichment scores
Estimating ECDFs in microarray data with Gaussian kernels
Using parallel with 1 cores
  |                                                                              |                                                                      |   0%  |                                                                              |===                                                                   |   4%  |                                                                              |=====                                                                 |   8%  |                                                                              |========                                                              |  12%  |                                                                              |===========                                                           |  15%  |                                                                              |=============                                                         |  19%  |                                                                              |================                                                      |  23%  |                                                                              |===================                                                   |  27%  |                                                                              |======================                                                |  31%  |                                                                              |========================                                              |  35%  |                                                                              |===========================                                           |  38%  |                                                                              |==============================                                        |  42%  |                                                                              |================================                                      |  46%  |                                                                              |===================================                                   |  50%  |                                                                              |======================================                                |  54%  |                                                                              |========================================                              |  58%  |                                                                              |===========================================                           |  62%  |                                                                              |==============================================                        |  65%  |                                                                              |================================================                      |  69%  |                                                                              |===================================================                   |  73%  |                                                                              |======================================================                |  77%  |                                                                              |=========================================================             |  81%  |                                                                              |===========================================================           |  85%  |                                                                              |==============================================================        |  88%  |                                                                              |=================================================================     |  92%  |                                                                              |===================================================================   |  96%  |                                                                              |======================================================================| 100%
Done with gsva.
kfs-all-msi-inferred wnt vs CIRC: t = -4.05456248411765 df = 288 nrow = 290 cor = -0.232377199819908 pval = 6.47018657543056e-05
kfs-all-msi-inferred tak1 vs CIRC: t = 0.0739344032913428 df = 288 nrow = 290 cor = 0.00435658514997042 pval = 0.941113905371728
kfs-all-msi-inferred wnt vs myc.sig: t = 36.5923055069957 df = 288 nrow = 290 cor = 0.907186170025461 pval = 2.67104772325775e-110

kfs-all-msi-inferred: Analyzing Glutathione vs KRAS using Wilcoxon rank sum test with continuity correction: W = 10036, n_WT = 175, n_MT = 115, p = 0.970311425752835
kfs-all-msi-inferred: Analyzing Glutamine vs KRAS using Wilcoxon rank sum test with continuity correction: W = 9112, n_WT = 175, n_MT = 115, p = 0.173868691078931
kfs-all-msi-inferred: Analyzing HK2 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 9354, n_WT = 175, n_MT = 115, p = 0.31083734059092
kfs-all-msi-inferred: Analyzing LDHA vs KRAS using Wilcoxon rank sum test with continuity correction: W = 10240, n_WT = 175, n_MT = 115, p = 0.799984895958754
kfs-all-msi-inferred: Analyzing MGLL vs KRAS using Wilcoxon rank sum test with continuity correction: W = 7469, n_WT = 175, n_MT = 115, p = 0.000205831347447837
kfs-all-msi-inferred: Analyzing ANGPTL4 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 10310, n_WT = 175, n_MT = 115, p = 0.723662546359545
kfs-all-msi-inferred: Analyzing VEGFA vs KRAS using Wilcoxon rank sum test with continuity correction: W = 9998, n_WT = 175, n_MT = 115, p = 0.927005681102242
kfs-all-msi-inferred: Analyzing ACSL5 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 9831, n_WT = 175, n_MT = 115, p = 0.740897579508817
kfs-all-msi-inferred: Analyzing PCK2 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 9502, n_WT = 175, n_MT = 115, p = 0.422777432762042
kfs-all-msi-inferred: Analyzing LPCAT4 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 8427, n_WT = 175, n_MT = 115, p = 0.0192620256205299
kfs-all-msi-inferred: Analyzing SLCO1B3 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 7823, n_WT = 175, n_MT = 115, p = 0.00135054710908031

kfs-all-msi-inferred: Analyzing Glutathione CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1901, n_CMS2 = 106, n_CMS1 = 26, p = 0.00279353027479506
kfs-all-msi-inferred: Analyzing Glutamine CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1034, n_CMS2 = 106, n_CMS1 = 26, p = 0.0493674436629938
kfs-all-msi-inferred: Analyzing HK2 CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1505, n_CMS2 = 106, n_CMS1 = 26, p = 0.46919145333153
kfs-all-msi-inferred: Analyzing LDHA CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1977, n_CMS2 = 106, n_CMS1 = 26, p = 0.000616071631425172
kfs-all-msi-inferred: Analyzing MGLL CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1269, n_CMS2 = 106, n_CMS1 = 26, p = 0.534728188899034
kfs-all-msi-inferred: Analyzing ANGPTL4 CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 2045, n_CMS2 = 106, n_CMS1 = 26, p = 0.000137004738438349
kfs-all-msi-inferred: Analyzing VEGFA CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1304, n_CMS2 = 106, n_CMS1 = 26, p = 0.6740873197283
kfs-all-msi-inferred: Analyzing ACSL5 CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 419, n_CMS2 = 106, n_CMS1 = 26, p = 4.15225172153869e-08
kfs-all-msi-inferred: Analyzing PCK2 CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1133, n_CMS2 = 106, n_CMS1 = 26, p = 0.161826173964204
kfs-all-msi-inferred: Analyzing LPCAT4 CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1954, n_CMS2 = 106, n_CMS1 = 26, p = 0.000991811788595342
kfs-all-msi-inferred: Analyzing SLCO1B3 CMS2 vs CMS1 using Wilcoxon rank sum test with continuity correction: W = 1611, n_CMS2 = 106, n_CMS1 = 26, p = 0.183420897829387
kfs-all-msi-inferred: Analyzing Glutathione CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2463, n_CMS2 = 106, n_CMS3 = 48, p = 0.753511453566905
kfs-all-msi-inferred: Analyzing Glutamine CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1431, n_CMS2 = 106, n_CMS3 = 48, p = 1.42732294393739e-05
kfs-all-msi-inferred: Analyzing HK2 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1497, n_CMS2 = 106, n_CMS3 = 48, p = 4.46182798063354e-05
kfs-all-msi-inferred: Analyzing LDHA CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2514, n_CMS2 = 106, n_CMS3 = 48, p = 0.908387301940459
kfs-all-msi-inferred: Analyzing MGLL CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1038, n_CMS2 = 106, n_CMS3 = 48, p = 4.28958092604558e-09
kfs-all-msi-inferred: Analyzing ANGPTL4 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2262, n_CMS2 = 106, n_CMS3 = 48, p = 0.272174370795338
kfs-all-msi-inferred: Analyzing VEGFA CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 3284, n_CMS2 = 106, n_CMS3 = 48, p = 0.00391879837115252
kfs-all-msi-inferred: Analyzing ACSL5 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 3106, n_CMS2 = 106, n_CMS3 = 48, p = 0.0285034445056079
kfs-all-msi-inferred: Analyzing PCK2 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2812, n_CMS2 = 106, n_CMS3 = 48, p = 0.296736183227268
kfs-all-msi-inferred: Analyzing LPCAT4 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1160, n_CMS2 = 106, n_CMS3 = 48, p = 6.78678288052231e-08
kfs-all-msi-inferred: Analyzing SLCO1B3 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2081, n_CMS2 = 106, n_CMS3 = 48, p = 0.0712140995825452
kfs-all-msi-inferred: Analyzing Glutathione CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 5876, n_CMS2 = 106, n_CMS4 = 78, p = 1.07251103102367e-06
kfs-all-msi-inferred: Analyzing Glutamine CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 5631, n_CMS2 = 106, n_CMS4 = 78, p = 2.76977378707655e-05
kfs-all-msi-inferred: Analyzing HK2 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 6547, n_CMS2 = 106, n_CMS4 = 78, p = 1.40607335275883e-11
kfs-all-msi-inferred: Analyzing LDHA CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 5507, n_CMS2 = 106, n_CMS4 = 78, p = 0.000120898753969983
kfs-all-msi-inferred: Analyzing MGLL CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 4628, n_CMS2 = 106, n_CMS4 = 78, p = 0.166889986656229
kfs-all-msi-inferred: Analyzing ANGPTL4 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 2675, n_CMS2 = 106, n_CMS4 = 78, p = 4.40430864867418e-05
kfs-all-msi-inferred: Analyzing VEGFA CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 4808, n_CMS2 = 106, n_CMS4 = 78, p = 0.059236196426199
kfs-all-msi-inferred: Analyzing ACSL5 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 6867, n_CMS2 = 106, n_CMS4 = 78, p = 1.95458085949092e-14
kfs-all-msi-inferred: Analyzing PCK2 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 6494, n_CMS2 = 106, n_CMS4 = 78, p = 3.87372182371631e-11
kfs-all-msi-inferred: Analyzing LPCAT4 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 5604, n_CMS2 = 106, n_CMS4 = 78, p = 3.85524121134823e-05
kfs-all-msi-inferred: Analyzing SLCO1B3 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 4904, n_CMS2 = 106, n_CMS4 = 78, p = 0.0311362623062059


kfs-all-msi-inferred: Analyzing Glutathione CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 179, n_CMS2 = 36, n_CMS1 = 6, p = 0.0085501009762884
kfs-all-msi-inferred: Analyzing Glutamine CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 39, n_CMS2 = 36, n_CMS1 = 6, p = 0.010964991709536
kfs-all-msi-inferred: Analyzing HK2 CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 59, n_CMS2 = 36, n_CMS1 = 6, p = 0.0812187153650568
kfs-all-msi-inferred: Analyzing LDHA CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 177, n_CMS2 = 36, n_CMS1 = 6, p = 0.010964991709536
kfs-all-msi-inferred: Analyzing MGLL CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 135, n_CMS2 = 36, n_CMS1 = 6, p = 0.349919344784557
kfs-all-msi-inferred: Analyzing ANGPTL4 CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 147, n_CMS2 = 36, n_CMS1 = 6, p = 0.170706925520789
kfs-all-msi-inferred: Analyzing VEGFA CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 132, n_CMS2 = 36, n_CMS1 = 6, p = 0.407916754514957
kfs-all-msi-inferred: Analyzing ACSL5 CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 35, n_CMS2 = 36, n_CMS1 = 6, p = 0.0065931015866831
kfs-all-msi-inferred: Analyzing PCK2 CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 109, n_CMS2 = 36, n_CMS1 = 6, p = 0.986028023255238
kfs-all-msi-inferred: Analyzing LPCAT4 CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 154, n_CMS2 = 36, n_CMS1 = 6, p = 0.103063296901551
kfs-all-msi-inferred: Analyzing SLCO1B3 CMS2 vs CMS1 (KRAS MT only) using Wilcoxon rank sum test: W = 106, n_CMS2 = 36, n_CMS1 = 6, p = 0.958111139112423
kfs-all-msi-inferred: Analyzing Glutathione CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 456, n_CMS2 = 36, n_CMS3 = 30, p = 0.284322476398598
kfs-all-msi-inferred: Analyzing Glutamine CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 324, n_CMS2 = 36, n_CMS3 = 30, p = 0.00499205485776451
kfs-all-msi-inferred: Analyzing HK2 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 363, n_CMS2 = 36, n_CMS3 = 30, p = 0.0223210379972394
kfs-all-msi-inferred: Analyzing LDHA CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 427, n_CMS2 = 36, n_CMS3 = 30, p = 0.148268917618362
kfs-all-msi-inferred: Analyzing MGLL CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 211, n_CMS2 = 36, n_CMS3 = 30, p = 1.05928639943232e-05
kfs-all-msi-inferred: Analyzing ANGPTL4 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 450, n_CMS2 = 36, n_CMS3 = 30, p = 0.25094774533553
kfs-all-msi-inferred: Analyzing VEGFA CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 583, n_CMS2 = 36, n_CMS3 = 30, p = 0.586527005201648
kfs-all-msi-inferred: Analyzing ACSL5 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 618, n_CMS2 = 36, n_CMS3 = 30, p = 0.32053516320865
kfs-all-msi-inferred: Analyzing PCK2 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 617, n_CMS2 = 36, n_CMS3 = 30, p = 0.32684751359689
kfs-all-msi-inferred: Analyzing LPCAT4 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 362, n_CMS2 = 36, n_CMS3 = 30, p = 0.02155397809898
kfs-all-msi-inferred: Analyzing SLCO1B3 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 439, n_CMS2 = 36, n_CMS3 = 30, p = 0.196984777158792
kfs-all-msi-inferred: Analyzing Glutathione CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 628, n_CMS2 = 36, n_CMS4 = 28, p = 0.0948189816842378
kfs-all-msi-inferred: Analyzing Glutamine CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 685, n_CMS2 = 36, n_CMS4 = 28, p = 0.0138459694665933
kfs-all-msi-inferred: Analyzing HK2 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 792, n_CMS2 = 36, n_CMS4 = 28, p = 5.73068012408172e-05
kfs-all-msi-inferred: Analyzing LDHA CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 606, n_CMS2 = 36, n_CMS4 = 28, p = 0.170724752958389
kfs-all-msi-inferred: Analyzing MGLL CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 618, n_CMS2 = 36, n_CMS4 = 28, p = 0.125126965970328
kfs-all-msi-inferred: Analyzing ANGPTL4 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 293, n_CMS2 = 36, n_CMS4 = 28, p = 0.00389291529045654
kfs-all-msi-inferred: Analyzing VEGFA CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 555, n_CMS2 = 36, n_CMS4 = 28, p = 0.49698610197016
kfs-all-msi-inferred: Analyzing ACSL5 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 879, n_CMS2 = 36, n_CMS4 = 28, p = 5.30067405649127e-08
kfs-all-msi-inferred: Analyzing PCK2 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 826, n_CMS2 = 36, n_CMS4 = 28, p = 5.2342762889855e-06
kfs-all-msi-inferred: Analyzing LPCAT4 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 728, n_CMS2 = 36, n_CMS4 = 28, p = 0.002114606202923
kfs-all-msi-inferred: Analyzing SLCO1B3 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 555, n_CMS2 = 36, n_CMS4 = 28, p = 0.49698610197016

kfs-all-msi-inferred: Analyzing Glutathione CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1010, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.0960238666288593
kfs-all-msi-inferred: Analyzing Glutamine CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1292, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.833558297529915
kfs-all-msi-inferred: Analyzing HK2 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1397, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.362502336489908
kfs-all-msi-inferred: Analyzing LDHA CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1093, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.266679960392063
kfs-all-msi-inferred: Analyzing MGLL CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1616, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.0177121360087399
kfs-all-msi-inferred: Analyzing ANGPTL4 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1241, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.901777974509518
kfs-all-msi-inferred: Analyzing VEGFA CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1159, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.502572809321947
kfs-all-msi-inferred: Analyzing ACSL5 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1166, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.532792237419438
kfs-all-msi-inferred: Analyzing PCK2 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1362, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.498330943660433
kfs-all-msi-inferred: Analyzing LPCAT4 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1596, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.0252106706427302
kfs-all-msi-inferred: Analyzing SLCO1B3 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1549, n_CMS2-MT = 36, n_CMS2-WT = 70, p = 0.05427731116211
kfs-all-msi-inferred: Analyzing Glutathione CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 37, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.0085501009762884
kfs-all-msi-inferred: Analyzing Glutamine CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 177, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.010964991709536
kfs-all-msi-inferred: Analyzing HK2 CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 157, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.0812187153650568
kfs-all-msi-inferred: Analyzing LDHA CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 39, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.010964991709536
kfs-all-msi-inferred: Analyzing MGLL CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 81, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.349919344784557
kfs-all-msi-inferred: Analyzing ANGPTL4 CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 69, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.170706925520789
kfs-all-msi-inferred: Analyzing VEGFA CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 84, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.407916754514957
kfs-all-msi-inferred: Analyzing ACSL5 CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 181, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.0065931015866831
kfs-all-msi-inferred: Analyzing PCK2 CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 107, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.986028023255238
kfs-all-msi-inferred: Analyzing LPCAT4 CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 62, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.103063296901551
kfs-all-msi-inferred: Analyzing SLCO1B3 CMS2-MT vs CMS1-MT using Wilcoxon rank sum test: W = 110, n_CMS2-MT = 36, n_CMS1-MT = 6, p = 0.958111139112423
kfs-all-msi-inferred: Analyzing Glutathione CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 215, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 0.0125670342488362
kfs-all-msi-inferred: Analyzing Glutamine CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 427, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 0.257981420720431
kfs-all-msi-inferred: Analyzing HK2 CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 300, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 0.311864392548244
kfs-all-msi-inferred: Analyzing LDHA CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 174, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 0.00115965948460609
kfs-all-msi-inferred: Analyzing MGLL CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 491, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 0.0247268584092454
kfs-all-msi-inferred: Analyzing ANGPTL4 CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 167, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 0.000722519255139741
kfs-all-msi-inferred: Analyzing VEGFA CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 381, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 0.728222223455761
kfs-all-msi-inferred: Analyzing ACSL5 CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 605, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 1.01872045308901e-05
kfs-all-msi-inferred: Analyzing PCK2 CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 475, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 0.0496394577049873
kfs-all-msi-inferred: Analyzing LPCAT4 CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 278, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 0.164812611474277
kfs-all-msi-inferred: Analyzing SLCO1B3 CMS2-MT vs CMS1-WT using Wilcoxon rank sum test: W = 335, n_CMS2-MT = 36, n_CMS1-WT = 20, p = 0.677879024962858
kfs-all-msi-inferred: Analyzing Glutathione CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 456, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 0.284322476398598
kfs-all-msi-inferred: Analyzing Glutamine CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 324, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 0.00499205485776451
kfs-all-msi-inferred: Analyzing HK2 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 363, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 0.0223210379972394
kfs-all-msi-inferred: Analyzing LDHA CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 427, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 0.148268917618362
kfs-all-msi-inferred: Analyzing MGLL CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 211, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 1.05928639943232e-05
kfs-all-msi-inferred: Analyzing ANGPTL4 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 450, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 0.25094774533553
kfs-all-msi-inferred: Analyzing VEGFA CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 583, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 0.586527005201648
kfs-all-msi-inferred: Analyzing ACSL5 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 618, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 0.32053516320865
kfs-all-msi-inferred: Analyzing PCK2 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 617, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 0.32684751359689
kfs-all-msi-inferred: Analyzing LPCAT4 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 362, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 0.02155397809898
kfs-all-msi-inferred: Analyzing SLCO1B3 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 439, n_CMS2-MT = 36, n_CMS3-MT = 30, p = 0.196984777158792
kfs-all-msi-inferred: Analyzing Glutathione CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 280, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 0.428369088095339
kfs-all-msi-inferred: Analyzing Glutamine CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 140, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 0.000512093926696793
kfs-all-msi-inferred: Analyzing HK2 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 206, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 0.030130679170727
kfs-all-msi-inferred: Analyzing LDHA CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 347, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 0.68251403611567
kfs-all-msi-inferred: Analyzing MGLL CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 224, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 0.0675744351382051
kfs-all-msi-inferred: Analyzing ANGPTL4 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 326, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 0.978256945587691
kfs-all-msi-inferred: Analyzing VEGFA CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 492, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 0.0016494298384133
kfs-all-msi-inferred: Analyzing ACSL5 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 405, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 0.140733185104561
kfs-all-msi-inferred: Analyzing PCK2 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 400, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 0.167473797406819
kfs-all-msi-inferred: Analyzing LPCAT4 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 168, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 0.00365256085078755
kfs-all-msi-inferred: Analyzing SLCO1B3 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 398, n_CMS2-MT = 36, n_CMS3-WT = 18, p = 0.179157204932334
kfs-all-msi-inferred: Analyzing Glutathione CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 628, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 0.0948189816842378
kfs-all-msi-inferred: Analyzing Glutamine CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 685, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 0.0138459694665933
kfs-all-msi-inferred: Analyzing HK2 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 792, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 5.73068012408172e-05
kfs-all-msi-inferred: Analyzing LDHA CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 606, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 0.170724752958389
kfs-all-msi-inferred: Analyzing MGLL CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 618, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 0.125126965970328
kfs-all-msi-inferred: Analyzing ANGPTL4 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 293, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 0.00389291529045654
kfs-all-msi-inferred: Analyzing VEGFA CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 555, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 0.49698610197016
kfs-all-msi-inferred: Analyzing ACSL5 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 879, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 5.30067405649127e-08
kfs-all-msi-inferred: Analyzing PCK2 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 826, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 5.2342762889855e-06
kfs-all-msi-inferred: Analyzing LPCAT4 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 728, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 0.002114606202923
kfs-all-msi-inferred: Analyzing SLCO1B3 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 555, n_CMS2-MT = 36, n_CMS4-MT = 28, p = 0.49698610197016
kfs-all-msi-inferred: Analyzing Glutathione CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1212, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 0.00639523850862012
kfs-all-msi-inferred: Analyzing Glutamine CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1250, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 0.00221751285897791
kfs-all-msi-inferred: Analyzing HK2 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1504, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 1.27157943886965e-07
kfs-all-msi-inferred: Analyzing LDHA CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1181, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 0.0140716039985989
kfs-all-msi-inferred: Analyzing MGLL CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1228, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 0.00414570134842999
kfs-all-msi-inferred: Analyzing ANGPTL4 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 600, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 0.00874791197737871
kfs-all-msi-inferred: Analyzing VEGFA CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1017, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 0.307817016519284
kfs-all-msi-inferred: Analyzing ACSL5 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1419, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 5.65683707271838e-06
kfs-all-msi-inferred: Analyzing PCK2 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1437, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 2.64795306439162e-06
kfs-all-msi-inferred: Analyzing LPCAT4 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1352, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 7.7395970345572e-05
kfs-all-msi-inferred: Analyzing SLCO1B3 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test with continuity correction: W = 1321, n_CMS2-MT = 36, n_CMS4-WT = 50, p = 0.000232360191637224

Computing linear model with interaction for Glutathione
Computing linear model with interaction for Glutamine
Computing linear model with interaction for HK2
Computing linear model with interaction for LDHA
Computing linear model with interaction for MGLL
Computing linear model with interaction for ANGPTL4
Computing linear model with interaction for VEGFA
Computing linear model with interaction for ACSL5
Computing linear model with interaction for PCK2
Computing linear model with interaction for LPCAT4
Computing linear model with interaction for SLCO1B3
Computing linear model for Glutathione
Computing linear model for Glutamine
Computing linear model for HK2
Computing linear model for LDHA
Computing linear model for MGLL
Computing linear model for ANGPTL4
Computing linear model for VEGFA
Computing linear model for ACSL5
Computing linear model for PCK2
Computing linear model for LPCAT4
Computing linear model for SLCO1B3
kfs-all-msi-inferred: Analyzing Glutathione CMS1 MT vs WT using Wilcoxon rank sum test: W = 48, n_MT = 6, n_WT = 20, p = 0.494192763757981
kfs-all-msi-inferred: Analyzing Glutamine CMS1 MT vs WT using Wilcoxon rank sum test: W = 86, n_MT = 6, n_WT = 20, p = 0.122903183772749
kfs-all-msi-inferred: Analyzing HK2 CMS1 MT vs WT using Wilcoxon rank sum test: W = 98, n_MT = 6, n_WT = 20, p = 0.0193893063458281
kfs-all-msi-inferred: Analyzing LDHA CMS1 MT vs WT using Wilcoxon rank sum test: W = 56, n_MT = 6, n_WT = 20, p = 0.835772922729444
kfs-all-msi-inferred: Analyzing MGLL CMS1 MT vs WT using Wilcoxon rank sum test: W = 35, n_MT = 6, n_WT = 20, p = 0.138956695478435
kfs-all-msi-inferred: Analyzing ANGPTL4 CMS1 MT vs WT using Wilcoxon rank sum test: W = 64, n_MT = 6, n_WT = 20, p = 0.835772922729444
kfs-all-msi-inferred: Analyzing VEGFA CMS1 MT vs WT using Wilcoxon rank sum test: W = 45, n_MT = 6, n_WT = 20, p = 0.387456022238631
kfs-all-msi-inferred: Analyzing ACSL5 CMS1 MT vs WT using Wilcoxon rank sum test: W = 66, n_MT = 6, n_WT = 20, p = 0.744472918385962
kfs-all-msi-inferred: Analyzing PCK2 CMS1 MT vs WT using Wilcoxon rank sum test: W = 41, n_MT = 6, n_WT = 20, p = 0.268079746340616
kfs-all-msi-inferred: Analyzing LPCAT4 CMS1 MT vs WT using Wilcoxon rank sum test: W = 42, n_MT = 6, n_WT = 20, p = 0.295426312817617
kfs-all-msi-inferred: Analyzing SLCO1B3 CMS1 MT vs WT using Wilcoxon rank sum test: W = 68, n_MT = 6, n_WT = 20, p = 0.656456586891369
kfs-all-msi-inferred: Analyzing Glutathione CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1510, n_MT = 36, n_WT = 70, p = 0.0960238666288593
kfs-all-msi-inferred: Analyzing Glutamine CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1228, n_MT = 36, n_WT = 70, p = 0.833558297529915
kfs-all-msi-inferred: Analyzing HK2 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1123, n_MT = 36, n_WT = 70, p = 0.362502336489908
kfs-all-msi-inferred: Analyzing LDHA CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1427, n_MT = 36, n_WT = 70, p = 0.266679960392063
kfs-all-msi-inferred: Analyzing MGLL CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 904, n_MT = 36, n_WT = 70, p = 0.0177121360087399
kfs-all-msi-inferred: Analyzing ANGPTL4 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1279, n_MT = 36, n_WT = 70, p = 0.901777974509518
kfs-all-msi-inferred: Analyzing VEGFA CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1361, n_MT = 36, n_WT = 70, p = 0.502572809321947
kfs-all-msi-inferred: Analyzing ACSL5 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1354, n_MT = 36, n_WT = 70, p = 0.532792237419438
kfs-all-msi-inferred: Analyzing PCK2 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1158, n_MT = 36, n_WT = 70, p = 0.498330943660433
kfs-all-msi-inferred: Analyzing LPCAT4 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 924, n_MT = 36, n_WT = 70, p = 0.0252106706427302
kfs-all-msi-inferred: Analyzing SLCO1B3 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 971, n_MT = 36, n_WT = 70, p = 0.05427731116211
kfs-all-msi-inferred: Analyzing Glutathione CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 610, n_MT = 28, n_WT = 50, p = 0.351203234230733
kfs-all-msi-inferred: Analyzing Glutamine CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 674, n_MT = 28, n_WT = 50, p = 0.790535429329446
kfs-all-msi-inferred: Analyzing HK2 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 599, n_MT = 28, n_WT = 50, p = 0.295174698786276
kfs-all-msi-inferred: Analyzing LDHA CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 608, n_MT = 28, n_WT = 50, p = 0.340544204724429
kfs-all-msi-inferred: Analyzing MGLL CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 646, n_MT = 28, n_WT = 50, p = 0.577341937237642
kfs-all-msi-inferred: Analyzing ANGPTL4 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 629, n_MT = 28, n_WT = 50, p = 0.462736402416545
kfs-all-msi-inferred: Analyzing VEGFA CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 686, n_MT = 28, n_WT = 50, p = 0.888170215453213
kfs-all-msi-inferred: Analyzing ACSL5 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 698, n_MT = 28, n_WT = 50, p = 0.987534011837472
kfs-all-msi-inferred: Analyzing PCK2 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 686, n_MT = 28, n_WT = 50, p = 0.888170215453213
kfs-all-msi-inferred: Analyzing LPCAT4 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 616, n_MT = 28, n_WT = 50, p = 0.384431461044297
kfs-all-msi-inferred: Analyzing SLCO1B3 CMS4 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 446, n_MT = 28, n_WT = 50, p = 0.00827765867191855
kfs-all-msi-inferred: Analyzing Glutathione CMS3 MT vs WT using Wilcoxon rank sum test: W = 266, n_MT = 30, n_WT = 18, p = 0.941194342744294
kfs-all-msi-inferred: Analyzing Glutamine CMS3 MT vs WT using Wilcoxon rank sum test: W = 322, n_MT = 30, n_WT = 18, p = 0.275773808792665
kfs-all-msi-inferred: Analyzing HK2 CMS3 MT vs WT using Wilcoxon rank sum test: W = 292, n_MT = 30, n_WT = 18, p = 0.650216839339942
kfs-all-msi-inferred: Analyzing LDHA CMS3 MT vs WT using Wilcoxon rank sum test: W = 213, n_MT = 30, n_WT = 18, p = 0.231430760545345
kfs-all-msi-inferred: Analyzing MGLL CMS3 MT vs WT using Wilcoxon rank sum test: W = 210, n_MT = 30, n_WT = 18, p = 0.207341586763028
kfs-all-msi-inferred: Analyzing ANGPTL4 CMS3 MT vs WT using Wilcoxon rank sum test: W = 229, n_MT = 30, n_WT = 18, p = 0.392144231793003
kfs-all-msi-inferred: Analyzing VEGFA CMS3 MT vs WT using Wilcoxon rank sum test: W = 160, n_MT = 30, n_WT = 18, p = 0.0186269854240848
kfs-all-msi-inferred: Analyzing ACSL5 CMS3 MT vs WT using Wilcoxon rank sum test: W = 247, n_MT = 30, n_WT = 18, p = 0.635083539880693
kfs-all-msi-inferred: Analyzing PCK2 CMS3 MT vs WT using Wilcoxon rank sum test: W = 246, n_MT = 30, n_WT = 18, p = 0.620098116458604
kfs-all-msi-inferred: Analyzing LPCAT4 CMS3 MT vs WT using Wilcoxon rank sum test: W = 328, n_MT = 30, n_WT = 18, p = 0.2231940194302
kfs-all-msi-inferred: Analyzing SLCO1B3 CMS3 MT vs WT using Wilcoxon rank sum test: W = 149, n_MT = 30, n_WT = 18, p = 0.00930237718812748

Computing linear model for Glutathione
Computing linear model for Glutamine
Computing linear model for HK2
Computing linear model for LDHA
Computing linear model for MGLL
Computing linear model for ANGPTL4
Computing linear model for VEGFA
Computing linear model for ACSL5
Computing linear model for PCK2
Computing linear model for LPCAT4
Computing linear model for SLCO1B3
Computing rectum vs left
kfs-all-msi-inferred: Analyzing Glutathione site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2518, n_rectum = 188, n_left = 28, p = 0.712967451393763
kfs-all-msi-inferred: Analyzing Glutamine site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2079, n_rectum = 188, n_left = 28, p = 0.0733333305743387
kfs-all-msi-inferred: Analyzing HK2 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2363, n_rectum = 188, n_left = 28, p = 0.384160431476564
kfs-all-msi-inferred: Analyzing LDHA site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2674, n_rectum = 188, n_left = 28, p = 0.893000200453283
kfs-all-msi-inferred: Analyzing MGLL site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2410, n_rectum = 188, n_left = 28, p = 0.472806111599641
kfs-all-msi-inferred: Analyzing ANGPTL4 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3124, n_rectum = 188, n_left = 28, p = 0.111151499984716
kfs-all-msi-inferred: Analyzing VEGFA site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 3206, n_rectum = 188, n_left = 28, p = 0.0630533233120351
kfs-all-msi-inferred: Analyzing ACSL5 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2461, n_rectum = 188, n_left = 28, p = 0.580523120535704
kfs-all-msi-inferred: Analyzing PCK2 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2427, n_rectum = 188, n_left = 28, p = 0.50744533091571
kfs-all-msi-inferred: Analyzing LPCAT4 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2483, n_rectum = 188, n_left = 28, p = 0.630292737859599
kfs-all-msi-inferred: Analyzing SLCO1B3 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 2522, n_rectum = 188, n_left = 28, p = 0.722657813337244
Computing right vs left
kfs-all-msi-inferred: Analyzing Glutathione site: right vs leftWilcoxon rank sum test with continuity correction: W = 733, n_right = 74, n_left = 28, p = 0.0233102849045013
kfs-all-msi-inferred: Analyzing Glutamine site: right vs leftWilcoxon rank sum test with continuity correction: W = 834, n_right = 74, n_left = 28, p = 0.130799335360846
kfs-all-msi-inferred: Analyzing HK2 site: right vs leftWilcoxon rank sum test with continuity correction: W = 803, n_right = 74, n_left = 28, p = 0.0812616306243277
kfs-all-msi-inferred: Analyzing LDHA site: right vs leftWilcoxon rank sum test with continuity correction: W = 979, n_right = 74, n_left = 28, p = 0.671808012370056
kfs-all-msi-inferred: Analyzing MGLL site: right vs leftWilcoxon rank sum test with continuity correction: W = 937, n_right = 74, n_left = 28, p = 0.460145727808952
kfs-all-msi-inferred: Analyzing ANGPTL4 site: right vs leftWilcoxon rank sum test with continuity correction: W = 1074, n_right = 74, n_left = 28, p = 0.778560437823344
kfs-all-msi-inferred: Analyzing VEGFA site: right vs leftWilcoxon rank sum test with continuity correction: W = 1307, n_right = 74, n_left = 28, p = 0.0425238208932949
kfs-all-msi-inferred: Analyzing ACSL5 site: right vs leftWilcoxon rank sum test with continuity correction: W = 1224, n_right = 74, n_left = 28, p = 0.159730771026825
kfs-all-msi-inferred: Analyzing PCK2 site: right vs leftWilcoxon rank sum test with continuity correction: W = 974, n_right = 74, n_left = 28, p = 0.644683344712815
kfs-all-msi-inferred: Analyzing LPCAT4 site: right vs leftWilcoxon rank sum test with continuity correction: W = 853, n_right = 74, n_left = 28, p = 0.171160351060295
kfs-all-msi-inferred: Analyzing SLCO1B3 site: right vs leftWilcoxon rank sum test with continuity correction: W = 836, n_right = 74, n_left = 28, p = 0.134664030749986

Plotting Glutathione ~ site
Plotting Glutamine ~ site
Plotting HK2 ~ site
Plotting LDHA ~ site
Plotting MGLL ~ site
Plotting ANGPTL4 ~ site
Plotting VEGFA ~ site
Plotting ACSL5 ~ site
Plotting PCK2 ~ site
Plotting LPCAT4 ~ site
Plotting SLCO1B3 ~ site
Computing MSS vs MSI
kfs-all-msi-inferred: Analyzing Glutathione status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 8698, n_MSS = 212, n_MSI = 78, p = 0.497610955160033
kfs-all-msi-inferred: Analyzing Glutamine status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 6147, n_MSS = 212, n_MSI = 78, p = 0.000812121489312666
kfs-all-msi-inferred: Analyzing HK2 status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 7145, n_MSS = 212, n_MSI = 78, p = 0.0762919651659562
kfs-all-msi-inferred: Analyzing LDHA status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 8223, n_MSS = 212, n_MSI = 78, p = 0.943976318996889
kfs-all-msi-inferred: Analyzing MGLL status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 7131, n_MSS = 212, n_MSI = 78, p = 0.072697245834314
kfs-all-msi-inferred: Analyzing ANGPTL4 status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 11893, n_MSS = 212, n_MSI = 78, p = 1.04227617886781e-08
kfs-all-msi-inferred: Analyzing VEGFA status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 7339, n_MSS = 212, n_MSI = 78, p = 0.142577635829838
kfs-all-msi-inferred: Analyzing ACSL5 status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 2172, n_MSS = 212, n_MSI = 78, p = 6.22020926552015e-22
kfs-all-msi-inferred: Analyzing PCK2 status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 5432, n_MSS = 212, n_MSI = 78, p = 7.54385790447158e-06
kfs-all-msi-inferred: Analyzing LPCAT4 status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 8708, n_MSS = 212, n_MSI = 78, p = 0.487653842132521
kfs-all-msi-inferred: Analyzing SLCO1B3 status: MSS vs MSIWilcoxon rank sum test with continuity correction: W = 7654, n_MSS = 212, n_MSI = 78, p = 0.332634596187823

Plotting Glutathione ~ status
Plotting Glutamine ~ status
Plotting HK2 ~ status
Plotting LDHA ~ status
Plotting MGLL ~ status
Plotting ANGPTL4 ~ status
Plotting VEGFA ~ status
Plotting ACSL5 ~ status
Plotting PCK2 ~ status
Plotting LPCAT4 ~ status
Plotting SLCO1B3 ~ status
Overlap of MSI and CMS1 in KFS inferred:
     
      CMS1 CMS2 CMS3 CMS4 NOLBL
  msi   29    1   13   38     7
  mss    1  109   36   47    26
Number of rows analyzed: 20534
Number of columns analyzed: 211
kfs-mss-msi-inferred-no-cms1: 46 of 49 genes from data set analyzed in set Glutathione: G6PD GCLC GCLM GGCT GGT1 GGT5 GGT6 GGT7 GPX1 GPX2 GPX3 GPX4 GPX5 GPX7 GSR GSS GSTA1 GSTA3 GSTA4 GSTK1 GSTM1 GSTM2 GSTM3 GSTM4 GSTM5 GSTO1 GSTO2 GSTP1 GSTT1 GSTT2 GSTZ1 IDH1 IDH2 LAP3 MGST1 MGST2 MGST3 ODC1 OPLAH PGD RRM1 RRM2 RRM2B SMS SRM TXNDC12
kfs-mss-msi-inferred-no-cms1: 3 of 49 genes missing from data set analyzed in set Glutathione: GPX6 GSTA2 GSTA5
kfs-mss-msi-inferred-no-cms1: 14 of 27 genes from data set analyzed in set Glutamine: CRYL1 DCXR DHDH GUSB RPE UGDH UGP2 UGT1A1 UGT2A3 UGT2B15 UGT2B17 UGT2B28 UGT2B4 XYLB
kfs-mss-msi-inferred-no-cms1: 13 of 27 genes missing from data set analyzed in set Glutamine: LOC729020 UGT1A10 UGT1A3 UGT1A4 UGT1A5 UGT1A6 UGT1A7 UGT1A8 UGT1A9 UGT2A1 UGT2B10 UGT2B11 UGT2B7
Estimating GSVA scores for 26 gene sets.
Computing observed enrichment scores
Estimating ECDFs in microarray data with Gaussian kernels
Using parallel with 1 cores
  |                                                                              |                                                                      |   0%  |                                                                              |===                                                                   |   4%  |                                                                              |=====                                                                 |   8%  |                                                                              |========                                                              |  12%  |                                                                              |===========                                                           |  15%  |                                                                              |=============                                                         |  19%  |                                                                              |================                                                      |  23%  |                                                                              |===================                                                   |  27%  |                                                                              |======================                                                |  31%  |                                                                              |========================                                              |  35%  |                                                                              |===========================                                           |  38%  |                                                                              |==============================                                        |  42%  |                                                                              |================================                                      |  46%  |                                                                              |===================================                                   |  50%  |                                                                              |======================================                                |  54%  |                                                                              |========================================                              |  58%  |                                                                              |===========================================                           |  62%  |                                                                              |==============================================                        |  65%  |                                                                              |================================================                      |  69%  |                                                                              |===================================================                   |  73%  |                                                                              |======================================================                |  77%  |                                                                              |=========================================================             |  81%  |                                                                              |===========================================================           |  85%  |                                                                              |==============================================================        |  88%  |                                                                              |=================================================================     |  92%  |                                                                              |===================================================================   |  96%  |                                                                              |======================================================================| 100%
Done with gsva.
kfs-mss-msi-inferred-no-cms1 wnt vs CIRC: t = -3.23020603368078 df = 209 nrow = 211 cor = -0.218061018136961 pval = 0.00143684613896936
kfs-mss-msi-inferred-no-cms1 tak1 vs CIRC: t = 0.103983849729605 df = 209 nrow = 211 cor = 0.00719252723590502 pval = 0.917281879818365
kfs-mss-msi-inferred-no-cms1 wnt vs myc.sig: t = 28.7641064192965 df = 209 nrow = 211 cor = 0.893496118953304 pval = 1.32909498722966e-74

kfs-mss-msi-inferred-no-cms1: Analyzing Glutathione vs KRAS using Wilcoxon rank sum test with continuity correction: W = 5906, n_WT = 121, n_MT = 90, p = 0.293774705625669
kfs-mss-msi-inferred-no-cms1: Analyzing Glutamine vs KRAS using Wilcoxon rank sum test with continuity correction: W = 4961, n_WT = 121, n_MT = 90, p = 0.270325286614632
kfs-mss-msi-inferred-no-cms1: Analyzing HK2 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 5072, n_WT = 121, n_MT = 90, p = 0.395742768454157
kfs-mss-msi-inferred-no-cms1: Analyzing LDHA vs KRAS using Wilcoxon rank sum test with continuity correction: W = 5856, n_WT = 121, n_MT = 90, p = 0.349333036299619
kfs-mss-msi-inferred-no-cms1: Analyzing MGLL vs KRAS using Wilcoxon rank sum test with continuity correction: W = 4275, n_WT = 121, n_MT = 90, p = 0.00766912701941966
kfs-mss-msi-inferred-no-cms1: Analyzing ANGPTL4 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 5610, n_WT = 121, n_MT = 90, p = 0.707632603431447
kfs-mss-msi-inferred-no-cms1: Analyzing VEGFA vs KRAS using Wilcoxon rank sum test with continuity correction: W = 5884, n_WT = 121, n_MT = 90, p = 0.317446064017885
kfs-mss-msi-inferred-no-cms1: Analyzing ACSL5 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 5966, n_WT = 121, n_MT = 90, p = 0.235358326744024
kfs-mss-msi-inferred-no-cms1: Analyzing PCK2 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 5712, n_WT = 121, n_MT = 90, p = 0.543463751844189
kfs-mss-msi-inferred-no-cms1: Analyzing LPCAT4 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 4573, n_WT = 121, n_MT = 90, p = 0.0469334115054556
kfs-mss-msi-inferred-no-cms1: Analyzing SLCO1B3 vs KRAS using Wilcoxon rank sum test with continuity correction: W = 4090, n_WT = 121, n_MT = 90, p = 0.00201457994275073

kfs-mss-msi-inferred-no-cms1: Analyzing Glutathione CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2073, n_CMS2 = 105, n_CMS3 = 35, p = 0.258101509544491
kfs-mss-msi-inferred-no-cms1: Analyzing Glutamine CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 979, n_CMS2 = 105, n_CMS3 = 35, p = 3.64422743568279e-05
kfs-mss-msi-inferred-no-cms1: Analyzing HK2 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 778, n_CMS2 = 105, n_CMS3 = 35, p = 3.4649841260333e-07
kfs-mss-msi-inferred-no-cms1: Analyzing LDHA CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1989, n_CMS2 = 105, n_CMS3 = 35, p = 0.467436223323724
kfs-mss-msi-inferred-no-cms1: Analyzing MGLL CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 569, n_CMS2 = 105, n_CMS3 = 35, p = 1.04754485084564e-09
kfs-mss-msi-inferred-no-cms1: Analyzing ANGPTL4 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1878, n_CMS2 = 105, n_CMS3 = 35, p = 0.847356937458245
kfs-mss-msi-inferred-no-cms1: Analyzing VEGFA CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 2455, n_CMS2 = 105, n_CMS3 = 35, p = 0.00298588771604122
kfs-mss-msi-inferred-no-cms1: Analyzing ACSL5 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1876, n_CMS2 = 105, n_CMS3 = 35, p = 0.854902161202015
kfs-mss-msi-inferred-no-cms1: Analyzing PCK2 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1826, n_CMS2 = 105, n_CMS3 = 35, p = 0.95778348747516
kfs-mss-msi-inferred-no-cms1: Analyzing LPCAT4 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 815, n_CMS2 = 105, n_CMS3 = 35, p = 8.73582733947328e-07
kfs-mss-msi-inferred-no-cms1: Analyzing SLCO1B3 CMS2 vs CMS3 using Wilcoxon rank sum test with continuity correction: W = 1451, n_CMS2 = 105, n_CMS3 = 35, p = 0.0632334387045019
kfs-mss-msi-inferred-no-cms1: Analyzing Glutathione CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 3284, n_CMS2 = 105, n_CMS4 = 46, p = 0.000445959517730174
kfs-mss-msi-inferred-no-cms1: Analyzing Glutamine CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 3189, n_CMS2 = 105, n_CMS4 = 46, p = 0.00176480155339658
kfs-mss-msi-inferred-no-cms1: Analyzing HK2 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 3813, n_CMS2 = 105, n_CMS4 = 46, p = 1.60464444234451e-08
kfs-mss-msi-inferred-no-cms1: Analyzing LDHA CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 2842, n_CMS2 = 105, n_CMS4 = 46, p = 0.0846526455277705
kfs-mss-msi-inferred-no-cms1: Analyzing MGLL CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 2567, n_CMS2 = 105, n_CMS4 = 46, p = 0.54020531568106
kfs-mss-msi-inferred-no-cms1: Analyzing ANGPTL4 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 1925, n_CMS2 = 105, n_CMS4 = 46, p = 0.0478148952132292
kfs-mss-msi-inferred-no-cms1: Analyzing VEGFA CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 2535, n_CMS2 = 105, n_CMS4 = 46, p = 0.629004095116783
kfs-mss-msi-inferred-no-cms1: Analyzing ACSL5 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 3542, n_CMS2 = 105, n_CMS4 = 46, p = 5.2547655270048e-06
kfs-mss-msi-inferred-no-cms1: Analyzing PCK2 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 3512, n_CMS2 = 105, n_CMS4 = 46, p = 9.29037203537154e-06
kfs-mss-msi-inferred-no-cms1: Analyzing LPCAT4 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 3261, n_CMS2 = 105, n_CMS4 = 46, p = 0.00063015977811823
kfs-mss-msi-inferred-no-cms1: Analyzing SLCO1B3 CMS2 vs CMS4 using Wilcoxon rank sum test with continuity correction: W = 2631, n_CMS2 = 105, n_CMS4 = 46, p = 0.383617941611147


kfs-mss-msi-inferred-no-cms1: Analyzing Glutathione CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 381, n_CMS2 = 35, n_CMS3 = 23, p = 0.740544290596449
kfs-mss-msi-inferred-no-cms1: Analyzing Glutamine CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 240, n_CMS2 = 35, n_CMS3 = 23, p = 0.00924725180592091
kfs-mss-msi-inferred-no-cms1: Analyzing HK2 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 218, n_CMS2 = 35, n_CMS3 = 23, p = 0.00293906650207765
kfs-mss-msi-inferred-no-cms1: Analyzing LDHA CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 329, n_CMS2 = 35, n_CMS3 = 23, p = 0.248100337682949
kfs-mss-msi-inferred-no-cms1: Analyzing MGLL CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 165, n_CMS2 = 35, n_CMS3 = 23, p = 9.43016342677198e-05
kfs-mss-msi-inferred-no-cms1: Analyzing ANGPTL4 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 397, n_CMS2 = 35, n_CMS3 = 23, p = 0.937176825181656
kfs-mss-msi-inferred-no-cms1: Analyzing VEGFA CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 422, n_CMS2 = 35, n_CMS3 = 23, p = 0.764497676750523
kfs-mss-msi-inferred-no-cms1: Analyzing ACSL5 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 367, n_CMS2 = 35, n_CMS3 = 23, p = 0.580822174484317
kfs-mss-msi-inferred-no-cms1: Analyzing PCK2 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 429, n_CMS2 = 35, n_CMS3 = 23, p = 0.681776847949769
kfs-mss-msi-inferred-no-cms1: Analyzing LPCAT4 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 264, n_CMS2 = 35, n_CMS3 = 23, p = 0.0274474892875374
kfs-mss-msi-inferred-no-cms1: Analyzing SLCO1B3 CMS2 vs CMS3 (KRAS MT only) using Wilcoxon rank sum test: W = 310, n_CMS2 = 35, n_CMS3 = 23, p = 0.144619831176267
kfs-mss-msi-inferred-no-cms1: Analyzing Glutathione CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 396, n_CMS2 = 35, n_CMS4 = 18, p = 0.131496116104732
kfs-mss-msi-inferred-no-cms1: Analyzing Glutamine CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 398, n_CMS2 = 35, n_CMS4 = 18, p = 0.122032520330967
kfs-mss-msi-inferred-no-cms1: Analyzing HK2 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 519, n_CMS2 = 35, n_CMS4 = 18, p = 6.26547882289718e-05
kfs-mss-msi-inferred-no-cms1: Analyzing LDHA CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 393, n_CMS2 = 35, n_CMS4 = 18, p = 0.146722427447959
kfs-mss-msi-inferred-no-cms1: Analyzing MGLL CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 363, n_CMS2 = 35, n_CMS4 = 18, p = 0.375848631836723
kfs-mss-msi-inferred-no-cms1: Analyzing ANGPTL4 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 217, n_CMS2 = 35, n_CMS4 = 18, p = 0.0667455248091025
kfs-mss-msi-inferred-no-cms1: Analyzing VEGFA CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 376, n_CMS2 = 35, n_CMS4 = 18, p = 0.258573851662861
kfs-mss-msi-inferred-no-cms1: Analyzing ACSL5 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 527, n_CMS2 = 35, n_CMS4 = 18, p = 2.8726782962859e-05
kfs-mss-msi-inferred-no-cms1: Analyzing PCK2 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 503, n_CMS2 = 35, n_CMS4 = 18, p = 0.000260997409022215
kfs-mss-msi-inferred-no-cms1: Analyzing LPCAT4 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 466, n_CMS2 = 35, n_CMS4 = 18, p = 0.00399986318682572
kfs-mss-msi-inferred-no-cms1: Analyzing SLCO1B3 CMS2 vs CMS4 (KRAS MT only) using Wilcoxon rank sum test: W = 349, n_CMS2 = 35, n_CMS4 = 18, p = 0.532791074333115

kfs-mss-msi-inferred-no-cms1: Analyzing Glutathione CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 962, n_CMS2-MT = 35, n_CMS2-WT = 70, p = 0.0743642010544588
kfs-mss-msi-inferred-no-cms1: Analyzing Glutamine CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1255, n_CMS2-MT = 35, n_CMS2-WT = 70, p = 0.841067069020106
kfs-mss-msi-inferred-no-cms1: Analyzing HK2 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1331, n_CMS2-MT = 35, n_CMS2-WT = 70, p = 0.47328449628024
kfs-mss-msi-inferred-no-cms1: Analyzing LDHA CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1078, n_CMS2-MT = 35, n_CMS2-WT = 70, p = 0.319324876147837
kfs-mss-msi-inferred-no-cms1: Analyzing MGLL CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1588, n_CMS2-MT = 35, n_CMS2-WT = 70, p = 0.0137348367151564
kfs-mss-msi-inferred-no-cms1: Analyzing ANGPTL4 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1182, n_CMS2-MT = 35, n_CMS2-WT = 70, p = 0.772659921469435
kfs-mss-msi-inferred-no-cms1: Analyzing VEGFA CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1107, n_CMS2-MT = 35, n_CMS2-WT = 70, p = 0.424454967944148
kfs-mss-msi-inferred-no-cms1: Analyzing ACSL5 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1108, n_CMS2-MT = 35, n_CMS2-WT = 70, p = 0.428408108829754
kfs-mss-msi-inferred-no-cms1: Analyzing PCK2 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1308, n_CMS2-MT = 35, n_CMS2-WT = 70, p = 0.574933365695626
kfs-mss-msi-inferred-no-cms1: Analyzing LPCAT4 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1529, n_CMS2-MT = 35, n_CMS2-WT = 70, p = 0.0391062578645841
kfs-mss-msi-inferred-no-cms1: Analyzing SLCO1B3 CMS2-MT vs CMS2-WT using Wilcoxon rank sum test with continuity correction: W = 1546, n_CMS2-MT = 35, n_CMS2-WT = 70, p = 0.0293594631551473
kfs-mss-msi-inferred-no-cms1: Analyzing Glutathione CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 381, n_CMS2-MT = 35, n_CMS3-MT = 23, p = 0.740544290596449
kfs-mss-msi-inferred-no-cms1: Analyzing Glutamine CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 240, n_CMS2-MT = 35, n_CMS3-MT = 23, p = 0.00924725180592091
kfs-mss-msi-inferred-no-cms1: Analyzing HK2 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 218, n_CMS2-MT = 35, n_CMS3-MT = 23, p = 0.00293906650207765
kfs-mss-msi-inferred-no-cms1: Analyzing LDHA CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 329, n_CMS2-MT = 35, n_CMS3-MT = 23, p = 0.248100337682949
kfs-mss-msi-inferred-no-cms1: Analyzing MGLL CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 165, n_CMS2-MT = 35, n_CMS3-MT = 23, p = 9.43016342677198e-05
kfs-mss-msi-inferred-no-cms1: Analyzing ANGPTL4 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 397, n_CMS2-MT = 35, n_CMS3-MT = 23, p = 0.937176825181656
kfs-mss-msi-inferred-no-cms1: Analyzing VEGFA CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 422, n_CMS2-MT = 35, n_CMS3-MT = 23, p = 0.764497676750523
kfs-mss-msi-inferred-no-cms1: Analyzing ACSL5 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 367, n_CMS2-MT = 35, n_CMS3-MT = 23, p = 0.580822174484317
kfs-mss-msi-inferred-no-cms1: Analyzing PCK2 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 429, n_CMS2-MT = 35, n_CMS3-MT = 23, p = 0.681776847949769
kfs-mss-msi-inferred-no-cms1: Analyzing LPCAT4 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 264, n_CMS2-MT = 35, n_CMS3-MT = 23, p = 0.0274474892875374
kfs-mss-msi-inferred-no-cms1: Analyzing SLCO1B3 CMS2-MT vs CMS3-MT using Wilcoxon rank sum test: W = 310, n_CMS2-MT = 35, n_CMS3-MT = 23, p = 0.144619831176267
kfs-mss-msi-inferred-no-cms1: Analyzing Glutathione CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 215, n_CMS2-MT = 35, n_CMS3-WT = 12, p = 0.913767670844871
kfs-mss-msi-inferred-no-cms1: Analyzing Glutamine CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 70, n_CMS2-MT = 35, n_CMS3-WT = 12, p = 0.000352786637291605
kfs-mss-msi-inferred-no-cms1: Analyzing HK2 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 73, n_CMS2-MT = 35, n_CMS3-WT = 12, p = 0.000492585492078868
kfs-mss-msi-inferred-no-cms1: Analyzing LDHA CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 279, n_CMS2-MT = 35, n_CMS3-WT = 12, p = 0.0950087767437338
kfs-mss-msi-inferred-no-cms1: Analyzing MGLL CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 78, n_CMS2-MT = 35, n_CMS3-WT = 12, p = 0.000838398077114168
kfs-mss-msi-inferred-no-cms1: Analyzing ANGPTL4 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 222, n_CMS2-MT = 35, n_CMS3-WT = 12, p = 0.781921495473515
kfs-mss-msi-inferred-no-cms1: Analyzing VEGFA CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 366, n_CMS2-MT = 35, n_CMS3-WT = 12, p = 4.79607811309434e-05
kfs-mss-msi-inferred-no-cms1: Analyzing ACSL5 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 220, n_CMS2-MT = 35, n_CMS3-WT = 12, p = 0.819141915296245
kfs-mss-msi-inferred-no-cms1: Analyzing PCK2 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 219, n_CMS2-MT = 35, n_CMS3-WT = 12, p = 0.837907432737511
kfs-mss-msi-inferred-no-cms1: Analyzing LPCAT4 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 87, n_CMS2-MT = 35, n_CMS3-WT = 12, p = 0.00203422159538074
kfs-mss-msi-inferred-no-cms1: Analyzing SLCO1B3 CMS2-MT vs CMS3-WT using Wilcoxon rank sum test: W = 280, n_CMS2-MT = 35, n_CMS3-WT = 12, p = 0.0901535284658277
kfs-mss-msi-inferred-no-cms1: Analyzing Glutathione CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 396, n_CMS2-MT = 35, n_CMS4-MT = 18, p = 0.131496116104732
kfs-mss-msi-inferred-no-cms1: Analyzing Glutamine CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 398, n_CMS2-MT = 35, n_CMS4-MT = 18, p = 0.122032520330967
kfs-mss-msi-inferred-no-cms1: Analyzing HK2 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 519, n_CMS2-MT = 35, n_CMS4-MT = 18, p = 6.26547882289718e-05
kfs-mss-msi-inferred-no-cms1: Analyzing LDHA CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 393, n_CMS2-MT = 35, n_CMS4-MT = 18, p = 0.146722427447959
kfs-mss-msi-inferred-no-cms1: Analyzing MGLL CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 363, n_CMS2-MT = 35, n_CMS4-MT = 18, p = 0.375848631836723
kfs-mss-msi-inferred-no-cms1: Analyzing ANGPTL4 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 217, n_CMS2-MT = 35, n_CMS4-MT = 18, p = 0.0667455248091025
kfs-mss-msi-inferred-no-cms1: Analyzing VEGFA CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 376, n_CMS2-MT = 35, n_CMS4-MT = 18, p = 0.258573851662861
kfs-mss-msi-inferred-no-cms1: Analyzing ACSL5 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 527, n_CMS2-MT = 35, n_CMS4-MT = 18, p = 2.8726782962859e-05
kfs-mss-msi-inferred-no-cms1: Analyzing PCK2 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 503, n_CMS2-MT = 35, n_CMS4-MT = 18, p = 0.000260997409022215
kfs-mss-msi-inferred-no-cms1: Analyzing LPCAT4 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 466, n_CMS2-MT = 35, n_CMS4-MT = 18, p = 0.00399986318682572
kfs-mss-msi-inferred-no-cms1: Analyzing SLCO1B3 CMS2-MT vs CMS4-MT using Wilcoxon rank sum test: W = 349, n_CMS2-MT = 35, n_CMS4-MT = 18, p = 0.532791074333115
kfs-mss-msi-inferred-no-cms1: Analyzing Glutathione CMS2-MT vs CMS4-WT using Wilcoxon rank sum test: W = 592, n_CMS2-MT = 35, n_CMS4-WT = 28, p = 0.161403013127004
kfs-mss-msi-inferred-no-cms1: Analyzing Glutamine CMS2-MT vs CMS4-WT using Wilcoxon rank sum test: W = 680, n_CMS2-MT = 35, n_CMS4-WT = 28, p = 0.00810667840224847
kfs-mss-msi-inferred-no-cms1: Analyzing HK2 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test: W = 800, n_CMS2-MT = 35, n_CMS4-WT = 28, p = 7.61968527440494e-06
kfs-mss-msi-inferred-no-cms1: Analyzing LDHA CMS2-MT vs CMS4-WT using Wilcoxon rank sum test: W = 496, n_CMS2-MT = 35, n_CMS4-WT = 28, p = 0.939800365018603
kfs-mss-msi-inferred-no-cms1: Analyzing MGLL CMS2-MT vs CMS4-WT using Wilcoxon rank sum test: W = 666, n_CMS2-MT = 35, n_CMS4-WT = 28, p = 0.0144596775242176
kfs-mss-msi-inferred-no-cms1: Analyzing ANGPTL4 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test: W = 402, n_CMS2-MT = 35, n_CMS4-WT = 28, p = 0.227927757770275
kfs-mss-msi-inferred-no-cms1: Analyzing VEGFA CMS2-MT vs CMS4-WT using Wilcoxon rank sum test: W = 416, n_CMS2-MT = 35, n_CMS4-WT = 28, p = 0.311664506336784
kfs-mss-msi-inferred-no-cms1: Analyzing ACSL5 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test: W = 616, n_CMS2-MT = 35, n_CMS4-WT = 28, p = 0.0825666460830805
kfs-mss-msi-inferred-no-cms1: Analyzing PCK2 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test: W = 700, n_CMS2-MT = 35, n_CMS4-WT = 28, p = 0.00329077608461202
kfs-mss-msi-inferred-no-cms1: Analyzing LPCAT4 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test: W = 721, n_CMS2-MT = 35, n_CMS4-WT = 28, p = 0.00115466663636308
kfs-mss-msi-inferred-no-cms1: Analyzing SLCO1B3 CMS2-MT vs CMS4-WT using Wilcoxon rank sum test: W = 673, n_CMS2-MT = 35, n_CMS4-WT = 28, p = 0.0108837676525383

Computing linear model with interaction for Glutathione
Computing linear model with interaction for Glutamine
Computing linear model with interaction for HK2
Computing linear model with interaction for LDHA
Computing linear model with interaction for MGLL
Computing linear model with interaction for ANGPTL4
Computing linear model with interaction for VEGFA
Computing linear model with interaction for ACSL5
Computing linear model with interaction for PCK2
Computing linear model with interaction for LPCAT4
Computing linear model with interaction for SLCO1B3
Computing linear model for Glutathione
Computing linear model for Glutamine
Computing linear model for HK2
Computing linear model for LDHA
Computing linear model for MGLL
Computing linear model for ANGPTL4
Computing linear model for VEGFA
Computing linear model for ACSL5
Computing linear model for PCK2
Computing linear model for LPCAT4
Computing linear model for SLCO1B3
kfs-mss-msi-inferred-no-cms1: Analyzing Glutathione CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1488, n_MT = 35, n_WT = 70, p = 0.0743642010544588
kfs-mss-msi-inferred-no-cms1: Analyzing Glutamine CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1195, n_MT = 35, n_WT = 70, p = 0.841067069020106
kfs-mss-msi-inferred-no-cms1: Analyzing HK2 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1119, n_MT = 35, n_WT = 70, p = 0.47328449628024
kfs-mss-msi-inferred-no-cms1: Analyzing LDHA CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1372, n_MT = 35, n_WT = 70, p = 0.319324876147837
kfs-mss-msi-inferred-no-cms1: Analyzing MGLL CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 862, n_MT = 35, n_WT = 70, p = 0.0137348367151564
kfs-mss-msi-inferred-no-cms1: Analyzing ANGPTL4 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1268, n_MT = 35, n_WT = 70, p = 0.772659921469435
kfs-mss-msi-inferred-no-cms1: Analyzing VEGFA CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1343, n_MT = 35, n_WT = 70, p = 0.424454967944148
kfs-mss-msi-inferred-no-cms1: Analyzing ACSL5 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1342, n_MT = 35, n_WT = 70, p = 0.428408108829754
kfs-mss-msi-inferred-no-cms1: Analyzing PCK2 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 1142, n_MT = 35, n_WT = 70, p = 0.574933365695626
kfs-mss-msi-inferred-no-cms1: Analyzing LPCAT4 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 921, n_MT = 35, n_WT = 70, p = 0.0391062578645841
kfs-mss-msi-inferred-no-cms1: Analyzing SLCO1B3 CMS2 MT vs WT using Wilcoxon rank sum test with continuity correction: W = 904, n_MT = 35, n_WT = 70, p = 0.0293594631551473
kfs-mss-msi-inferred-no-cms1: Analyzing Glutathione CMS4 MT vs WT using Wilcoxon rank sum test: W = 267, n_MT = 18, n_WT = 28, p = 0.746666370478317
kfs-mss-msi-inferred-no-cms1: Analyzing Glutamine CMS4 MT vs WT using Wilcoxon rank sum test: W = 227, n_MT = 18, n_WT = 28, p = 0.584933461682059
kfs-mss-msi-inferred-no-cms1: Analyzing HK2 CMS4 MT vs WT using Wilcoxon rank sum test: W = 266, n_MT = 18, n_WT = 28, p = 0.763608919724639
kfs-mss-msi-inferred-no-cms1: Analyzing LDHA CMS4 MT vs WT using Wilcoxon rank sum test: W = 290, n_MT = 18, n_WT = 28, p = 0.402486978403759
kfs-mss-msi-inferred-no-cms1: Analyzing MGLL CMS4 MT vs WT using Wilcoxon rank sum test: W = 207, n_MT = 18, n_WT = 28, p = 0.319995074089879
kfs-mss-msi-inferred-no-cms1: Analyzing ANGPTL4 CMS4 MT vs WT using Wilcoxon rank sum test: W = 224, n_MT = 18, n_WT = 28, p = 0.539717630373301
kfs-mss-msi-inferred-no-cms1: Analyzing VEGFA CMS4 MT vs WT using Wilcoxon rank sum test: W = 333, n_MT = 18, n_WT = 28, p = 0.0697186953743824
kfs-mss-msi-inferred-no-cms1: Analyzing ACSL5 CMS4 MT vs WT using Wilcoxon rank sum test: W = 362, n_MT = 18, n_WT = 28, p = 0.0126484176295089
kfs-mss-msi-inferred-no-cms1: Analyzing PCK2 CMS4 MT vs WT using Wilcoxon rank sum test: W = 310, n_MT = 18, n_WT = 28, p = 0.197737271253414
kfs-mss-msi-inferred-no-cms1: Analyzing LPCAT4 CMS4 MT vs WT using Wilcoxon rank sum test: W = 244, n_MT = 18, n_WT = 28, p = 0.867335311058131
kfs-mss-msi-inferred-no-cms1: Analyzing SLCO1B3 CMS4 MT vs WT using Wilcoxon rank sum test: W = 197, n_MT = 18, n_WT = 28, p = 0.222431088056855
kfs-mss-msi-inferred-no-cms1: Analyzing Glutathione CMS3 MT vs WT using Wilcoxon rank sum test: W = 128, n_MT = 23, n_WT = 12, p = 0.744883309017969
kfs-mss-msi-inferred-no-cms1: Analyzing Glutamine CMS3 MT vs WT using Wilcoxon rank sum test: W = 190, n_MT = 23, n_WT = 12, p = 0.0731835991006311
kfs-mss-msi-inferred-no-cms1: Analyzing HK2 CMS3 MT vs WT using Wilcoxon rank sum test: W = 178, n_MT = 23, n_WT = 12, p = 0.172304250527113
kfs-mss-msi-inferred-no-cms1: Analyzing LDHA CMS3 MT vs WT using Wilcoxon rank sum test: W = 78, n_MT = 23, n_WT = 12, p = 0.0373380247966389
kfs-mss-msi-inferred-no-cms1: Analyzing MGLL CMS3 MT vs WT using Wilcoxon rank sum test: W = 148, n_MT = 23, n_WT = 12, p = 0.744883309017969
kfs-mss-msi-inferred-no-cms1: Analyzing ANGPTL4 CMS3 MT vs WT using Wilcoxon rank sum test: W = 135, n_MT = 23, n_WT = 12, p = 0.93179350083492
kfs-mss-msi-inferred-no-cms1: Analyzing VEGFA CMS3 MT vs WT using Wilcoxon rank sum test: W = 51, n_MT = 23, n_WT = 12, p = 0.00183421499000901
kfs-mss-msi-inferred-no-cms1: Analyzing ACSL5 CMS3 MT vs WT using Wilcoxon rank sum test: W = 114, n_MT = 23, n_WT = 12, p = 0.419612744558763
kfs-mss-msi-inferred-no-cms1: Analyzing PCK2 CMS3 MT vs WT using Wilcoxon rank sum test: W = 146, n_MT = 23, n_WT = 12, p = 0.79730301738219
kfs-mss-msi-inferred-no-cms1: Analyzing LPCAT4 CMS3 MT vs WT using Wilcoxon rank sum test: W = 190, n_MT = 23, n_WT = 12, p = 0.0731835991006311
kfs-mss-msi-inferred-no-cms1: Analyzing SLCO1B3 CMS3 MT vs WT using Wilcoxon rank sum test: W = 55, n_MT = 23, n_WT = 12, p = 0.00311928382202543

Computing linear model for Glutathione
Computing linear model for Glutamine
Computing linear model for HK2
Computing linear model for LDHA
Computing linear model for MGLL
Computing linear model for ANGPTL4
Computing linear model for VEGFA
Computing linear model for ACSL5
Computing linear model for PCK2
Computing linear model for LPCAT4
Computing linear model for SLCO1B3
Computing rectum vs left
kfs-mss-msi-inferred-no-cms1: Analyzing Glutathione site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 1486, n_rectum = 154, n_left = 20, p = 0.800704646322679
kfs-mss-msi-inferred-no-cms1: Analyzing Glutamine site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 1250, n_rectum = 154, n_left = 20, p = 0.171944779061778
kfs-mss-msi-inferred-no-cms1: Analyzing HK2 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 1233, n_rectum = 154, n_left = 20, p = 0.148122643103566
kfs-mss-msi-inferred-no-cms1: Analyzing LDHA site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 1288, n_rectum = 154, n_left = 20, p = 0.235353212500865
kfs-mss-msi-inferred-no-cms1: Analyzing MGLL site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 1331, n_rectum = 154, n_left = 20, p = 0.325218893038121
kfs-mss-msi-inferred-no-cms1: Analyzing ANGPTL4 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 1889, n_rectum = 154, n_left = 20, p = 0.100100206059295
kfs-mss-msi-inferred-no-cms1: Analyzing VEGFA site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 1637, n_rectum = 154, n_left = 20, p = 0.648873891526671
kfs-mss-msi-inferred-no-cms1: Analyzing ACSL5 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 1339, n_rectum = 154, n_left = 20, p = 0.344126942588293
kfs-mss-msi-inferred-no-cms1: Analyzing PCK2 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 1327, n_rectum = 154, n_left = 20, p = 0.316023280698243
kfs-mss-msi-inferred-no-cms1: Analyzing LPCAT4 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 1255, n_rectum = 154, n_left = 20, p = 0.179469772841591
kfs-mss-msi-inferred-no-cms1: Analyzing SLCO1B3 site: rectum vs leftWilcoxon rank sum test with continuity correction: W = 1304, n_rectum = 154, n_left = 20, p = 0.266487865710523
Computing right vs left
kfs-mss-msi-inferred-no-cms1: Analyzing Glutathione site: right vs leftWilcoxon rank sum test: W = 343, n_right = 37, n_left = 20, p = 0.660392446684672
kfs-mss-msi-inferred-no-cms1: Analyzing Glutamine site: right vs leftWilcoxon rank sum test: W = 284, n_right = 37, n_left = 20, p = 0.154028799489384
kfs-mss-msi-inferred-no-cms1: Analyzing HK2 site: right vs leftWilcoxon rank sum test: W = 302, n_right = 37, n_left = 20, p = 0.261549298930191
kfs-mss-msi-inferred-no-cms1: Analyzing LDHA site: right vs leftWilcoxon rank sum test: W = 392, n_right = 37, n_left = 20, p = 0.721540314356472
kfs-mss-msi-inferred-no-cms1: Analyzing MGLL site: right vs leftWilcoxon rank sum test: W = 299, n_right = 37, n_left = 20, p = 0.240778325428713
kfs-mss-msi-inferred-no-cms1: Analyzing ANGPTL4 site: right vs leftWilcoxon rank sum test: W = 427, n_right = 37, n_left = 20, p = 0.347883477402904
kfs-mss-msi-inferred-no-cms1: Analyzing VEGFA site: right vs leftWilcoxon rank sum test: W = 443, n_right = 37, n_left = 20, p = 0.227581803838232
kfs-mss-msi-inferred-no-cms1: Analyzing ACSL5 site: right vs leftWilcoxon rank sum test: W = 385, n_right = 37, n_left = 20, p = 0.810086988302456
kfs-mss-msi-inferred-no-cms1: Analyzing PCK2 site: right vs leftWilcoxon rank sum test: W = 330, n_right = 37, n_left = 20, p = 0.512226610460892
kfs-mss-msi-inferred-no-cms1: Analyzing LPCAT4 site: right vs leftWilcoxon rank sum test: W = 365, n_right = 37, n_left = 20, p = 0.940557995531836
kfs-mss-msi-inferred-no-cms1: Analyzing SLCO1B3 site: right vs leftWilcoxon rank sum test: W = 278, n_right = 37, n_left = 20, p = 0.126796167595295

Plotting Glutathione ~ site
Plotting Glutamine ~ site
Plotting HK2 ~ site
Plotting LDHA ~ site
Plotting MGLL ~ site
Plotting ANGPTL4 ~ site
Plotting VEGFA ~ site
Plotting ACSL5 ~ site
Plotting PCK2 ~ site
Plotting LPCAT4 ~ site
Plotting SLCO1B3 ~ site
There were 50 or more warnings (use warnings() to see the first 50)
Reading CIRC signature again
R version 3.3.1 (2016-06-21)
Platform: x86_64-apple-darwin13.4.0 (64-bit)
Running under: OS X 10.11.6 (El Capitan)

locale:
[1] C

attached base packages:
 [1] grid      parallel  stats4    methods   stats     graphics  grDevices
 [8] utils     datasets  base     

other attached packages:
 [1] ggdendro_0.1-20      biomaRt_2.28.0       gplots_3.0.1        
 [4] glmnet_2.0-5         foreach_1.4.3        GSA_1.03            
 [7] forestmodel_0.4.1    gridExtra_2.2.1      ggbeeswarm_0.5.3    
[10] BayesFactor_0.9.12-2 Matrix_1.2-7.1       coda_0.19-1         
[13] caret_6.0-73         lattice_0.20-34      maxstat_0.7-24      
[16] data.table_1.10.0    corrplot_0.77        gtable_0.2.0        
[19] ggplot2_2.2.1        hgu133plus2.db_3.2.3 org.Hs.eg.db_3.3.0  
[22] GSVA_1.20.0          synapseClient_1.13-4 annotate_1.50.1     
[25] XML_3.98-1.5         AnnotationDbi_1.34.4 IRanges_2.6.1       
[28] S4Vectors_0.10.3     Biobase_2.32.0       BiocGenerics_0.18.0 

loaded via a namespace (and not attached):
 [1] tidyr_0.6.1           splines_3.3.1         gtools_3.5.0         
 [4] assertthat_0.1        vipor_0.4.4           RSQLite_1.1-2        
 [7] quantreg_5.29         digest_0.6.11         minqa_1.2.4          
[10] colorspace_1.3-2      psych_1.6.12          plyr_1.8.4           
[13] GSEABase_1.34.1       broom_0.4.1           SparseM_1.74         
[16] xtable_1.8-2          mvtnorm_1.0-5         scales_0.4.1         
[19] gdata_2.17.0          lme4_1.1-12           MatrixModels_0.4-1   
[22] tibble_1.2            mgcv_1.8-16           car_2.1-4            
[25] pbapply_1.3-1         nnet_7.3-12           lazyeval_0.2.0       
[28] mnormt_1.5-5          pbkrtest_0.4-6        magrittr_1.5         
[31] memoise_1.0.0         nlme_3.1-128          MASS_7.3-45          
[34] foreign_0.8-67        beeswarm_0.2.3        graph_1.50.0         
[37] tools_3.3.1           stringr_1.1.0         munsell_0.4.3        
[40] caTools_1.17.1        RCurl_1.95-4.8        nloptr_1.0.4         
[43] iterators_1.0.8       rjson_0.2.15          bitops_1.0-6         
[46] labeling_0.3          ModelMetrics_1.1.0    codetools_0.2-15     
[49] DBI_0.5-1             reshape2_1.4.2        R6_2.2.0             
[52] dplyr_0.5.0           exactRankTests_0.8-28 KernSmooth_2.23-15   
[55] stringi_1.1.2         Rcpp_0.12.9          
Error: could not find function ".off"
Execution halted
